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This thesis examines the evidence for positive and balancing selection on immune genes
in 388 individuals grouped into thirteen geographically diverse populations. The data are
high coverage whole genome sequences, many from populations that have been sparsely
represented in global genetic diversity studies in the past.
Two main analyses were performed for both positive and balancing selection: enrichment
tests for each population and class of immune genes, and filtering for top variants or genes
driving selection signals. Four different measures of positive selection and three measures
of balancing selection were used to scan the whole genome data for evidence of selection.
Further filters, including functional importance predictors, were used to filter results for
potential driver variants.
Positive selection results show significant enrichment for genes associated with bacteria
or virus interaction, the innate immune system, and antigen processing and presentation.
Results also include variants potentially driving signals of selection. One of these is a
missense variant in the Northeast Siberian population in the gene IL27, which is involved in
modulation of immune response to infection.
Balancing selection enrichment tests show that genes associated with T cell function
and antigen processing and presentation are significantly enriched in every population. The
HLA region features heavily in these enrichments. One top gene result is GNLY, a gene that
produces the antimicrobial protein granulysin, in the West Siberian and Island Southeast
Asian populations. Another is PGLYRP4, which is a top gene in seven populations and is
involved in recognition and defense against Gram-negative and -positive bacteria.
In conclusion, as a general trend there is more enrichment in genes that interact with
bacteria and viruses in the positive selection results, and more enrichment in genes involved
with antigen processing and presentation and T cell function in the balancing selection
results. The combined results show the different immune-driven selection histories of each
population, as well as highlight a number of variants and genes that are potential drivers of
selection and promising candidates for further study.
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1.1 Introduction to the human evolutionary landscape
Fossil evidence suggests that modern humans emerged as a species not from a single
place on the African continent, but rather from multiple groups of early modern humans over
300,000 years ago (Gunz et al., 2009; Hublin et al., 2017). The oldest fossil specimens of
modern humans have been found in Africa, and predate other modern human fossil remains
in other parts of the world by at least 50,000 years (review by Nielsen et al. (2017)). Further
supporting Africa as the original location in which modern humans arose as a species, modern
African populations have the highest overall levels of genetic heterozygosity of any human
population (Tishkoff and Kidd, 2004) (review by Nielsen et al. (2017)). This supports the
idea of genetic bottlenecks as people migrated out of Africa, reflected by lower levels of
genetic heterozygosity in the rest of the world compared to Africa. African populations also
show, compared to populations from other parts of the world, the lowest levels of linkage
disequilibrium (LD) and the highest effective population sizes (Tishkoff and Kidd, 2004).
These factors all point to a recent African origin for all currently living human populations.
At some point, some humans began to move out of Africa and into the rest of the world.
The main out of Africa migration took place around 100,000 years ago, though the exact
timing continues to be under debate (Fan et al., 2016)(review by Nielsen et al. (2017). Based
on the dataset used in this very thesis, it has been suggested that there was a smaller, initial
out of Africa wave that left almost no genetic trace except for in parts of Island Southeast
Asia (Pagani et al., 2016). The migration routes followed by expanding populations are also
under continuing debate. Genetically, this initial migration out of Africa and the following
expansion left its trace in the human genome in the form of a bottleneck and drop in effective
population size and genetic diversity in all non-African populations, as well as genetic drift
between African and non-African populations (Tishkoff and Kidd, 2004).
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Further genetic differences accumulated between groups as populations adapted to their
new environments. As humans spread out into new geographic regions, they encountered
vastly different environments to those in which the species had evolved and had to adapt to
them in order to survive. These new environmental factors include sun exposure, altitude,
temperature, different types of food available, and new pathogens. Accordingly, adaptations
in genes associated with temperature regulation, skin pigmentation, hemoglobin levels, innate
immune response, fatty acid metabolism, height, and lactose tolerance are just some examples
of ways in which humans have adapted to their new environments (Fan et al., 2016)(review
by Nielsen et al. (2017)). Some of these adaptations are represented in Figure 1.1.
Fig. 1.1 A small subset of local human adaptations to the environment, from Fan et al. (2016).
In some cases, modern humans adapted to their new environments with some help from
other hominins through interbreeding. Neanderthals and Denisovans are archaic hominins
who split from the lineage that would become modern humans. Based on a recently-analyzed
high coverage Neanderthal genome from Vindija Cave in Croatia, Neanderthals likely split
with modern humans between 520 and 630 thousand years ago, and with Denisovans between
390 and 440 thousand years ago (Prüfer et al., 2017). Based on fossil evidence, Neanderthals
were living in western Eurasia up to around 40,000 years ago (Higham et al., 2014), and
Denisovans were living in the Altai mountains of Siberia between 30,000 and 50,000 years
1.1 Introduction to the human evolutionary landscape 3
ago, and were also likely present in other parts of East Asia (Reich et al., 2010). Since these
archaic hominins were already living in these regions when modern humans encountered
them, when interbreeding occurred, modern humans were able to benefit from some of the
beneficial adaptations to the environment Neanderthals and Denisovans had accumulated.
Introgression analysis has found that Denisovans likely contributed between between
3 and 6% of modern-day Melanesian, Papuan, and Australian genomes, as well as smaller
amounts to other East Asian genomes (see review by Racimo et al. (2015)). Similarly, all
non-African populations contain a Neanderthal contribution of between around 1 and 3%
(Prüfer et al., 2017). When we look at the patterns of which genes appear to be introgressed
from archaic hominins, it appears that retention of archaic hominin genes has not been
uniform across the genome. This suggests that beneficial regions have been positively
selected to stay in the genome and deleterious regions have been selected out of the genome.
Alleles contributed by Denisovans are found in genes associated with the HLA region, innate
immune response, and altitude adaptation. Alleles contributed by Neanderthals are also
associated with HLA regions, innate immune response, autoiummune disease, pigmentation,
skin and hair morphology, and metabolism (see review by Racimo et al. (2015)). Regions of
the modern human genome related to reproduction (specifically, genes on the X chromosome
and genes only highly expressed in the testes) are significantly lacking in Neanderthal alleles,
suggesting that Neanderthal alleles had a deleterious effect on human fertility and were
selected against (Sankararaman et al., 2014). This evidence shows that not only did humans
adapt to their new environments with contributions from archaic hominins, but that the past
population history of interbreeding and introgression was a complex one.
Moving into new regions and encountering new environmental challenges is one scenario
that introduces genetic adaptations. Another is cultural transition. With the adoption of
agricultural and pastoralist lifestyles, some populations experienced changes in diet and new
immune challenges due to larger population sizes. One major group of adaptations hypothe-
sized to come from this cultural transition is dietary adaptations. For example, variants that
cause lactase persistence in European and African populations correspond in age to times at
which pastoralism and animal domestication spread into those populations (Tishkoff et al.,
2006). There are several hypotheses as to why lactase persistence is advantageous. Milk is
a source of calories, especially in times of famine (Gerbault et al., 2011). It has also been
proposed that lactase persistence offers the benefit of better calcium absorption in places
with little sunlight and/or insufficient vitamin D (Flatz and Rotthauwe, 1973). In addition, it
has been suggested that the copy number of the amylase gene AMY1 has been under positive
selection in populations with high starch diets (Perry et al., 2007). Since high starch diets are
associated with agricultural societies, it has been suggested that this selection is associated
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with the transition to agriculture during the Neolithic transition (McClure, 2015; Perry et al.,
2007). It has also been proposed that positive selection on an allele in the HFE gene that
causes potentially pathogenic increased absorption of iron occurred due to increased levels
of anemia caused by agriculturalist reliance on starch and dairy associated with the Neolithic
transition (McCullough et al., 2015).
Another major group of adaptations to the Neolithic transition are those related to immune
function. Those will be addressed in greater detail in Section 1.2.
1.2 Infectious disease as a driver of human adaptation
Infectious disease is widely considered to be one of the most important drivers of human
evolution (Fumagalli et al., 2011)(review by Nielsen et al. (2017)). Genetic adaptations that
allow individuals or populations to survive and pass on their genes to the next generation
are preferentially retained in the genome, and the stronger the selective pressure, the more
severe the selection event. Few selective pressures have exerted such powerful pressure as
infectious disease. According to one estimate, infectious disease has been responsible for
more deaths than all natural disasters, wars, and noninfectious diseases combined throughout
human history (Inhorn and Brown, 1990). Before the discovery of vaccines and antibiotics,
around half of all children were killed by infectious disease before the age of 15 (Siddle and
Quintana-Murci, 2014), and from the Paleolithic to the Industrial Revolution, the average life
expectancy was only 25 years (Casanova and Abel, 2005). Looking specifically at the two
populations from the U.K., Figure 1.2 shows the stark difference between life expectancy
before and after modern antibiotics, vaccines, and sanitation practices (Casanova and Abel,
2005). Because of its high death toll over thousands of years, and the continual evolution
of pathogenic microorganisms, infectious disease has the potential to be one of the most
important drivers of natural selection in human history. Indeed, many studies have found
immune-related genes to be among top targets of selection in human populations (see Sections
3.1 and 4.1). These are examples of human populations adapting to pathogen pressure over
time, and evolving to be better suited to their environment.
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Fig. 1.2 Human life expectancy of different populations at different times during history, from
Casanova and Abel (2005).
Rook’s breakdown of human history into three major epidemiological phases provides a
useful way to look at different pathogen environments humans would have been exposed to
at different times in history, and shows the backdrop against which adaptation would have
taken place. These three major groups of lifestyles, with corresponding sets of pathogens, are
Paleolithic, Neolithic to pre-industrial (19th century), and modern day. These are presented
in Figure 1.3.
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Fig. 1.3 Pathogen landscapes from different phases of human history, modified from Rook (2011).
Before the Neolithic transition, humans lived at low population density and carried
diseases that were adapted to those demographic conditions. Specifically, they were adapted
to live in the host for long periods of time and not be especially pathogenic, so that they
could be transmitted over many years, often involving periods of latency and activation.
Pathogens causing high mortality rates were selected against, since they were not able to
be passed into large populations and eventually died out with the host populations (Blaser
and Kirschner, 2007; Comas et al., 2013). It has been considered likely that various types of
parasites probably infected paleolithic humans (McNeill, 1976), and that species of bacteria
carried by humans during that time are likely to be those that were also encountered by early
hominins in hunter-gatherer groups, as well as those that are encountered in modern hunter-
gatherer groups. These include salmonella, typhi, and staphylococci bacteria (see review by
Armelagos et al. (2005)), as well as tuberculosis (Comas et al., 2013; Rook, 2011). Similarly,
it has been considered likely that paleolithic humans carried similar viruses to those carried
by our hominin ancestors and primate relatives. In general, these viruses were able to thrive
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in low density populations, because they often cause non-acute, chronic infections. Sporadic
bursts of zoonotic disease are thought to have occurred from time to time throughout all of
human evolution, as hominins interacted with wildlife around them, such as birds, insects,
bats, and other primates (Van Blerkom, 2003). Arboviruses also likely infected humans
from time to time due to contact with disease-carrying mosquitoes (McNeill, 1976). Some
authors emphasize the importance of interactions between African great apes and ancestral
hominin groups in Africa, as well as interactions between humans and Neanderthals and
Denisovans outside of Africa, for the transmission of diseases such as various Papilloma-
and Herpesviruses (see review by Pimenoff et al. (2018)).
During the Neolithic transition, population density grew as farming technology allowed
for larger population sizes. Humans came into prolonged contact with domesticated animals
and their associated pathogens, which led to zoonotic disease. According to the views of
some authors, these conditions led to selection for pathogens that thrived in high population
densities and spread much more quickly and caused more host damage (Blaser and Kirschner,
2007; Comas et al., 2013). Habitat area of the mosquito Anopheles gambiae is thought to have
increased with clearing of forests for agricultural reasons, leading it to grow to rely on human
blood as its principal source of food and a subsequent increase in the incidence of malaria and
other mosquito-borne diseases (McNeill, 1976). More prevalent bacterial infections included
cholera from contaminated water, typhus from lice, and plague from fleas (Armelagos et al.,
2005). Fast-evolving RNA viruses became endemic in human populations from contact
with livestock and domesticated animals, and the rodents that are associated with storage of
farming surplus. Such viruses are also more likely to jump between species. These viruses
include calici- and rotaviruses, which cause diarrhea, coronaviruses, which cause colds, and
para- and orthomyxoviruses that cause the flu and other respiratory diseases (Van Blerkom,
2003). Sumeria has been suggested as the oldest city population large enough to host measles
and other childhood diseases characteristic of the Neolithic transition. Thus, some earlier
authors have considered 3000 BCE as the earliest date for "diseases of civilization" (McNeill,
1976).
A table illustrating the different types of infection and the periods of human history
associated with them can be seen in Figure 1.4.
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Fig. 1.4 Bacterial and viral persistence dynamics, from Blaser and Kirschner (2007).
The distribution of different pathogens through different ecological landscapes plays a
key role in determining which populations contend with and adapt to specific pathogens.
Pathogen richness has been shown to be associated with latitude, with higher levels of
richness at lower levels of latitude (Cashdan, 2014; Guernier et al., 2004). A plot of number
of pathogens vs. latitude can be seen in Figure 1.5. Cashdan (2014) suggest that outside of
the tropics, pathogen species richness is especially affected by temperature and the presence
or absence of frost. Conversely, she suggests that in the tropics, it is mostly affected by
the amount of precipitation in a year. Mosquito-borne infections, for example, are highly
associated with annual rainfall. High levels of dryness on a seasonal basis is also associated
with increased levels of typhus, schistosomiasis, and leishmaniasis, potentially due to host
and vector behavior (Cashdan, 2014). Because selection signals that are likely to be detected
in this thesis are most probably thousands or tens of thousands of years old, it would require
some climate reconstruction to hypothesize which regions experienced frost or extreme
seasonal dryness at a given point in history. However, latitude remains constant, and the
association of pathogen richness with latitude has likely remained strong throughout human
history. Therefore, it will be interesting to see whether populations at lower latitudes exhibit
more signals of selection in immune-related genes than populations at higher latitudes.
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Fig. 1.5 Correlation between latitude and pathogen density, from Cashdan (2014).
Since pathogen diversity varies geographically, it follows that different populations adapt
over time in response to local infectious diseases. Such adaptations, and the corresponding
lack of adaptations to unfamiliar diseases in unexposed populations, have shaped not only
the genetic landscape of the local population but human history as well with devastating
consequences. This disease pressure came most catastrophically through outbreaks of
"diseases of civilization", such as the bubonic plague, measles, smallpox, influenza, typhoid,
and dysentery (McNeill, 1976) (see also review by Archer (2016)).
Human diseases can be most severe in previously unexposed human populations soon
after exposure (review by Riley (2010)). For example, Europe and the Middle East were
affected especially devastatingly by the plague in the 14th century, as was the Roman empire
by its exposure to smallpox in the second century (review by Archer (2016)). However, over
time these populations acquired some population immunity to such diseases. By around
the year 1200, most of the Old World had been exposed to the various diseases listed above
through overland and sea trade between Europe, the Middle East, China, and India and
had adapted to them enough to be experiencing steady population increase (McNeill, 1976).
When Old World populations came into contact with populations in which these diseases
were not endemic, this mismatch in immunity often led to devastating population loss in the
unexposed population.
One of the most illustrative examples of the drastic consequences of this differential
immunity is the contribution of disease, carried by European colonists, to the decimation of
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Native American populations. Using smallpox as an example of one of these diseases, the
most important factor thought especially to have led to such catastrophically high mortality
rates in Native Americans as compared to those of European colonists was the complete lack
of immunity from prior exposure to any Poxvirus that could grant immunity to smallpox
virus. In Europe, where smallpox was endemic and regular outbreaks occurred, a portion of
the population at any time would have lived through a prior infection and be protected by
acquired immunity. However, in the Americas, where it was not endemic, sporadic infections
had much higher mortality rates because likely none of the population had been previously
exposed (review by Riley (2010)). While there is debate as to exactly which diseases were
introduced, and the precise scale of population decline, it is widely accepted that Native
American populations were severely affected by post-contact infectious disease introduced
by European colonists (Ramenofsky, 2003). One paper by Lindo et al. estimates a 57%
reduction in effective population size between a pre-contact Pacific Northwest population
and a related modern population of Tsimshian individuals. This same study finds evidence
of positive selection on the immune gene HLA-DQA1 pre-contact and negative selection on
the same gene post-contact, again suggesting adaptation to a changed disease environment
(Lindo et al., 2016).
Widespread mortality of indigenous peoples (and in some cases, replacement with
immunologically advantaged European populations) when met with epidemic disease took
place not only in the Americas, but also in parts of Siberia, Africa, the Pacific Islands, and
Australia (McNeill, 1976), and thus has likely left a significant genetic signature in the
genomes of surviving descendants. Interestingly, several of the above populations belong to
the group of populations included in this thesis that have not often been included in previous
genetic analyses. Since infectious disease has been such an important driver of adaptation in
different human populations, it is likely that such adaptations will be visible in the genome.
Though tempting, it is often difficult, if not impossible, to predict which specific disease
was responsible for a historical epidemic or signature of selection based on historical record.
It is difficult to match descriptions of a past epidemic to a certain disease for several reasons.
Historical medical terminology is different from modern medical terminology, and symptoms
from a disease well established in its host population are different from symptoms of that
same disease in the process of adapting to a previously unexposed population (McNeill,
1976). Because specific resistance to particular pathogens is acquired during the lifetime
of an individual and not passed to the next generation through the germline, protective
adaptations against infectious disease are most likely to be found in the first two layers of
defense of the immune system: physical barriers and the innate immune system. Both of
these two categories of defense rely on recognizing general attributes of infectious agents.
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Because of this, it may be possible to ascertain the overall category of pathogen responsible
for a signal of selection–for example, flagellated bacteria are responsible for selection at the
TLR5 locus (Grossman et al., 2013). However, in other cases it is difficult to know which
specific organism is responsible. For example, there is continuing disagreement regarding
the specific disease (bubonic plague or smallpox) responsible for selection on the CCR5 gene
(see Section 1.5) (Galvani and Slatkin, 2003).
1.3 A brief introduction to the human immune response to
infection
The immune system exists to protect the human body from pathogenic organisms that
exist in the environment. Because of the need to differentiate between host cells and invading
organisms, as well as beneficial microorganisms and pathogenic ones, the immune response is
very complex. This complexity is also necessary to respond to the many strategies employed
by pathogens to cause disease. Most generally, the body detects and responds to pathogenic
intruders by recognizing structural differences between pathogens and host cells. This is
done in two complementary ways by the innate and adaptive branches of the immune system
(Chaplin, 2010).
1.3.1 Innate immune response
The innate branch of the immune system is the first line of response to an infection. The
overall purpose of this branch is to recognize general microbial patterns common to multiple
pathogens to distinguish invading organisms from host cells. Elements of the innate immune
system are all of those that are fully coded for in an individual’s genome at birth (Chaplin,
2010).
The two main branches of the innate immune system are physical barriers and the cell-
based innate immune response. Physical barriers include skin and skin secretions which
keep microbes out of the body and keep the skin at a pH that is unfavorable to bacterial
growth; mucus membranes and mucosal secretions (tears, mucus, and saliva) which again
prevent microbial entry and contain defensins (antimicrobial peptides that act against bacteria,
viruses, and fungi); stomach acid that kills microbes that have entered the digestive tract; and
ciliated epithelia, which move mucus and microbes out of the respiratory tract (Murray et al.,
2009; Reece et al., 2014). These barriers all keep infectious agents out of the body and create
environments unfavorable for pathogen growth or entry.
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However, if an infectious agent does make its way past those barriers and into the body,
it next encounters the cell-based innate immune system, which acts quickly and relatively
locally to try to eliminate infection (Murray et al., 2009). There are two main types of cells
that act in the innate immune response: phagocytes and natural killer cells (Reece et al.,
2014). Phagocytes are cells that engulf pathogens, and include neutrophils, macrophages,
and dendritic cells. Generally these cells engulf and destroy pathogens and help to stimulate
the adaptive immune system (Reece et al., 2014). The other main type of cell involved in
the innate immune response is the natural killer cell, which is especially important in viral
infections. Natural killer cells are lymphocytes that release chemicals that kill host cells
presenting viral or cancerous antigens (Reece et al., 2014).
Several vital elements of the innate immune system that appear in the results of this thesis
are pathogen-associated molecular pattern recognition receptors (PRRs), interferons, and
the complement system (Murray et al., 2009; Reece et al., 2014). PRRs, such as Toll-like
receptors (TLRs), recognize foreign substances such as flagellin, double-stranded RNA, and
lipopolysaccharide (LPS), all of which are not found in the healthy human body and are
indicative of microbial infection (Reece et al., 2014). Interferons are vital in the immune
response to viral infections, and act to limit the replication of viruses in cells neighboring
infected cells, and to activate macrophages (Reece et al., 2014). The complement system is a
set of proteins that are activated by PAMPs and are involved in causing lysis of pathogenic
cells, among other functions (Reece et al., 2014).
1.3.2 Adaptive immune response
The adaptive immune system is the next line of response to infection, which provides a
specifically targeted response against any surviving infectious agents (Murray et al., 2009).
The adaptive immune response relies on two main types of lymphocytes, or white blood
cells. These are B cells and T cells. B cells mature in bone marrow, and T cells mature in the
thymus (Reece et al., 2014).
Both B cells and T cells have antigen receptors on their cell surfaces. These receptors
exhibit enormous diversity, generated by different combinations of variable segments. Upon
exposure to a new pathogen, a B or T cell is activated when it binds to the pathogen antigen.
Once activated, the cell will divide, creating two new types of cells: effector cells and memory
cells. Effector cells for B cells are called plasma cells, which are responsible for producing
antibodies specific to that pathogen. Effector cells for T cells are helper and cytotoxic T cells,
which are described in more depth below. Memory cells enable a faster immune response
should the the same antigen be presented again in a future infection (Reece et al., 2014).
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There are two main facets of the adaptive immune response: the humoral response and
the cell-mediated response. The humoral response takes place in the blood and lymph, and is
centered around antibody response to infection. Antibodies in the blood or lymph will bind
to pathogen antigens, which can block their normal function (for example, prevent a virus
from entering a cell), or mark them for destruction by other immune cells. The cell-mediated
response is based on the destruction of infected cells by cytotoxic T cells (Reece et al., 2014).
The helper T cell is at the base of each of these responses. If the helper T cell’s T cell re-
ceptor binds to the MHC molecule and antigenic peptide presented by the antigen-presenting
cell (a cell with an MHC class II molecule, which can be dendritic cells, macrophages, or B
cells), the helper T cell becomes activated. This can lead to more activated helper T cells,
activated B cells, and activation of cytotoxic T cells, which are the basis of the cell-mediated
immune system. Cytotoxic T cells become activated by signals from helper T cells, and from
binding to antigen-presenting cells. Cytotoxic T cells are responsible for destroying infected
host cells (Reece et al., 2014).
Based on whether an individual has been exposed to a particular antigen before, they will
experience either a primary or secondary immune response. The primary immune response
takes place in an immunologically naive individual, who is encountering an antigen for the
first time. The peak immune response in this case occurs between 10 and 17 days after
exposure. The secondary response, occurring in an individual who has already encountered
an antigen, peaks between 2 and 7 days after exposure. The immune response is also of
greater magnitude in a secondary immune response (Reece et al., 2014). Since memory T and
B cells can live for decades, exposed individuals have a clear advantage over non-exposed
individuals. This stark difference in response time and magnitude underlines the advantage
an immunologically experienced population would have over an immunologically naive one
with regards to a particular disease and the potential influence of disease in shaping world
history, as stated in Section 1.2.
Self-tolerance and the ability to avoid runaway immune and inflammatory responses
are also vital requirements of the immune system. B cells and T cells that react with host
tissues are removed from the lymphocyte pool (Reece et al., 2014). Regulatory T cells play
an important role in negative/homeostatic regulation of immune response and suppressing
autoimmunity (see review by Beissert et al. (2006).)
Adaptive mutations in any one of the branches of innate or adaptive immunity might
allow an individual to better survive an infection. Consideration of the different types of cells
important in the immune system went into choosing the classes of genes examined in this
thesis (see Section 2.1). By studying whether certain genes or gene classes have been under
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past selection, we may learn which genes are phenotypically important in an infection and
have made contributions to a population’s immunological adaptations.
1.4 Using statistics to look for signatures of selection in the
genomic era
In order to examine more precisely the ways in which populations have adapted to
pressure from infectious disease, researchers have turned to searching for genetic signals of
selection. Until recently, these searches were confined to candidate gene studies (Akey, 2009;
Sabeti et al., 2006). Though these studies were successful in finding several classic selection
targets, they suffered from a major disadvantage in study design. For a candidate gene study,
a selection hypothesis must be generated before analyses are performed. This hypothesis
relies on adequate knowledge of how a given genotype corresponds to a phenotype of interest
(Akey, 2009).
With the development of genotyping and sequencing technologies, and the explosion
of genetic data from projects like the International HapMap Project and the 1000 Genomes
Project in the last 15 years or so, it has become possible to look through the whole genome for
increasingly high-resolution evidence of selection (Akey, 2009). In principle, this approach
avoids the major pitfall of candidate gene studies mentioned above, since a whole genome
scan makes no hypotheses about candidate genes. Additionally, demographic effects are less
of a confounding factor because of the assumption that demographic effects affect the whole
genome equally, and selection effects affect only certain loci (Akey, 2009). However, it is
important to note the drawbacks of these types of selection scans. First, neither candidate
gene studies nor classic genome-wide scans are designed to detect evidence of polygenic
selection, which is an important mode of selection compared to the relatively rare "hard
sweep" mode in which a single allele drives a selection event. Second, given that any
selection scan gives a list of top results, it is not always obvious without further functional
information which genes have actually been under selection and which are false positive
results (see review by Pritchard et al. (2010)).
The type of genetic data used in selection studies has also evolved over time. With
the falling cost of full genome sequencing, it has become possible to use whole genome
sequences in selection studies instead of the historically more common genotype data. Using
whole genome data has many advantages over using genotype data. These include the
avoidance of ascertainment bias in SNP sampling and the potential to find the causative
variant itself (Karlsson et al., 2014).Various statistics have been developed to enable genome-
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wide scans for such evidence. These statistics have different strengths and can be used in
combination to find not only a signature of selection but the likely causative SNP as well.
There are three main types of genetic selection: negative/purifying, positive, and bal-
ancing. Negative selection acts to remove deleterious mutations, and is expected to affect
a large number of protein-altering mutations, since between around 38-75% of mutations
causing amino acid changes are expected to be deleterious on some level (Eyre-Walker and
Keightley, 1999; Kryukov et al., 2007)(also see review by Barreiro and Quintana-Murci
(2010)). Negative selection is the most common type of selection occurring in the genome,
since it acts to preserve the integrity of the genome. Positive selection is the process in which
a beneficial allele rises in frequency within a population. It has been estimated that between
10 and 20% of amino acid changes between humans and chimpanzees have been caused
by positive selection (Boyko et al., 2008). In general, positive selection can leave signals
of regions of decreased diversity, longer haplotypes, or extreme differentiation. Targets of
positive selection in the human genome have been found to include genes relating to skin
pigmentation, dietary adaptations, olfactory receptors, brain size, and immune function (see
review by Nielsen et al. (2007)). Balancing selection leads to the maintenance of diversity
at a genetic location in the presence of a selective pressure that favors genetic diversity
or a heterozygote advantage. In a region under balancing selection, an excess of diversity
compared to neutral expectations would be observed.
Since this thesis is focused on regionally differential adaptation of multiple populations, I
am most interested in searching for signals of positive and balancing selection. Adaptations
in these two categories are not likely to be found in genes with a function so important to
survival that any change will have severe detrimental effects. Because of this, evolutionary
constraints are somewhat relaxed compared to genes under strong negative selection, and
local variation can emerge and be acted upon by positive and balancing selection. Looking
for negative selection in immune genes in this dataset would be an interesting opportunity
for further study.
Most generally, statistics used to look for signals of selection seek regions of the genome
that have different characteristics from surrounding regions, and that look different from
what would be expected under neutral conditions. Because each statistic has limitations and
the potential to return false negatives or false positives along with true positives or negatives,
it is helpful to use several different statistics when analyzing a dataset. The different statistics
used in this thesis to detect positive and balancing selection, as well as findings from previous
studies on positive and balancing selection, are discussed in Chapters 3 and 4.
Each of these three types of selection can act on single genes, but another important mode
of selection is polygenic selection. This is selection that acts on certain pathway and whose
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effects are spread out over a number of genes, instead of the classic hard sweep example
of strong selection acting on a single gene. It is thought that this mode of selection is an
important complement to the hard sweep model, and that it may have acted on a significant
number of traits (see reviews by Pritchard et al. (2010) and Nielsen et al. (2017)). Perhaps
the most well-known example of polygenic selection is on height in Europeans (review by
Nielsen et al. (2017)). However, methods to detect polygenic selection still have less power
to detect sweeps than the most commonly used positive selection statistics, which in general
look for evidence of hard sweeps. This is because looking for polygenic selection requires
knowledge about not only the genetic components of an entire pathway, but the functional
sites at each of those sites as well (review by Pritchard et al. (2010)). For this reason, the
focus of this thesis is selection tests that detect hard sweeps.
1.5 Medical relevancy of selection studies
While the results of selection studies are interesting in their own right as a record of
human adaptation to environmental pressures over time, they can also be medically useful.
Selection studies can help distinguish regions of the genome which are phenotypically
important, including regions associated with disease (Heyer and Quintana-Murci, 2009). Past
adaptations to pathogen pressures can help us understand modern health conditions and why
our immune systems function the way they do. They can also serve as potential inspirations
for new approaches to disease treatment.
In general, it is expected that mutations which lower the fitness of individuals in a popu-
lation will be removed from that population over time through negative selection. However,
some deleterious immune-related mutations, such as those implicated in autoimmune disease
or allergies, exist at relatively high frequencies that do not follow this expectation. One
explanation for this is that these mutations were protective against infectious disease in the
past. For example, a variant in the gene SH2B3 that confers stronger protection against
bacterial infection has been shown to have been under selection between 1200 and 1700 years
ago. However, this variant is also associated with susceptibility to celiac disease (Zhernakova
et al., 2010). The gene HAVCR1, which has also been under selection, is associated with
both susceptibility to hepatitis A as well as allergies and asthma (Nakajima et al., 2005). The
classic example of sickle cell anemia and malaria (Allison, 1954) also falls into this category.
Sickle cell anemia is a disease most often found in populations with ancestry from regions
where malaria is endemic. Individuals with one wild type and one sickle cell copy of the
hemoglobin gene are relatively protected against malaria compared to individuals with two
wild type copies of the hemoglobin gene (Ackerman et al., 2005). Despite the morbidity and
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mortality caused by having two copies of the sickle cell hemoglobin gene, because of the
advantage to heterozygotes the sickle cell variant is maintained at relatively high frequencies
in certain populations.
Studying past adaptations to infectious disease can also yield useful insights for drug
development and medical treatment of disease. Because variants under past selection nec-
essarily are closely linked to human health, they are likely to be of medical relevance (see
review by Nielsen et al. (2017)). One well-known target of positive selection in European
populations is a deletion in the CCR5 gene, which codes for one of the two receptors used by
HIV to enter host cells. However, the HIV strains present in humans today only date back to
about the 1930s (see review by Rambaut et al. (2004)), and signatures of genetic selection
often take much longer to appear (on the order of thousands of years). Therefore, the disease
causing this selection must have been something else, possibly bubonic plague or smallpox
(experts still disagree) (Galvani and Slatkin, 2003). However, it was noted that individuals
with two copies of this crucial deletion were in a way immune to HIV since the virus couldn’t
gain entry to their cells. At least two methods of HIV treatment are based on the blocking of
the CCR5 receptor. One is the CCR5-inhibiting drug maraviroc, and the other is stem cell
transplant from a donor with a double deletion in the CCR5 gene (Dorr et al., 2005; Hütter
et al., 2009).
TLR5 is a good example of a variant found through a selection scan that could serve as
inspiration for medical treatment. Grossman et al. found that a nonsynonymous variant in
TLR5 in the Yoruba population shows signals of having been under selection (Grossman et al.,
2013). In Europe and South Asia, this gene also can have relatively high incidence of the stop
gain mutation TLR5-392STOP (Barreiro et al., 2009; Wlasiuk et al., 2009). Both this stop
gain mutation and the Yoruban nonsynonymous variant act to decrease the the magnitude of
NF-kappaB signaling in response to infection by flagellated bacteria (Barreiro et al., 2009;
Grossman et al., 2013). It has been shown that decreased NF-kappaB signaling can lead to
better outcomes in bacterial infections (Grossman et al., 2013; Koedel et al., 2000). In mice
with knocked out TLR5 genes, transport of Salmonella typhimurium from the intestines to
other organs was impaired, leading to increased survival (Uematsu et al., 2006). Therefore,
decreased NF-kappaB function mediated through TLR5 variants can have a large effect on
survival from bacterial infections and has likely played an important role in shaping human
adaptation to those infections.
Following these examples, it is possible that future treatments may be inspired by findings
of selection scans in which it is clear that an important immune response has been shaped by
past selection.
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1.6 Diversity in genomic studies
European populations are heavily overrepresented in genome-wide association study
(GWAS) literature, and there is a lack of diversity in genomic research as whole. As of 2016,
only twenty percent of participants in GWAS were non-European. Of the non-European
twenty percent, Asian populations are disproportionately represented due to an increase in
the number of GWAS completed in Asia in recent years. Other populations continue to be
underrepresented, if represented at all (Popejoy and Fullerton, 2016).
This is a problem for many reasons. The first is that it gives the impression that research
on populations of European descent is more important than research on other populations. It
also means we may be missing valuable connections between genotype and disease. And
because many associations may not be as meaningful or even valid at all in populations
not included in the initial study, it means that underrepresented populations may receive
suboptimal or even harmful treatment for a disease (Popejoy and Fullerton, 2016). A recent
study on the effect of demography on genetic risk prediction found that application of GWAS
results to populations other than the population on which the study was completed gives
limited, biased, and unpredictable risk predictions (Martin et al., 2017).
There are some resources that do aim to represent human genetic diversity more com-
pletely. The 1000 Genomes Project is one of these resources. It includes a combination
of whole-genome sequences, exome sequences, and genotype data for more than 2,000
individuals in 26 different populations (Auton et al., 2015). Recent large genomic analyses
have focused more on including more genetic diversity in their studies. These include three
papers from 2016 that introduced the Simons Genome Diversity Project dataset (Mallick
et al., 2016), a dataset of genomes from Aboriginal Australians and Papuans (Malaspinas
et al., 2016), and the Estonian Biocentre Human Genome Diversity Panel (Pagani et al.,
2016).
Selection studies suffer from a similar lack of diversity to more medically-based genomics
research. The majority of past selection studies have focused on three major continental
populations: Europe, mainland East Asia, and Africa (and most often, specifically the Yoruba
population) (Grossman et al., 2010; Lao et al., 2007; Racimo, 2015; Sabeti et al., 2007;
Voight et al., 2006a). Using these three populations can give a broad picture of selection
and distribution of allele frequencies between populations and potentially minimize the
complications of interpreting the results from a large number of populations. However, it
is not clear how well a relatively simple model of these three populations explains global
genetic diversity and adaptations.
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1.7 Dataset studied in this project
This thesis is based on population genetic analysis of data from the Estonian Biocentre
Human Genome Diversity Panel (EGDP), which was published in 2016 by Pagani et al.
(Pagani et al., 2016), and a set of 19 Colla genomes from a 2017 paper by Eichstaedt et al.
(Eichstaedt et al., 2017). The Pagani et al. paper published 483 whole genome sequences,
369 of which were used for selection tests in that paper. That subset of the full genomic data
was clustered using ChromoPainter and fineSTRUCTURE into populations of at least 15
individuals, which generated 12 population groups (Pagani et al., 2016). The populations
represented from this set are the twelve following populations: West and Central Africa, West
Asia and Armenia, Southwest Europe, Northeast Europe, Volga Uralic, South Asia, Central
Siberia, West Siberia, South Siberia and Mongolia, Northeast Siberia, Mainland Southeast
Asia, and Island Southeast Asia. The set of populations studied in this thesis includes those
same twelve populations as well as the Colla population (from the Northwest Argentinian
Highlands) mentioned above. It should be noted that some populations may contain multiple
subpopulations–for example, the West and Central African population. Because this group
likely contains lots of diversity and some population structure, this may have an effect on the
selection results for this population.
The full set of genome sequences included in this thesis consists of 388 whole genome
sequences with coverage between 30X and 80X coverage (Eichstaedt et al., 2017; Pagani
et al., 2016). The dataset was filtered to contain only SNPs of high quality calls, excluding
any structural variants. All the analyses in this thesis were performed on the cleaned, filtered
dataset that was produced from the Pagani et al. 2016 publication. It is important to note
that regions containing copy number variants (CNV) and structural variation are difficult
to accurately assemble using short read sequencing technology. Therefore it is likely that
the sequence data does not capture the haplotypic diversity of such regions. Because of this,
despite the immunological importance of some of these regions (such as the KIR region on
chromosome 19), their presence or absence in top selection results might not reflect their true
biological significance. Different sequencing methods, such as long-read sequencing, are
more appropriate for such regions (Roe et al., 2017).For more information on the sequencing
and quality control steps of this dataset, please see the Supplementary Information of Pagani
et al. 2016. The number of individuals per population can be seen in Table 1.1, along with
three letter abbreviations for each population. A geographic map of the general location of
each of the populations included in this thesis can be seen in Figure 1.6.
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Population Population abbreviation Number of individuals
West and Central Africa AFR 26
West Asia and Armenia WAA 26
Southwest Europe SWE 32
Northeast Europe ENE 53
Volga Uralic VOL 23
South Asia SOA 28
Central Siberia CSI 31
West Siberia WSI 17
South Siberia and Mongolia SSI 34
Northeast Siberia NSI 25
Colla COL 19
Mainland Southeast Asia SEM 29
Island Southeast Asia SEA 45
Table 1.1 Number of individuals per population grouping.
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Fig. 1.6 A map of approximate geographical locations of individuals included in this thesis. Note that
the numbers of points does not match the number of individuals in each population, since
multiple individuals may be from the same place. Latitude and longitude coordinates taken
from Pagani et al. (2016). To see exactly how many individuals are in each population, please
see Table 1.1.
Several populations represented in the EGDP include regions that have rarely been
included in selection studies, such as Island Southeast Asia, Siberia, and South America.
Because of this, this thesis may be one of few studies on local immune-driven adaptation
history in these populations. The results of this project should add greater resolution to the
literature on immune-driven human adaptation and be a useful foundation for further study.
1.8 Questions to be answered in this thesis
The questions to be answered in this thesis can be separated into the following broad
categories: those regarding methodology, those regarding population selection histories, and
those regarding targets of selection.
Methodology
How much do the results of each of the selection tests overlap with each other?
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How can a relatively large, window-based signal of selection be narrowed down to an
individual variant potentially driving the signal?
How are the results influenced by the choice of which immune genes to examine for
evidence of selection?
Population selection histories
What is the distribution of global and local signals in the results of each selection statistic,
and how do those compare to the results of previous studies?
Is there evidence of more selective pressure on immune genes in populations living in
lower latitudes, where pathogen richness is greater?
Targets of selection
Do different classes of immune genes show different selection histories (positive vs.
balancing vs. none)?
Do different classes of immune genes show different ages of selective pressure (ancient
vs. recent)?
What are some of the most striking targets of positive and balancing selection?
Chapter 2
Methods for inferring positive and
balancing selection from genomic data
2.1 Selection of immune genes
In order to search for signatures of selection in immune-specific genes, several lists of
immune-related genes were assembled based on key sets of immune cell and peptide classes
(see Section 1.3). In the interest of avoiding bias and assembling as complete a list as possible
for different immune phenotypes, these lists were assembled from existing databases. It
should be noted that no list of pathogen-interacting genes is fully complete, but using a
database is potentially the most comprehensive way to assemble a list of relevant genes.
Multiple databases were used to give a more complete view of different phenotypes. The
datasets used are the Gene Ontology (GO) Consortium database (Ashburner et al., 2000) and
the Host-Pathogen Interaction Database (HPIDB) (Ammari et al., 2016).
Genes chosen from the Gene Ontology Consortium database were selected based on
their vital involvement in the human immune system. Since the innate immune system is
the first line of defense and is passed down in the germline, unlike defenses gained during a
lifetime through the adaptive immune system, it is the likely site of many possible beneficial
adaptations. Because of this, genes with the following ontologies relating to innate immunity
were selected from this database: innate immunity, interaction with bacteria, interaction with
viruses, and antigen processing and presentation. Bacteria and viruses are included here since
they are potentially the two most important classes of pathogens to affect humans. However,
it is also possible that mutations that affect the way T cells or B cells function could result
in faster, better, or longer lasting adaptive immunity, which could also result in increased
survival of individuals with that mutation. Therefore, a subset of genes with ontologies
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relating to adaptive immunity (adaptive immunity, T cells, and B cells) were also included.
The full list of gene ontology terms for all genes (assembly GRCh37) was downloaded from
the Gene Ontology Consortium website in February 2014, and afterward immune gene lists
based on ontology were assembled by filtering for genes with the following immune-related
search terms in their gene ontology description: "adaptive immun," "bact," "vir," "T cell,"
"B cell," "innate immun," and "antigen processing and presentation." These search terms
corresponded respectively to the gene lists for genes associated with adaptive immunity,
defense against bacterial infection, defense against viral infection, T cell function, B cell
function, and innate immunity (see Table 2.1). These terms were chosen to give broad
coverage over innate and adaptive immune processes.
The Host-Pathogen Interaction Database (Ammari et al., 2016) is organized into inter-
actions between host genes and pathogen genes. From the human host category, genes that
interacted with bacteria, viruses, protozoa, and amoebozoa were chosen to be included in
this thesis. Bacteria and viruses are important classes of pathogens to include for the reasons
listed above. The HPIDB also includes human genes that interact with fungal pathogens, but
since relatively few fungal diseases cause disease in immunocompetent individuals (Murray
et al., 2009), it is unlikely that they have been responsible for significant selection events
in human history. The full list of host-pathogen protein interactions was downloaded from
HPIDB 2.0 Ammari et al. (2016) in July 2016, and all interactions between human proteins
and pathogen proteins of the types listed above (bacteria, virus, protozoa, and amoebozoa)
were separated into groups based on type of pathogen. The list of genes associated with each
of these proteins made up the gene list used for each pathogen group (see Table 2.1).
Both of these lists of genes were further filtered to contain protein coding genes only,
based on classification by Ensembl BioMart in January 2018.
For both of these categories, the immune function lists and number of genes per list are
shown in Table 2.1. The full lists of genes in each of the immune categories can be seen in
Appendix A.
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Database Function Abbrev. No. of unique genes
GO Adaptive immune response GO.Adapt 31
GO Bacteria GO.Bact 226
GO Virus GO.Virus 833
GO T cell GO.Tcell 423
GO B cell GO.Bcell 186
GO Innate immune response GO.Innate 605
GO Antigen proc. and pres. GO.APP 208
HPIDB Bacteria HP.Bact 3545
HPIDB Virus HP. Virus 5522
HPIDB Protozoa HP.Prot 19
HPIDB Amoebozoa HP.Amoe 7
Both databases All above phenotypes 8912
Table 2.1 Number of unique genes per immune function category. This also includes abbreviations
for each gene category that may be use later in the text. Abbreviation: "proc. and pres." =
"processing and presentation."
2.2 Overview of selection statistics used in this thesis
2.2.1 Positive selection statistics
Positive selection is the process by which the frequency of an allele which confers survival
or other adaptive benefits increases within a population over time. There are three main types
of statistics used to look for this evidence of positive selection in a single species. These
are methods based on the site frequency spectrum, linkage disequilibrium, and population
differentiation (review by Akey (2009)). Since each statistic has its pros and cons, it can
be useful to analyze the same dataset with multiple statistics. This can help correct against
false positives and false negatives. Out of the 360 immune-related genes found to be under
positive selection mentioned in the above section, only around half of those were highlighted
by more than one study (review by Barreiro and Quintana-Murci (2010)). For example, of
the fourteen percent of the genome found to have been under positive selection by at least
one study, only fourteen percent of those regions have been found by more than one study
(review by Akey (2009)). Clearly, different studies and selection statistics pick up different
results. In order to avoid the pitfalls of only using one statistic, this thesis uses multiple tests
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of positive and balancing selection. The specific statistics used to detect positive selection
are outlined below.
Tajima’s D was developed in 1989 by Fumio Tajima, and is a widely used statistic for
selection studies. The two main components of the Tajima’s D statistic are the number of
segregating sites and the average number of pairwise differences in a given sequence (Tajima,
1989). It is one of several selection tests based on the site frequency spectrum (SFS), or the
allele frequency distribution of SNPs (Nielsen et al., 2007). A negative value of Tajima’s D
implies possible positive selection, and is found in regions where there is less heterozygosity
than would be expected for a given number of segregating sites under neutral conditions
(Carlson et al., 2005). This result can also be seen due to demographic effects, such as a
sudden population expansion after a previous bottleneck, or if a neutral site is linked to
a site under selection (Tajima, 1989). This statistic is best used for picking up relatively
ancient selection of signals (between 50,000 and 250,000 years old) (Grossman et al., 2013;
Sabeti et al., 2006). Compared to other statistics, Tajima’s D is more relevant to looking for
complete selective sweeps (Pybus et al., 2015).
A second type of statistic used for whole genome scans for positive selection are those
based on haplotype homozygosity. These statistics are based on the structure of linkage
disequilibrium in various regions of the genome. A region containing an unexpectedly long
haplotype at a high frequency is a candidate region for an incomplete positive selective sweep
(Nielsen et al., 2007). The particular strength of these tests lies in detecting signatures of
incomplete sweeps (review by Karlsson et al. (2014)). These types of tests are used to find
evidence of relatively recent selective sweeps that took place within the last 25,000 years
(review by Sabeti et al. (2006)). Both iHS and nSL were used in this thesis to compare the
results of these related tests. As opposed to Tajima’s D, which is relatively more applicable to
finding evidence of a complete selective sweep, statistics based on haplotype homozygosity
are better used to find evidence of incomplete sweeps (Pybus et al., 2015).
Two different statistics based on haplotype homozygosity will be used in this analysis.
The iHS statistic, or integrated haplotype score, is based on the EHH test (Sabeti et al.,
2002), which quantifies haplotype decay as a function of distance from a specific allele at
one end of the haplotype (Voight et al., 2006b). The nSL statistic was published in 2014 by
Ferrer-Admetlla et al., and is similar to the iHS test. The main difference between these two
statistics is that the iHS statistic measures the distance between mutations in terms of genetic
distance, whereas the nSL statistic measures it in the number of mutations. This means that
the nSL statistic does not require a recombination map (Ferrer-Admetlla et al., 2014).
The DIND (derived intra-allelic nucleotide diversity) statistic, developed by Barreiro
et al. in 2009, is a statistic that is used in this project to narrow down candidate regions
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for relatively recent selection to candidate alleles or haplotypes. This statistic is based on
the idea that a region having undergone a selective sweep will be characterized by a high
frequency allele surrounded by a region of low heterozygosity, since the beneficial mutation
will have risen in frequency faster than the normal time to accumulate genetic diversity in
linked regions (Barreiro et al., 2009).
The di statistic was developed by Akey et al. in 2010, and is based on the FST between
one population compared to all other populations. FST is a classic statistic of genetic
differentiation in the field of population genetics, developed by Sewall Wright. It is a
measure of the proportion of variance within a subpopulation to the variance within the
total population (Holsinger and Weir, 2009). Because of this, the strength of the di lies in
finding regions where one population is particularly differentiated compared to all other
populations (Akey et al., 2010). FST is used to detect signals younger than 50-75,000 years
old (review by Sabeti et al. (2006)). While extreme differentiation doesn’t necessarily imply
selection, it can be one of several indicators (Xue et al., 2009), and if the differentiated alleles
are functionally significant, can be phenotypically noteworthy regardless of the underlying
reason for differentiation.
2.2.2 Balancing selection statistics
Three different statistics were used to look for evidence of balancing selection in this
project. These are the HKA statistic, the b statistic, and Tajima’s D. Details about the methods
used to calculate these statistics can be seen in the following sections of this chapter. These
three statistics were chosen because they are best powered in different time ranges, allowing
an examination of balancing selection at different times in history. Additionally, Tajima’s
D was calculated for the positive selection analysis already and can be applied to look for
balancing selection as well–however, as will be noted in future, the window size should be
much smaller for balancing selection than for positive selection. It should also be noted that
because variants need time in order to accumulate, a somewhat older time frame is required
when looking for balancing selection.
The HKA statistic, developed by Hudson et al. in 1987, is used to look for balancing
selection by comparing the ratio of polymorphisms to divergences in a region of interest to
the expected ratio of that region under neutral conditions (Hudson et al., 1987). Balancing
selection can be inferred if there are more polymorphisms than would be expected under
neutral conditions. The HKA statistic is used to detect signals younger than 250,000 years
old (review by Sabeti et al. (2006)).
The b statistic is a recently developed statistic by Siewert and Voight. According to
their work, alleles surrounding a SNP under balancing selection are expected to show
28 Methods for inferring positive and balancing selection from genomic data
the same distribution of allele frequencies that the SNP itself should show–namely an
overrepresentation of mid-range frequencies. b is therefore a summary statistic that searches
for groups of alleles showing these target frequencies. According to the authors, this statistic
has maximum power to detect balancing selection older than 100,000 generations, thus
selection that happened before the split of major continental population groups and indeed
before the emergence of anatomically modern humans (Siewert and Voight, 2017a). Despite
the fact that the b statistic is most highly powered to detect extremely ancient selection, it has
been run on each of the 13 populations used in this project because it may be still somewhat
powered to detect more recent selection.
Tajima’s D was used in this project to look for balancing selection as well as positive
selection. Whereas extreme negative values of Tajima’s D suggest positive selection, extreme
positive values of Tajima’s D suggest balancing selection. Positive values of Tajima’s D
suggest that the number of haplotypes is greater than the number of segregating sites. This
implies more diversity than would be expected under neutral conditions (Carlson et al., 2005).
However, it should be kept in mind that just as negative values of Tajima’s D can be caused
by a recent population bottleneck and expansion, positive values of Tajima’s D can indicate
population contraction (Stajich, 2004; Tajima, 1989).
Summary of statistics listed above
Statistic Brief description Time frame
Tajima’s D Regions of increased/decreased diversity 50-250 kya
iHS Extended haplotypes < 25 kya
nSL Extended haplotypes < 25 kya
di Extreme differentiation of one population vs others < 75 kya
HKA High ratio of polymorphisms to divergences < 250 kya
beta Groups of alleles at target frequency > 2.5 mya




Table 2.2 Timeframes under which statistic is best powered.
Table 2.2 shows a summary of each of the statistics used in this thesis, as well as a brief
description of what each is designed to find and the time frame under which each is best
powered/used. Citations and more information on each can be found in the text above.
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2.3 Calculation of selection statistics
2.3.1 nSL, iHS, and Tajima’s D
The analyses in this section are based on two datasets. The first is the Tajima’s D, nSL,
and iHS results published by Pagani et al. in 2016, which used window sizes of 200 KB, and
so this thesis has done the same.
nSL and iHS are both haplotype homozygosity tests, which are designed to pick up signals
of positive selection through detection of long haplotypes. Tajima’s D is based on the site
frequency spectrum, and is designed to find regions where there is less (or more, if looking
for balancing selection) heterozygosity than expected for a given number of segregating sites
under neutral expectation (see Section 3.1.2 for more details on positive selection statistics).
These results consist of a score per each 200 KB window in the genome that passed a number
of quality filters. Though nSL and iHS are SNP-based statistics, these tests were used to
assign scores to 200 B windows in the Pagani et al. 2016 analysis, and so this is the approach
used for this thesis as well. These quality filters are: windows with average sequencing
coverage of 0 were removed, windows outside of two standard deviations from the genome
wide depth of sequencing coverage were removed, and all windows with fewer than 20 SNPs
were removed (Pagani et al., 2016). The second dataset is based on a population of 19 Colla
individuals published by Eichstaedt et al. in 2017 (Eichstaedt et al., 2017) and the results
for the Tajima’s D, nSL, and iHS tests run on that population by Dr. Charlotte Inchley, Dr.
Georgi Hudjashov and Dr. Tiago Antão respectively. Those windows were also filtered to
include only the windows from the first dataset that passed quality filters. The coverage per
window for all populations was between 30X and 72X (Eichstaedt et al., 2017; Pagani et al.,
2016).
Choosing balancing selection candidate genes in top Tajima’s D windows
Tajima’s D can be used to detect signals of balancing selection as well as positive selection.
In the case of balancing selection, extreme positive values of the statistic suggest potential
balancing selection. Therefore, the top one percent of 200 KB windows with the highest test
statistics was assembled for each population as candidate windows for balancing selection. It
should be noted that 200 KB is probably much too large of a window to use for this purpose,
and it is not the same window size used with other balancing selection statistics–however, the
window scores already existed from the Pagani et al. 2016 analysis and it made sense to see
whether that data could be repurposed to look for balancing selection. Since each window
usually contains multiple genes, further filtering was needed to narrow down the list of genes
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potentially driving a signal of balancing selection. This was done by calculating the mean
minor allele frequency per gene in each population, and assuming the gene with the highest
mean minor allele frequency to be the gene most likely to be under balancing selection in a
given 200 KB window. The reasoning behind this step is that balancing selection maintains
diversity in a gene, and a higher minor allele frequency means a more even balance between
two alleles as opposed to dominance by one allele and a small representation by another
allele. The top 50 protein coding genes per population were assembled, consisting of the
gene with the maximum minor allele frequency per top window. When there were no genes
in a top window, that window was not included in the results.
2.3.2 di
Population differentiation-based analyses were based on di scores estimated by Pagani et
al. for the EGDP dataset (Pagani et al., 2016) and by Tiago Antão and Georgi Hudjashov
for the Colla population. The di statistic is based on the FST statistic, and is designed to
find SNPs at which one population is especially differentiated in comparison to all other
populations (see Section 3.1.2 for more information on this statistic). In order to filter out
SNPs in regions with poor coverage, and to preserve consistency between different analyses,
genomic regions outside the 200 KB windows that passed the quality filters used in the
window-based positive selection analysis were removed from the set of scores. In order to
compare relative di values of genes, each gene was assigned the highest di value of all SNPs
between its start and end coordinates.
The set of genes and gene start/end coordinates was downloaded form Ensembl’s BioMart
website on January 8th, 2018 and is based on the GRCh37.p13 dataset. It is filtered to contain
gene start and stop coordinates of only protein coding genes. This gene list was further
filtered to only include the longest gene length per gene where duplicate gene entries were
included. All genes on non-autosomal chromosomes were removed, as well as all genes
containing a decimal point in their gene name, since literature searches for these genes
returned results suggesting they were not protein-coding genes.
2.3.3 HKA
The HKA statistic detects signals of balancing selection by comparing the ratio of
polymorphisms to substitutions in a region of interest to the expected ratio of that region
under neutral conditions (see Section 4.1.2 for a more detailed description of this statistic).
Here, polymorphisms are polymorphic loci and substitutions are loci where the derived allele
is fixed. The HKA statistic was calculated in windows of 2000 base pairs with a shift of 500
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base pairs, as described in the Pagani et al. paper (Pagani et al., 2016). The script used to
calculate the statistic per window used the chi squared formula given for the HKA statistic in
the supplementary materials of that paper, which is the following:
c2 = ((npoly   epoly)2/epoly)+((nsubs   esubs)2/esubs)
This chi squared value was calculated per 2000 bp window. npoly and nsubs are the
observed number of polymorphisms and substitutions in a given window, epoly = p(npoly +
nsubs), and esubs = (1  p)(npoly +nsubs). p is npoly/(npoly +nsubs) for the whole genome. In
short, this statistic calculates whether there are more or fewer polymorphisms per window
than would be expected based on the genome-wide ratio of polymorphisms to polymorphisms
and substitutions. Where there are more polymorphisms than expected, the statistic receives
a positive value and when there are fewer it is assigned a negative value.
All HKA windows were removed which were not within the bounds of the 200 KB
windows that passed the quality filters, as with the di analysis. Each protein coding gene was
assigned the maximum HKA value of all the 2000 bp windows whose center was between
the start and stop coordinates of the gene, as in the Pagani et al. paper (Pagani et al., 2016).
2.3.4 b
The b statistic detects regions where there is an overrepresentation of SNPs at mid-range
frequencies (please see Section 4.1.2 for a more detailed description of the b statistic). The
unfolded (meaning that whether the allele is ancestral or derived at a given site is taken into ac-
count) b statistic was applied to each chromosome of each population using the Python script
from the paper in which the b statistic was published (https://github.com/ksiewert/BetaScan)
(Siewert and Voight, 2017a). The authors assume a lineage split between humans and chim-
panzees of 250,000 generations, so based on that assumption and the author-stated lower
bound of 100,000 generations, any balancing selection detected would be in between 100,000
and 250,000 generations ago. Based on these numbers and the recombination rate (2.5e-8,
used both in the b paper and Pagani et al. 2016 HKA analysis), the authors chose a window
size of 1000 base pairs, which I have used as well. Other program parameters used the default
parameters based on author recommendations and the high coverage of the EGDP data.
I have removed SNPs that do not have a folded (folded meaning that the ancestral or
derived identity of a given allele is not taken into account) frequency of 15 percent in at least
one population, as the authors did, since the authors were not able to simulate balancing
selection in that scenario and wanted to avoid false positives.
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b windows that were not within the bounds of the 200 KB windows that passed quality
filters were discarded, and the remaining windows were used to assign each protein-coding
gene a b score that was the maximum score for all windows intersecting with that gene.
Windows were intersecting if the window center point was between the gene start and end.
2.4 Enrichment tests
2.4.1 nSL, iHS, and Tajima’s D
In order to look for enrichment in immune phenotypes in top selection results, a list of the
top one percent of windows based on their selection statistic score was assembled for each
of the three window-based selection statistics. Since extreme negative values of Tajima’s D
are suggestive of positive selection and extreme positive values of Tajima’s D are suggestive
of balancing selection, an enrichment test was performed on both the top one percent of
windows (positive selection) and the bottom one percent of windows (balancing selection).
For each combination of selection statistic and class of immune genes, a Fisher’s exact test
was performed to see if windows containing immune genes were overrepresented in the top
one percent of selection results. In order to correct for false positive results due to multiple
testing, a Benjamini-Hochberg correction was applied using a false discovery rate of 0.1 in
order to get a corrected p-value. P-value cutoffs of 0.05 and 0.01 were considered. Please
note that the Benjamini-Hochberg correction was applied across each population and not
within each category of immune genes, so in enrichment tables presented in Chapters 3 and
4, two populations may have the same number of genes in the top 1% of results in a category,
but one of those populations may be significantly enriched and the other not. This is due
to the different significance levels within the Benjamini-Hochberg tests for each of those
populations.
2.4.2 b , HKA, and di
The HKA, and di, and b tests are all different from the large window-based tests (nSL,
iHS, and Tajima’s D) in that the the calculation of test statistics took place on a much finer
scale. In the case of b and HKA, each window was 100 to 200 times smaller than those
used in the large window-based tests, and in the case of the di test, the test statistic was
calculated for each SNP. Because of this, a positive correlation between gene size/number of
SNPs per gene and test statistic was expected to be a confounding factor in ranking genes by
maximum test statistic. In order to account for this and be able to find the true top hits for
each statistic unskewed by confounding gene size, several different binning methods were
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considered to create bins containing approximately the same number of genes. An advantage
of using the bin approach is that it controls for gene size, however, one disadvantage is that
the targets of selection are not necessarily equally distributed among the size bins, which is
an assumption of the binning method. Other methods, such as re-sampling, could also work
here.The b statistic as run on the South Asian population was used to run the binning method
comparisons.
The first binning method was to divide the datasets by gene length into 6 bins with the
following bin dividers: 10 KB, 50 KB, 100 KB, 500 KB, and 1 MB. The second method was
to divide the results into quartiles by gene size. The third and fourth methods were to divide
the results into quintiles and deciles by gene size, respectively. Each of these four methods
was used on the unfiltered dataset, as well as a version of the dataset which had all genes
with fewer than 20 SNPs filtered out of it. 20 SNPs was chosen as a cutoff based on its use
as a cutoff for small windows in another selection paper by Pickrell et al. (Pickrell et al.,
2009). Tables including average number of SNPs per gene, average maximum b score per
bin, number of genes in the bin, bin start and bin end can be seen in Tables 2.3 and 2.4.
Based on this data, the method of binning by quintiles on data filtered for a minimum of
20 SNPs per gene was chosen as the best method. The quintiles method is better than the
quartiles or deciles method because it captures the relationship between gene size/SNPs per
gene and average maximum test score per gene without over- or under-dividing the data. It is
better than method 1 because it does just as good a job capturing the correlation between the
two variables of interest but is simpler to calculate. Using this method, we have roughly the
same number of genes per each of the five bins.
The different binning methods for the HKA and di statistic (minus the quartiles method,
since it proved to be not much different from the quintiles method) run on the South Asian
population as an example are shown in tables 2.5 through 2.8.
For each statistic, once the data was appropriately divided into bins, the top 10 genes per
bin, resulting in 50 genes total, was assembled for each population and each test.
The top one percent of genes was used to perform an enrichment test for each statistic
identical to those performed on the top one percent of windows in the iHS, nSL and Tajima’s













Table 2.3 Comparison of binning methods for the unfiltered b statistic. Method 1 is divided by gene length into bins using bin dividers of 10 KB,
50 KB, 100 KB, 500 KB, and 1 MB. Methods 2, 3 and 4 are divided into quartiles, quintiles, and deciles by gene length, respectively.
Table 2.4 Comparison of binning methods for the b statistic, where all genes with fewer than 20 SNPs have been filtered out. Binning methods are





Table 2.5 Comparison of binning methods for the unfiltered HKA statistic. Method 1 is divided by gene length into bins using bin dividers of 10
KB, 50 KB, 100 KB, 500 KB, and 1 MB. Methods 2 and are divided into quintiles and deciles by gene length, respectively.
Table 2.6 Comparison of binning methods for the HKA statistic, where all genes with fewer than 20 SNPs have been filtered out. Binning methods













Table 2.7 Comparison of binning methods for the unfiltered di statistic. Method 1 is divided by gene length into bins using bin dividers of 10 KB,
50 KB, 100 KB, 500 KB, and 1 MB. Methods 2 and are divided into quintiles and deciles by gene length, respectively.
Table 2.8 Comparison of binning methods for the di statistic, where all genes with fewer than 20 SNPs have been filtered out. Binning methods are
the same as in Figure 2.5.
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2.5 Finding driver SNPs
2.5.1 nSL, iHS, and Tajima’s D
The DIND (derived intra-allelic diversity) statistic (Barreiro et al., 2009) was used to
move from units of windows to actual SNPs potentially responsible for observed signals of
selection. While Tajima’s D is already a window-based test, both nSL and iHS are SNP-based
tests. However, the scores were available in 200 KB windows from the Pagani et al. 2016
analysis, so DIND was needed to move from those windows back into individual SNPs. In
future work, recalculating those statistics and not converting them to scores per 200 KB
windows would be ideal. The DIND statistic looks for SNPs under positive selection by
finding derived alleles at high frequency that are linked with lower diversity sites than would
be expected under neutral conditions (Barreiro et al., 2009). The DIND statistic was run on
each SNP in each of the top one percent windows in each of the three selection statistics,
using a script based on one written by Dr. Florian Clemente. The statistic was run in the
same way as in the Pagani et al. paper: a DIND score was calculated in a 100 KB window
around each SNP. A neutral cutoff was established for each population from performing
a DIND analysis on a set of randomly selected 100 non-genic SNPs from each derived
allele frequency class, and defining the cutoff as 3 standard deviations above the neutral
DIND score. (It should be noted that the use of SNPs from non-genic regions as a neutral
comparison is somewhat biased by the effect of purifying selection resulting in a smaller
effective population size in genic regions than non-genic regions.) The DIND statistic was
run such that significant SNPs have frequencies between 0.4 and 0.9, meaning that no SNPs
will show up that are near fixation in a given population (Pagani et al., 2016).
The resulting list of SNPs from each population was then filtered for predicted functional
importance using the CADD (Combined Annotation Dependent Depletion) variant scoring
tool (Kircher et al., 2014). CADD calculates a single scaled C-score per SNP using 63
different variant scoring systems based on diverse metrics in order to predict the delete-
riousness or functional importance of a SNP. This score takes into account factors such
as predicted pathogenicity, evolutionary conservation scores, regulatory information, and
protein-based scores of deleteriousness such as SIFT and PolyPhen. All SNPs not passing
the recommended cutoff of 15 for the scaled C-score were filtered out (Kircher et al., 2014).
This step is to filter out SNPs with lesser functional importance and leave only SNPs that
potentially have a function that may be important enough to drive an observed selection
signal.
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This final list of SNPs was run through the Ensembl Variant Effect Predictor (VEP) tool
(McLaren et al., 2016) in order to classify SNPs as nonsense, missense, synonymous, and
assign them to gene names if in genic regions.
2.5.2 A note on looking for driver SNPs in balancing selection results
Statistics for finding signals of balancing selection are generally based on looking for
regions where there is more observed polymorphism than would be expected under neutral
expectations. Therefore, depending on the statistic, it can be more difficult to look for single
SNPs as the drivers of balancing selection signals than of positive selection signals, where
one particular SNP can be responsible for driving an observed signal. Because of this, this
thesis stops at the resolution of genes and doesn’t look for specific SNPs which may be
responsible for driving observed balancing selection signals. However, window sizes used
to calculate balancing selection statistics are usually smaller than those used for calculating
positive selection statistics, meaning that window-based balancing selection results are easier
to localize to smaller regions. Additionally, there are SNP-based statistics such as beta that
can be used to this end. This could be an interesting avenue for future work, though for
this thesis windows were used in order to keep the downstream analysis of the beta results
comparable with the other two balancing selection statistics.
It would also be difficult to screen significant variants for functional importance using
the methods used in this thesis (CADD), since CADD is based on evolutionary conservation
among other things. Loci which are under balancing selection are necessarily under somewhat
relaxed evolutionary constraint, which allows for variation. It would be an interesting
direction for further research to attempt to look for individual variants, using a test like the
maximum likelihood HKA (Wright and Charlesworth, 2004), and to look into other functional
screening methods that would be more appropriate for screening targets of balancing selection.
Future work might also make use of the balancing selection statistics NCD (Bitarello et al.,




3.1.1 Previous evidence of positive selection in immune genes
As of 2010, around fourteen percent of the genome had been reported to be under positive
selection by at least one study (review by Akey (2009)). However, replication of results in
selection studies is notoriously low (review by Akey (2009)), so this should not be taken to
mean that fourteen percent of the genome has actually been under selection. Of the variety
of functional classes of genes found to be under positive selection (review by Akey (2009)),
immune-related genes have been shown in multiple studies to exhibit some of the strongest
signals of selection (see reviews by Barreiro and Quintana-Murci (2010); Karlsson et al.
(2014); Quintana-Murci and Clark (2013); Siddle and Quintana-Murci (2014)). Specifically,
according to Barreiro et al., 360 genes with immune function have been found to exhibit
significant signs of positive selection in at least one study (review by Barreiro and Quintana-
Murci (2010)). Not only do some immune-related genes display strong signals of selection,
but the immune gene class as a whole is significantly overrepresented in regions found to
have experienced recent positive selection (Voight et al., 2006b; Wang et al., 2006)(see also
review by Barreiro and Quintana-Murci (2010)).
Further evidence for the impact of infectious disease on the human genome is given
by studies showing that diversity at immune-related genes is driven by pathogen richness
(Fumagalli et al., 2009a,b; Prugnolle et al., 2005a)(see also review by Barreiro and Quintana-
Murci (2010)). While it can be difficult to assign a particular cause to a selection event,
migrations across Eurasia, the Neolithic expansion and rise of agriculture, and trade links and
colonization between continents all presented evolutionarily recent immunological challenges
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which may have given rise to the selection signatures we see today (review by Karlsson et al.
(2014)).
In general, the types of immune genes that might be expected to have undergone positive
selection are those where a specific, directional change is beneficial, such as selection for or
against cell-surface proteins that are used by viruses during a viral infection (Van Blerkom,
2003). One famous example of this is the positive selection on a deletion in the gene CCR5,
which produces a chemokine receptor on white blood cells used by HIV during an infection
(see Section 1.5.) In a list of genes suggested to be targets of positive selection by more than
one study, genes included components of the complement system, chemokines, interleukins,
interferon-related genes, various protein kinases, different viral receptors, and other genes
with less obvious connections to immune function (review by Barreiro and Quintana-Murci
(2010)). These gene categories largely fall into those chosen to be examined in this thesis.
3.2 Results of window-based tests: nSL, iHS, and Tajima’s
D
The nSL, iHS, and Tajima’s D tests were all run in 200 KB windows across the whole
genome (leaving out regions that didn’t pass a coverage filter, please see Chapter 2 for more
information) and each window was assigned a test score. This information was published in
the Pagani et al. 2016 paper (Pagani et al., 2016). Windows with the highest test scores (or
lowest, in the case of Tajima’s D) are the regions that are the best candidates for having been
under past positive selection. In order to focus on the most likely candidates and eliminate at
least some of the false positives, only the top one percent of windows were considered for
selection candidates. These windows are informative in several ways. They can be used to
look for enrichment of immune genes in the top results. They can also be used as a starting
point for looking for individual SNPs that may be driving signals of selection. As a reminder,
the nSL and iHS tests are best powered to find signals of selection younger than 25,000 years
old, whereas Tajima’s D best finds signals between 50,000 and 250,000 years old. Therefore
the results in the following sections represent selection on different timescales.
3.2.1 Enrichment for immune genes in top results
In order to see whether top selection results are enriched for genes with immune functions,
an enrichment test was performed for each immune category and population in the top one
percent of each of the three window-based tests (see Chapter 2 for more information on
enrichment tests). The results of these enrichment tests can be seen in Tables 3.1 through 3.5.
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These tables show positive enrichment, where more immune genes are represented in the top
one percent of results than would be expected given a uniform distribution of immune genes
in the selection results.
nSL
The results of the enrichment tests for the nSL statistic are shown in Table 3.1. The pale
orange cells show significant positive enrichment for immune genes in a given category,
and darker orange cells show significance at a smaller p-value. In this test, there is a
wide distribution of enrichment results across most immune gene classes and populations.
The bacteria and virus genes from both the GO database and the HPI database both show
significant enrichments, though generally not in the same populations. The only overlap is in
the Northeast European population in genes involved in defense against bacterial infections.
Some of the most striking enrichments are in T cell genes in the Northeast Siberian population,
antigen processing and presentation genes in the Island Southeast Asian population, and
innate immune genes in the Colla population.
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Table 3.1 Enrichment of top one percent windows from the nSL test containing immune genes
based on the GO DB and HPIDB. The "exp" row gives the expected number of windows
containing immune genes in any given one percent of the data, and the counts in each cell
represent the number of windows containing immune genes of a given category in the top
one percent of windows. Light orange indicates significant enrichment at p = 0.05, dark
orange at p=0.01 in a Fisher’s exact test with correction for multiple testing, as described in
Chapter 2.
It is interesting to know which genes are driving significant signals of enrichment. A
subset of these (based on clear immune function based on the literature) is shown in Table
3.2. Please note that the necessarily concise descriptions of genes in the results presented
in Chapters 3 and 4 are not comprehensive and are largely focused on how each of the
genes relates to immune function.The full list of immune genes from each significantly
enriched category are listed in Appendix B. Genes from the HPIDB categories are not shown
here or included in descriptions of enrichment tables for other statistics, since there are
many more genes in those categories, and many are shared with the categories from the
Gene Ontology DB. The descriptions of the genes in the enrichment table are divided into
paragraphs according to the immune gene category in which they appear. Additionally, since
some genes appear in multiple immune gene categories, they will be described in the first
category in which they appear but not repeated in every category.
Based on Table 3.2, there is not much sharing of genes driving enrichment signals
between populations. There are some genes that are shared between populations (such as
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TNFSF4 in the South Siberia and Mongolian and Central Siberian populations), but these are
often shared between populations that are relatively close geographically. This pattern fits
with nSL as a measure of relatively recent, local selection.
Table 3.2 Subset of immune-related genes driving significant nSL enrichment signals
In the enrichment results for the GO.Bacteria gene category and in the Northeast European
population, LCN2 (lipocalin 2) expression is TLR-induced, playing an important role in the
innate immune response to bacterial infection via sequestration of iron (Flo et al., 2004). In
the Colla population, CHIT1, or chitinase 1, is a marker of macrophage activation and has
been associated with immune response to tuberculosis and leprosy (Cakır et al., 2012; Iyer
et al., 2009), as well as malaria, allergies, and fungal infections (Di Rosa et al., 2012). Various
defensin genes such as DEFA1, DEFA1B, DEFA3, and DEFA5 appear in multiple immune
categories (GO.Bact, GO.Virus, GO.Innate) in different populations, namely the Colla and
the South Siberian and Mongolian populations. Defensins are antimicrobial peptides found
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in mucosal surfaces and secretions (Murray et al., 2009). In the Island Southeast Asian
population, ERAP1 in the GO.Bact category plays role in peptide processing by the MHC
and has been implicated in psoriasis susceptibility (Strange et al., 2010). Also in the results
for the Island Southeast Asian population, TLR4 is one of the keystones of the innate immune
response to infection. It is most well known as a receptor for LPS, or lipopolysaccharide,
which is part of the cell membrane of Gram-negative bacteria. However, it also responds to
respiratory syncytial virus and hepatitis C virus (Murray et al., 2009).
In the enrichment results for the GO.Virus category and the Northeast European popu-
lation, CXCR4 is one of the receptors used by HIV to enter human T cells (Murray et al.,
2009). DUOX2 is a NADPH oxidase that is induced by interferon and plays a role in
antiviral immune response (Fink et al., 2013). HLA-A, HLA-F and HLA-G appear in this
list in the GO.Virus, GO.Tcell and GO.APP categories in the Colla and Island Southeast
Asian populations. HLA genes are highly polymorphic genes involved in antigen process-
ing and presentation. IFNLR1, or IL28RA, is in a top window in the GO.Virus category
in the Colla population. Again in the Colla population, IFNLR is a receptor for type-III
interferons and IFNLR1 is one of the subunits of that receptor and is expressed in epithelial
cells. Knockout mice for this gene experienced increased viral titers or increased shedding
(in general, stronger infections) when infected with a variety of viruses including West
Nile virus, norovirus, rotavirus, and influenza virus (review by Lazear et al. (2015)). When
inhibited in humans cells infected with influenza, increased titers of the virus were observed
(review by Lazear et al. (2015)). Blockage of the protein product of this gene has been
suggested as a way to boost vaccine response (Egli et al., 2014). TRIM56 is a ubiquitin ligase
whose expression is induced by interferon and is involved in the innate immune response to
double-stranded DNA virus infection (Tsuchida et al., 2010), and plays a role in immune
response against influenza virus as well (Liu et al., 2016a). UNC93B1 is a transmembrane
protein used by multiple TLRs for passage within the cell and required for their function
(Lee et al., 2013). XPO1, or exportin 1, has been shown to be associated with influenza
replication. Inhibition of XPO1 led to a reduction in replication of influenza virus and this
gene has been suggested as a potential drug target (Perwitasari et al., 2014). In the Mainland
Southeast Asian population, CD86 is involved in the induction of T cell immune response
(Freeman et al., 1993). EPHA2 is an ephrin receptor that is a host factor for hepatitis C
virus and has been suggested to be a potential target for antiviral treatment (Lupberger et al.,
2011). TRIM23 is important in the TLR3 antiviral and innate immune response (Arimoto
et al., 2010).
In the results for the T cell category of genes and in the Central Siberian population
(though it also appears in other immune gene categories), TNFSF4 is a member of the tumor
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necrosis factor family that is expressed on antigen presenting cells and is a stimulator for
T cells. It has been associated with risk for autoimmune disease (Graham et al., 2007;
Gramaglia et al., 1998; Ohshima et al., 1997). In the Northeast Siberian population, NDFIP1
is a regulator of gastrointestinal inflammation caused by T cells (Ramon et al., 2010). SMAD3
is a transcription factor involved in the regulation of T cell activation via TGF-b and mucosal
immunity, as well as activation of interferon-b (Qing et al., 2004; Yang, 1999).
There are several cytokine genes that appear in different categories and populations. IL1A
and IL1B play a role in the innate immune response and appear in the Central Siberian
population in the GO.Tcell category. IL4 and IL7 are involved in the Th2 response and are in
the Western Asian and Armenian and Central Siberian populations for the GO.Bcell category
(Murray et al., 2009). In the Colla population, IL27 (GO.Innate, GO.Virus) and IL22RA1
(GO.Bact) also appear in top windows. IL15 is in a top window in the GO.Tcell category of
the Northeast Siberian population population.
In the results for the innate immune category and in the Western Siberian population, the
gene DDX58 produces the protein RIG-I, which is an interferon-induced recognizer of viral
DNA/RNA and plays a role in the antiviral immune response (Malathi et al., 2007; Ramos and
Gale, 2011; Suárez-Calvet et al., 2014). LGR4 is a modulator of TLR2 and TLR4 function
(Du et al., 2013). In the South Siberian and Mongolian population, RNF125 is involved in
the regulation of RIG-I signaling (Arimoto et al., 2007). CAMK4 has been shown to play
a role in the regulation of antibody response in a mouse influenza vaccine study (Nakaya
et al., 2011). It is also involved in the inflammatory response and T cell development (Illario
et al., 2008; Krebs et al., 1997). NCF1 has a role in the oxidase complex and mice with
mutations in this gene experience deficient neutrophil killing (Miao et al., 2010a; Sumimoto
et al., 2005). Mutations in NRG1 have been associated with immune dysregulation, including
increased levels of autoimmune markers and altered cytokine expression (Marballi et al.,
2010). TICAM2 is a TLR adaptor that is involved in the TLR4 immune response (Seya et al.,
2005). Variants in this gene have been associated with TB susceptibility (Hall et al., 2014).
In the Central Siberian population, DDX41 is a helicase that activates an interferon innate
immune response to bacterial messengers cyclic di-GMP and cyclic di-AMP (Parvatiyar
et al., 2012). DMBT1 is involved in pathogen recognition in mucosal tissues (Bikker et al.,
2002; Rosenstiel et al., 2007). IRAK2 plays a role in the early and late phases of the innate
immune TLR response (Kawagoe et al., 2008). In the results for the Colla population, AGO1
and AGO3 have been implicated in a mouse study of influenza A infection to be involved
in tolerance of inflammation in the lung during infection (Van Stry et al., 2012). FCN3 is a
pattern recognition molecule that is involved in the lectin complement pathway, with highest
expression in the lungs (Garred et al., 2009; Hummelshoj et al., 2008). In the Mainland
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Southeast Asian population, C4B is part of the complement pathway, which is part of the
innate immune response against bacterial infection (Murray et al., 2009).
AP2M1 in the antigen processing and presentation category is a membrane trafficking
protein that is essential for HCV replication and assembly (Neveu et al., 2012). This gene was
in the enrichment results for both the South Siberian and Mongolian and Colla populations.
In the enrichment results for the Go.Adapt gene category in the South Asian population,
ZAP70 is required for the formation of the immune synapse (Blanchard et al., 2002).
iHS
Table 3.3 shows the results for the enrichment test results based on the iHS statistic.
Compared to the nSL test, there are more enrichments in the GO.Virus (though not the
GO.Bact), HP.Bact, and HP.Virus categories. There are also fewer GO.APP enrichments and
GO.Innate enrichments. Some of the most striking enrichments are in the GO.Virus category,
in the Volga Uralic, Colla, and Mainland Southeast Asia populations. The Southwest
European population in the GO.APP category is also very enriched for top iHS scores.
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Table 3.3 Enrichment of top one percent windows from the iHS test containing immune genes
based on the GO DB and HPIDB. The "exp" row gives the expected number of windows
containing immune genes in any given one percent of the data, and the counts in each cell
represent the number of windows containing immune genes of a given category in the top
one percent of windows. Light orange indicates significant enrichment at p = 0.05, dark
orange at p=0.01 in a Fisher’s exact test with correction for multiple testing, as described in
Chapter 2.
The full list of immune genes from each significantly enriched category are listed in
Appendix B. A representative subset of these (based on clear immune function based on the
literature) is shown in Table 3.4. Genes from the HPIDB categories are not shown here, since
there are many more genes in those categories, and many are shared with the categories from
the Gene Ontology DB. Several of the genes in this figure have been discussed in the nSL
enrichment section above and will not be described again. This section is organized in the
same way as the one covering the nSL enrichment results, where one immune gene category
is described per paragraph.
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Table 3.4 Subset of immune-related genes driving significant iHS enrichment signals
In the enrichment results for the GO.Virus category and in the Southwest European
population, TNFRSF14 is a receptor used by herpes simplex virus 1 to enter human cells and
has been implicated in autoimmune disease (see review by Steinberg et al. (2011)). DDX5 is
involved in TH17 cell differentiation and function, and this association has led DDX5 to be
suggested as a target for minimizing pathogenesis caused by the pro-inflammatory effects of
TH17 (Huang et al., 2015). TH17 cells are T cells that are involved in protection of mucosal
surfaces from bacteria and fungi, but also are involved in autoimmune and inflammatory
disease (Huh et al., 2011; Weaver et al., 2007). RPLP1 is a phosphoprotein that has been
identified as an essential host factor for flavivirus infection (Campos et al., 2016). In the
Volga Uralic population, HNRNPK has been implicated in the viral replication of influenza
A virus (Tsai et al., 2013). In a study of macaque proteome response to influenza infection,
PSMC2 had a strong correlation with disease (Brown et al., 2010). SRPK2 is involved in
hepatitis B infection and has been suggested as a potential target for therapeutic intervention
(Daub et al., 2002). In the South Asian population, CD247 is involved in T cell signaling and
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variants in this gene have been associated with multiple autoimmune diseases (Holmberg
et al., 2016). In the Western Siberian population, SYNCRIP is involved in hepatitis C virus
replication (Liu et al., 2009). In the Colla population, ANKRD17 is involved in regulating
RLR (RIG-I-like)-associated immune response in response to viral RNA (Wang et al., 2012b).
In the Mainland Southeast Asian population, RHOA is a GTPase that has been suggested as
an antiviral target for viruses that cause syncytium (Pastey et al., 2000).
In the enrichment results for the T cell gene category and in the South Siberian and
Mongolian populations, variants in the tyrosine phosphatase gene PTPN22 have been linked
to multiple autoimmune diseases, potentially through altered T cell receptor signaling (see
review by Bottini et al. (2006)). In the Northeast Siberian population, ZEB1 is involved in T
cell development and memory B cell response (Arnold et al., 2012).
In the B cell category, both FNIP1 in the Southwest European population and GON4L
in the West Asian and Armenian population play a role in B cell lymphopoiesis (Lu et al.,
2010; Park et al., 2012). In the West Asian and Armenian population, MZB1 influences
antibody secretion and calcium homeostasis in innate-like B cells (Flach et al., 2010). In the
Volga Uralic population, LAT and LAT2 are transmembrane adaptor proteins that play a role
in the activation of of T cells and B cells (and other immune cells), respectively (Brdička
et al., 2002). In the South Siberian and Mongolian population, CD19 has been associated
with humoral immune response. Lower CD19 expression results in suppressed immune
response (Ogura et al., 2016). In the Island Southeast Asian population, BANK1 is an adaptor
protein for B cells and has been associated with autoimmune disease risk (Jordan et al., 2003;
Kozyrev et al., 2008).
In the enrichment results for the innate immune category and in the Volga Uralic and
Colla populations, ADRBK1, or GRK2, is a G protein-coupled receptor kinase expressed at
relatively high levels in immune cells and its expression levels are altered in experimental
models of autoimmune disease. It plays a role in the innate immune response to infection
(see review by Vroon et al. (2006)). In the Volga Uralic population, TRAFD1, or FLN29,
has a dampening effect on the innate immune response to LPS. Knockout mice for this gene
were more susceptible to sepsis than wild type mice (Sanada et al., 2008). In the Colla
population, TYRO3 is an immunoregulatory receptor tyrosine kinase. Knockout mice for
this gene develop autoimmunity (Lu, 2001).
In the adaptive immunity category and the Central Siberian population, TGFB1 is a
cytokine that promotes TH17 cell function (Murray et al., 2009) and is seen in the Central
Siberian population in both the GO.Adapt and the HP.Bact categories.
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Tajima’s D
Based on Table 3.5, there is more sharing of significant enrichment between populations
than there was for either the nSL or the iHS tests. Given that Tajima’s D is supposed to pick
up older signals of selection, these could be older shared signals of selection that are shown
here compared to the younger selection signals shown in the results of the nSL or iHS tests.
Every population is enriched in the HP.Bact category, and many are significantly enriched
in the GO.Bact category as well. The West and Central African population is significantly
enriched in the GO.APP category.
Table 3.5 Enrichment of top one percent windows from the Tajima’s D test containing immune genes
based on the GO DB and HPIDB. The "exp" row gives the expected number of windows
containing immune genes in any given one percent of the data, and the counts in each cell
represent the number of windows containing immune genes of a given category in the top
one percent of windows. Light orange indicates significant enrichment at p = 0.05, dark
orange at p=0.01 in a Fisher’s exact test with correction for multiple testing, as described in
Chapter 2.
A subset of genes driving the above enrichment signals is shown in Table 3.6. The full
list of immune genes from each significantly enriched category are listed in Appendix B.
Sharing at the specific gene level is higher in the Tajima’s D results as well when compared
to the nSL and iHS results, as shown in Table 3.6. Many of the populations share a core set
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of genes driving the selection signal in a given class of genes. Descriptions for genes below
may appear in the descriptions for the enrichment tables for the nSL and iHS tests.
In general, when compared to the enrichment results of the nSL and iHS populations, the
Tajima’s D enrichment results show more sharing of genes between populations. Unlike in
the nSL and IHS enrichment results, there are some significant enrichments in the West and
Central African population. In the case of enrichments in the GO.Virus category, two genes
(TMEM173 and RTN3) are found in both African and non-African populations, suggesting a
potentially relatively ancient selection pressure shared that predates the split between modern
African and non-African populations.
Table 3.6 Subset of immune-related genes driving significant Tajima’s D positive selection enrichment
signals
In the enrichment results GO.Bacteria category and in the Colla population, CD36 is a
receptor for bacteria and contributes to the immune response to especially Gram-negative
bacteria and LPS (Baranova et al., 2008). GPX1, or glutathione peroxidase-1, plays a role in
the inflammatory response in the intestine in a mouse model (Esworthy et al., 2001).
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In the GO.Virus category in the West and Central African population, HNRNPA1 is
an RNA-binding protein that plays a role in hepatitis C replication (Kim et al., 2007).
MAGI3 interacts with multiple viruses, including HPV and influenza A (Golebiewski et al.,
2011; Thomas et al., 2002). RTN3 is involved in enterovirus replication (Tang et al., 2006).
SNRNP200 is an RNA helicase that is an RNA sensor and activator of the innate antiviral
immune response (Tremblay et al., 2016). TMEM173, or STING (stimulator of interferon
genes), plays a role in innate immune response to viral infection and interferon production
(Ishikawa and Barber, 2008). In the West Asian and Armenian population, HDAC1 is a
histone deacetylase that plays a role in the regulation of TLR and interferon response (see
review by Shakespear et al. (2011)). LCK plays a role in T cell receptor signaling (Philipsen
et al., 2017). STAT2 in the West Asian and Armenian and Southwest European populations
associates with HDAC1 and is also important in the innate immune viral response (Nusinzon
and Horvath, 2003). In the Colla population, NXF1 is a nuclear export factor that has a role
in influenza virus replication (Karlas et al., 2010; Satterly et al., 2007). STAT3 is involved
in antigen-specific tolerance in T cells (Cheng et al., 2003) and plays a role in hepatitis C
infection (Yoshida et al., 2002).
In the enrichment results for the T cell category and in the Northeast European population,
SLA2, or SLAP, is an adaptor protein that plays a role in signal regulation of multiple types
of immune cells (see review by Kazi et al. (2015)). THEMIS2 is involved in macrophage
inflammatory responses (Peirce et al., 2010).
In the B cell category and in the West and Central African population, PTEN plays a role
in modulation of the innate immune response (Günzl and Schabbauer, 2008). PTPN22 is
involved in the antiviral immune response and regulation of interferon secretion (Wang et al.,
2013b).
In the innate immune category and South Siberian and Mongolian population, GRB2
performs an inhibitory role in T cells along with LAT (Yamasaki et al., 2003). In the Island
Southeast Asian population, NCK1 is involved in formation of immune synapses between
antigen-presenting cells and T cells (Yiemwattana et al., 2011). NFATC3 is a regulator of T
cell receptor responsiveness (Rengarajan et al., 2001).
3.2.2 Finding driver SNPs
Enrichment results from the previous sections list many promising and exciting potential
immune targets of selection. The long list of genes supports previous findings that immune
genes are often among the top results for positive selection. However, while genes in the top
one percent of results discussed in the previous section may indeed be targets of positive
selection, this list of genes can also serve as a starting point for further analysis. The genes
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highlighted in this section often share their 200 KB window with other genes that may not
be associated with immunity. Therefore, the next step in this analysis is to narrow down the
selection signal in each top window to find potential causative SNPs (or SNPs that are in
linkage with causative SNPs) that are in immune genes.
Overall characteristics of significant SNPs
The method for finding individual SNPs based on the results from the genome-wide
window-based nSL, iHS, and Tajima’s D tests is described in Chapter 2 and is summarized
by Figure 3.1. In short, the top one percent of results based on each of the window-based
tests was run through a DIND filter, which resulted in SNPs that are derived alleles at
high frequency and linked with lower diversity sites than would be expected under neutral
conditions, suggesting positive selection. These SNPs were then passed through the CADD
filter (see Section 2.5 on page 37) of functional importance, which scored each SNP based
on a large number of scores including evolutionary conservation and predicted functional
deleteriousness. Those SNPs that passed the CADD cutoff statistic were then run through
the Kaviar tool (Glusman et al., 2011) to assign them to rsIDs, which were run through
the Ensembl Variant Effect Predictor (Version GRCh37) (Zerbino et al., 2017) to find SNP
consequences, gene names, and other characteristics.










Fig. 3.1 Flow chart of window-based positive selection analysis.
After passing through the statistical and functional filters shown above, a total of 755
unique SNPs were counted as significant in all 13 populations. The number of significant
SNPs per population can be seen in Table 3.7. There are the most significant SNPs in the
West and Central African population, which has over twice as many as any other population.
The Northeast Siberian population has the fewest significant SNPs.
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No. top 1% 200 KB SNPs above SNPs above
wins (all tests) ! DIND cutoff ! CADD cutoff
AFR 375 11281 147
WAA 375 3464 37
SWE 375 3428 48
ENE 375 4317 63
VOL 375 4598 61
SOA 375 4090 56
WSI 375 2695 43
SSI 375 4049 52
CSI 375 2844 38
NSI 375 1893 28
COL 373 3016 53
SEM 375 3700 52
SEA 375 3477 77
Table 3.7 Number of windows and SNPs before and after the DIND and CADD filters
Figure 3.2 shows the relative number of SNPs with different Variant Effect Predictor
(VEP)-defined consequences between the thirteen populations. The West and Central African
population has the most variants at this stage overall, and that is evident from the figure.
This figure is also a quick way to compare relative levels of different types of variants in the
filtered dataset as a whole. The largest classes of variants are intron variants and non coding
transcript variants. There are a fair number of missense variants, and very few stop gain or
splice acceptor variants.





























































































































































































Fig. 3.2 Relative numbers of variants in each VEP-defined functional class. Each population is shown
in a different color. "NMD" is an abbreviation for nonsense-mediated decay, "UTR" for
untranslated region, and "TF" for transcription factor.
Figure 3.3 shows a distribution of CADD score for different Variant Effect Predictor
variant types, separated into facets by VEP-defined impact. The four levels of impact are
high, moderate, low, and modifier (labeled as A, B, C, and D, respectively). This shows how
CADD ranks different types of variants in this dataset, as well as shows that the VEP-defined
impact levels and the CADD scores generally tend to be in overall agreement.
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Fig. 3.3 Comparison of CADD scores and VEP impact categorizations (defined by VEP as "subjective
impact classification of consequence type"). VEP-defined consequences are on the x-axis,
and the data is separated into facets by impact. The four impact levels are "high", "moderate",
"low", and "modifier", denoted by the labels A, B, C, and D, respectively. "NMD" is an
abbreviation for nonsense-mediated decay, "UTR" for untranslated region, and "TF" for
transcription factor.
Population-specific significant SNPs
In the following sections, a subset of the significant SNPs from the DIND and CADD
filter will be presented along with the derived allele frequency in each population, the VEP-
predicted consequence ("Cons."), the CADD score, the gene or genes associated with the
SNP, and the window-based test in which the given SNP was in the top one percent of results.
The full list of significant SNPs for each population can be found in Appendix C. SNPs were
chosen for presentation in the following sections (in Tables 3.9 through 3.21) because of
immune function or other function of interest based on a literature search. The colors in the
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tables are a heat map-style visual representation of derived allele frequency. SNPs that are
located near each other on a chromosome are grouped together by horizontal lines, as are
SNPs that were assigned to multiple genes by the VEP. This is because likely only one SNP
in a given region is causing a signal of positive selection, and others around it appear in the
top results due to being in linkage disequilibrium with the driver SNP. Sometimes a given
SNP appears multiple times, because VEP has assigned it multiple genes or consequences.
Genes will be described in the first population in which they are significant, though they may
be in the top results for more than one population. Table 3.8 shows the different abbreviations
that are used in the following tables.
Column Abbreviation Full term
Tests T Tajima’s D
Tests N nSL
Tests I iHS
Cons. I intron variant
Cons. N non coding transcript variant
Cons. M missense variant
Cons. 5 5 prime UTR variant
Cons. 3 3 prime UTR variant
Cons. SR splice region variant
Cons. S synonymous variant
Cons. D downstream gene variant
Cons. IG intergenic variant
Cons. R regulatory region variant
Cons. U upstream gene variant
Cons. NC non coding transcript exon variant
Cons. SA splice acceptor variant
Cons. TF TF binging site variant
Cons. NMD NMD transcript variant
Cons. SG stop gained
Table 3.8 Abbreviations used in significant SNP tables. "NMD" is an abbreviation for nonsense-
mediated decay, "UTR" for untranslated region, and "TF" for transcription factor.
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Significant SNPs in the West and Central African population
Table 3.9 Derived allele frequencies of immune-related DIND-significant SNPs in the West and
Central African population compared to other populations
The SNPs presented in Table 3.9 can be separated into several different broad functional
categories. One of these categories is T cell function. ITGAE, or CD103, is a receptor
expressed on T cells and dendritic cells and is involved in immune homeostasis in both the
intestine and the airways. In the intestine, its expression or lack thereof by dendritic cells
determines the ratio of effector to regulatory T cells (Annacker et al., 2005). In the airways,
its expression may maintain the balance between regulatory T cells and Th2 effector cells.
This balance influences asthma susceptibility, tolerance to inhaled allergens, and clearance
of respiratory viral infections (Nawijn et al., 2011), such as pulmonary poxvirus in mice
(Beauchamp et al., 2010). ITGAE is in a region of the genome that has been shown to be
under selection in a Yoruban population (The International HapMap Consortium, 2005).
CD276 also has an important role in T cell stimulation, and is released from monocytes,
activated T cells, and monocyte-derived dendritic cells (Zhang et al., 2008). In a study of
meningitis in children, higher levels of CD276 were found to be circulating in patients with
bacterial meningitis compared to aseptic meningitis or controls, and it was suggested that the
60 Results: Positive selection
levels of circulating CD276 can be a useful tool in discerning the intensity of inflammation
of the infection (Chen et al., 2009b). FOXO3 is a transcription factor that is involved in the
immune response via modulation of dendritic cells and magnitude of T cell response (Dejean
et al., 2009). RGS3 is a regulator of G protein signaling protein, and is involved in T cell
migration (Williams et al., 2013). NPNT (nephronectin) plays a role in kidney development,
but is also involved in hepatitis. In mouse models, it is upregulated and attracts T cells to the
liver, which causes more acute disease. It is also involved in human hepatitis (Inagaki et al.,
2013).
Another broad category of function is that of activation of other immune cells and the
innate immune response. In a comparative genomics study, TULP4 was identified as a host
defense gene in C. elegans and a regulator of cytokine production in mouse macrophages
(Alper et al., 2008). FBXL7 is a ubiquitin protein ligase that interacts with members of
the TLR7/9 pathway and is involved in the innate immune response (Chiang et al., 2012).
MAL codes for a protein that is necessary for TLR4 signal transduction. This implies its
importance in bacterial infections and to LPS specifically (Fitzgerald et al., 2001). RABGEF1
is a negative activator of skin inflammation and mast cell activation (Tam et al., 2004). RTN3
has been suggested to be involved in monocyte differentiation and recruitment (Chen et al.,
2011).
Viral interaction is another category of immune function represented in Table 3.9. CPVL
is a carboxypeptidase that plays a role in the immune system as well as other body systems.
In macrophages, it is thought that CPVL may participate in pruning antigen peptides for
presentation or digestion in the lysosome (Mahoney et al., 2001). In a comparison of hepatic
transcriptomes between patients with chronic hepatitis B who responded to peginterferon
treatment and those who did not, CPVL expression was associated with patient response in
hepatitis B e antigen, and higher expression was associated with loss of hepatitis B surface
antigen after two years (Jansen et al., 2015). This suggests that CPVL plays a role in immune
response to viral infection. HMGCR is associated with cholesterol biosynthesis that plays an
important role in the pathogenesis of West Nile Virus and potentially other flaviviruses. It
is upregulated in infected cells, which allows for a larger intracellular membrane platform
on which the virus can replicate (Mackenzie et al., 2007). However, this gene also has other
biologically important functions, such as muscle differentiation and regeneration (Mammen
et al., 2011; Martini et al., 2009), and it also is the pharmalogic target of statin medications
(Mammen et al., 2011).
Finally, MAGI3 is a gene that is associated with tight junctions in the intestine. Decreased
expression of MAGI3 was associated with inflammatory bowel disease and ulcerative colitis
in a Swedish population, potentially via promotion of intestinal inflammation. This suggests
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a role for this gene in the relationship between the gut microbiome and immune system
(Norén et al., 2017). Several SNPs in MAGI3 have also been associated with HPV clearance
in HIV-positive women (Sudenga et al., 2014).
Significant SNPs in the West Asian and Armenian population
Table 3.10 Derived allele frequencies of immune-related DIND-significant SNPs in the West Asian
and Armenian population compared to other populations
MAST2 is a signaling cofactor of TLR7/9, and has been associated via GWAS with
Crohn’s disease and rheumatoid arthritis, which are both autoimmune diseases. TLR7 and
TLR9 are microbial pattern recognition receptors that instigate an innate immune response to
infection (Chiang et al., 2012).
KCNH5 is a potassium channel gene that has been found to be associated with severe
cholera infection and to have been under positive selection in a Bangladeshi population
(Karlsson et al., 2013).
NEB, or nebulin, plays an important role in skeletal muscle (Horowits et al., 1986).
While not related to immune function, it is included here because of its striking geographic
pattern of derived allele frequency. It’s interesting to note that this missense SNP has a high
frequency in the Colla population, who also have a number of missense SNPs in the titin
gene, which also plays an important role in skeletal muscle.
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Significant SNPs in the Southwest European population
Table 3.11 Derived allele frequencies of immune-related DIND-significant SNPs in the Southwest
European population compared to other populations
R3HDM1 is underexpressed in patients with celiac disease, which suggests a role in
inflammation and autoimmunity and therefore perhaps also immune response (Garcia-
Etxebarria et al., 2016). However, the SNP represented here (rs1446585 or 2:136407479)
in R3HDM1 is in linkage disequilibrium with rs4988235, which is correlated with lactase
persistence (Goodrich et al., 2016). rs1446585 is also associated with levels of Bifidobac-
terium in the gut microbiome, however, this correlation may also be due to confounding
by the lactase persistence SNP (Goodrich et al., 2016). It is possible that the signature of
selection seen in this SNP is driven by the adaptive advantage of lactase persistence.
MSR1, or macrophage scavenger receptor1, binds to extracellular double-stranded RNA
and transports it into the cell so it can be bound to by TLR3, which then sets off the
innate immune response to viral infection via activation of interferons (Dansako et al., 2013;
DeWitte-Orr et al., 2010).
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Significant SNPs in the Northeast European population
Table 3.12 Derived allele frequencies of immune-related DIND-significant SNPs in the Northeast
European population compared to other populations
One broad category of genes shown in Table 3.12 are those that have been associated with
immune disease. KCNK2, or TREK1, codes for a potassium channel that regulates immune
cell entry into the central nervous system. Knockout mice for this gene experienced more
severe experimental autoimmune encephalomyelitis (a mouse model for MS). Therefore,
this gene has been suggested as a potential drug target for diseases involving malfunction
of the blood-brain barrier (Bittner et al., 2013). This channel is opened by polyunsaturated
fatty acids and lysophospholipids (Maingret et al., 2000; Patel, 1998). KIAA1328 is in a
chromosomal region that has been associated with type 1 diabetes and thus potentially plays
a role in the immune response (Cooper et al., 2009). RTKN2 is involved in T cell activation
and was upregulated in response to a vaccine for enterovirus 71, which causes hand-foot-and-
mouth disease (Liu et al., 2013b). It is also associated with rheumatoid arthritis in a Japanese
population (Myouzen et al., 2012).
Another category of genes are those associated with innate immune response to infection.
CDK8 is responsible for regulation of over forty percent of interferon-g -responsive genes,
via phosphorylation of STAT1. This suggests that it plays an important role in the antiviral
interferon immune response (Bancerek et al., 2013). ZBTB20 is a transcriptional repressor
that promotes activation of TLR signaling. Knockout mice for this gene were less susceptible
to endotoxin shock and sepsis caused by E. coli (Liu et al., 2013c). Mutations in LRBA, the
gene coding for an LPS-responsive anchor protein, have been associated with an immune
deficiency characterized by B cell activation defects and impaired autophagy (Lopez-Herrera
et al., 2012).
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The selection signal seen in the windows containing the genes LCT and MCM6 (two
adjacent 200 KB windows) are both likely due to the well-known selection for lactase
tolerance (see above section on the Southwest European population). Neither of these are
immune-related genes, but are included here because they are well-known signals of positive
selection.
BBS9 has been identified as a leprosy susceptibility locus in a GWAS on a population
with Chinese ancestry, though the mechanism for its involvement in the disease pathogenesis
is unknown (Wang et al., 2016).
Significant SNPs in the Volga Uralic population
Table 3.13 Derived allele frequencies of immune-related DIND-significant SNPs in the Volga Uralic
population compared to other populations
GDF5 is a growth differentiation factor and is involved in LPS signal transduction,
thus serving as part of the innate immune response to Gram-negative bacterial infection
(Triantafilou et al., 2001).
The windows containing the SNPs from the genes R3HDM1 and DARS are the same two
that have been represented in the SWE and ENE populations and are likely coming from the
strong signal of selection on the LCT/MCM6 loci.
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Significant SNPs in the South Asian population
Table 3.14 Derived allele frequencies of immune-related DIND-significant SNPs in the South Asian
population compared to other populations
There are several genes shown in Table 3.14 that play a role in the immune response to
viruses. SFPQ, or splicing factor proline/glutamine-rich, is a repressor of IL8 transcription
and plays a role in regulation of antiviral genes (Imamura et al., 2014). PARD3B has been
associated with the rate of AIDS progression, via interaction with other genes (Troyer
et al., 2011). It is also a tight junction gene and has been associated with celiac disease
and ulcerative colitis (Wapenaar et al., 2007). RUFY3 has been shown to be differentially
regulated during an infection with Dengue virus, though the function of this gene in an
infection is not clear (Folly et al., 2011). Generally, it is expressed in neurons and is involved
in axon growth control (Wei et al., 2014). This SNP was in the top one percent of windows
in each of the three selection tests.
MTOR is a kinase that plays an important role in the maturation, activation, and function
of B cells, T cells, and antigen-presenting cells (Powell et al., 2012). It also plays an important
role in metabolism (see review by Waickman and Powell (2012)).
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EVI5 is a common retroviral integration site (Liao et al., 1995) was shown to be a risk
locus for MS in a Dutch population (Hoppenbrouwers et al., 2008). The two neighboring
windows shown in Figure 3.14 are likely showing the same signal from EVI5.
PRSS53 is a serine protease that is overexpressed in psoriatic skin (Quaranta et al.,
2014; Tsoi et al., 2012). It also plays a role in hair growth and keratinization. rs201075024
(16:31099000) is associated with hair shape at the scalp and hair curliness and has been
detected by the FineMAV method for detecting variants under positive selection for functional
follow-up (Szpak et al., 2018).
rs2229177 (11:60893235) is a missense mutation in the cytoplasmic region of the CD5
gene (Carnero-Montoro et al., 2011; Moreno-Estrada et al., 2009). This cytoplasmic region
is highly conserved between species, potentially implying an important functional role for
this region (Moreno-Estrada et al., 2009). CD5 is a negative regulator of T- and B-cell
receptor signaling and a pathogen-associated molecular pattern (PAMP) receptor for b-
glucans, which are fungal cell wall components (Carnero-Montoro et al., 2011; Vera et al.,
2009). In functional analyses, individuals who are homozygous for the derived allele at this
locus show significantly stronger early and late signaling responses in response to b-glucan
exposure than did ancestral homozygous individuals (Carnero-Montoro et al., 2011). The late
response consisted of the release of the cytokine IL8, attracting neutrophils, which are part
of the immune response to microbial (especially fungal) infections (Carnero-Montoro et al.,
2011). According to the authors of this study, the geographic distribution and the functional
importance of this allele suggest selection pressure from a fungal pathogen in East Asia. This
selection mechanism could be either a direct regulation of interactions between CD5 and
pathogens, or an indirect regulation, by regulating the T cell/B cell receptor (TCR/BCR))
response to infection (Carnero-Montoro et al., 2011). While the varied global diversity of
this SNP may have been produced long ago due to selection pressure from an unknown
fungal pathogen (Carnero-Montoro et al., 2011), its repercussions are relevant today in other
diseases. Due to its decreased inhibition of TCR signaling compared to the derived allele, the
ancestral allele is associated with stronger proliferation of T cells and higher prevalence of
nephritis in autoimmune disease systemic lupus erythematosus (SLE) patients (Cenit et al.,
2014). It has also been suggested that global diversity at this locus may be associated with
the noted variance in severity and incidence of SLE in different ethnic groups (Cenit et al.,
2014). This SNP has been found to be a candidate for selection in East Asian populations
in several previous studies (Carnero-Montoro et al., 2011; Moreno-Estrada et al., 2009). It
shows the highest derived allele frequencies in South and Central Asian populations, as well
as in Siberian and Colla populations.
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Significant SNPs in the Western Siberian population
Table 3.15 Derived allele frequencies of immune-related DIND-significant SNPs in the West Siberian
population compared to other populations
The SNPs in Table 3.15 are separated into two overall loci. The first contains PUM1,
which regulates LGP2. LGP2 is a major regulator of innate immunity genes, including those
involved in the interferon response (Liu et al., 2017).
The second group of SNPs includes one in the gene MARVELD3, which is involved in
susceptibility to malaria, according to a GWAS in a Ghanaian population (Timmann et al.,
2012). MARVELD3 is a tight junction protein that is expressed in endothelial cells and is
thought to be involved in the pathology-causing adherence of malaria-infected erythrocytes
to the endothelium of various internal organs (Gowda and Ockenhouse, 1999).
Significant SNPs in the South Siberian and Mongolian population
Table 3.16 Derived allele frequencies of immune-related DIND-significant SNPs in the South Siberian
and Mongolian population compared to other populations
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EDAR, while not an immune-related gene, is a well known target of selection in several
Asian populations (Sabeti et al., 2007). This gene influences hair thickness, sweat glands,
and tooth development (Botchkarev and Fessing, 2005; Bryk et al., 2008). According to
Fumagalli et al., rs3827760 (2:109513601, the SNP putatively under selection here) shares
a haplotype with multiple other SNPs that were found to be significantly correlated with
helminth diversity (Fumagalli et al., 2010).
CEP63, containing rs1127826 (3:134278270), is associated with bacteria, virus, and
fungi interactions according to the HPIDB. CEP63 is a centrosomal protein involved in
intracellular trafficking and is part of the cellular cytoskeleton. According to Le Baron et
al., many viruses target the host cytoskeleton. The targeting of CEP63 by flaviruses (which
include Dengue, yellow fever, and West Nile virus) is an example of this attack strategy
(Le Breton et al., 2011). According to the HPIDB, this gene also interacts with Hepatitis
C virus, Yersinia pestis, Bacillus anthracis, Francisella tularensis, and yeast, among other
pathogens (Ammari et al., 2016). However, this gene likely has other cellular functions that
are not involved with immune processes.
Significant SNPs in the Central Siberian population
Table 3.17 Derived allele frequencies of immune-related DIND-significant SNPs in the Central
Siberian population compared to other populations
CDK8 is responsible for regulation of over forty percent of interferon-g -responsive
genes, via phosphorylation of STAT1. This suggests that it plays an important role in the
antiviral interferon immune response (Bancerek et al., 2013).
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Significant SNPs in the Northeast Siberian population
Table 3.18 Derived allele frequencies of immune-related DIND-significant SNPs in the Northeast
Siberian population compared to other populations
WARS2 has been shown to have been under positive selection in a Greenlandic Inuit
population. The time of selection is thought to be during the peopling of the Americas,
because the selected haplotype is present in some East Asians and high proportions of Native
Americans. The selected haplotype is thought to be an example of adaptive introgression
from Denisovans. WARS2 is associated with body fat distribution, as well as many other
traits, thus the exact phenotype under selection is not known (Racimo et al., 2016). The SNPs
shown in Figure 3.18 were in the top one percent of windows in each of the three selection
tests.
RGMB, or repulsive guidance molecule b, is involved in promotion of respiratory immu-
nity and respiratory tolerance in the lung, via expansion of T cells to the antigen (Xiao et al.,
2014).
GPR152 is a G-protein coupled receptor with unknown function. However, it is about
thirty percent identical with two proteins (CRTH2 and FPRL1, (Elagoz et al., 2004; Nagata
and Hirai, 2003), respectively) that are both involved in inflammation.Therefore, it is possible
that this gene is also involved in inflammatory processes (Gloriam et al., 2005).
IL27 is included in the list of immune phenotypes for virus, bacteria, innate immunity,
and T cells based on the GO term ontology searches. IL27 is a cytokine that is formed of
two subunits, EBI3 and IL27p28. Mandatory coexpression of these two subunits for the
formation of IL27 prevents out of control systemic inflammation. The receptor of IL27 is
WSX1, which is expressed on naive, effector, regulatory, and memory T cells, as well as NK
cells, macrophages, and mast cells. This variety shows the wide influence of IL27 (Hunter,
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2005). IL27 is produced in response to certain pathogen stimulants as well as host immune
signals such as interferon-g (Hunter, 2005; van de Vosse et al., 2009).
IL27 has both pro- and anti-inflammatory effects. This is a common trait of cytokines
and allows them to influence the immune system in nuanced ways (Hunter, 2005). The
pro-inflammatory effects of IL27 have been shown in cancer and autoimmune studies (Hunter,
2005). In several murine cancer studies, the increased IFN-g production, MHC expression,
and cytotoxic T cell response caused by IL27 overexpression contributed to increased tumor
clearance (Chiyo et al., 2005; Hisada et al., 2004; Salcedo et al., 2004). Evidence from rodent
studies has also shown that by targeting IL27 with antibodies, the severity of rodent arthritis
and multiple sclerosis models can be lessened (Goldberg et al., 2004a,b). In humans, IL27
has a pro-inflammatory effect on monocytes. It does this by activating expression of STAT1
and its target genes, causing a bigger release of inflammatory cytokines by monocytes upon
TLR exposure, and causing a reduction in the production and function of IL10 (Kalliolias
and Ivashkiv, 2008; Murray et al., 2009). Since IL10 is anti-inflammatory and is involved
in monocyte deactivation, inhibiting IL10 has pro-inflammatory effects. However, this pro-
inflammatory role for IL27 in monocytes is short-lived and self-limiting, lasting for only
around 30 minutes after TLR-ligand binding. This is because the production of gp130, one
of the subunits of the IL27 receptor, is inhibited by the presence of TLRs (Kalliolias and
Ivashkiv, 2008).
Despite its involvement in pro-inflammatory processes, IL27’s most important role seems
to be limiting the innate and adaptive immune response. Multiple animal studies have
demonstrated that animals deficient in the IL27/WSX-1 pathway, though able to mount
normal or more effective than wild type early immune response to pathogen stimulus, suffer
severe or lethal pathogenic effects from an inability to downregulate the initial immune
response (Hamano et al., 2003; Hölscher et al., 2005; Villarino et al., 2003). The absence
of WSX1 on other immune cell types such as NK cells and macrophages leads to increased
levels of inflammatory cytokines compared to the wild type (Artis et al., 2004a; Villarino
et al., 2005; Yamanaka et al., 2004). As in mice, IL27 has an anti-inflammatory effect on
human T cells through promotion of IL10 and inhibition of IL17. Upon activation by IL27,
CD4+ T cells stimulate the differentiation of Tr1 (T regulatory type 1) cells, which play an
important role in self-tolerance (Murugaiyan et al., 2009; Pot et al., 2011). Tr1 cells produce
IL10, which suppresses T cell response and the release of inflammatory cytokines (Murray
et al., 2009; Murugaiyan et al., 2009). In addition to its promoting effect on IL10, IL27 also
has an inhibitory effect on the pro-inflammatory IL17 (Murugaiyan et al., 2009). IL17 has
been found to be involved in various human autoimmune diseases (Murugaiyan et al., 2009).
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In mouse studies, IL17-deficient mice are partially protected from experimental models of
autoimmune disease (Komiyama et al., 2006).
IL27 also has antiviral functions. It inhibits replication of influenza A and hepatitis C
viruses by phosphorylation of STAT genes and antiviral factor protein kinase R (Frank et al.,
2010; Liu et al., 2012). It inhibits the replication of HIV by inducing interferon-inducible
genes in macrophages (Imamichi et al., 2008).
rs181206 (16:28513403) in IL27 has been associated with susceptibility to asthma and
inflammatory bowel disease (Chae et al., 2007; Li et al., 2009; Zicca et al., 2014).
Significant SNPs in the Colla population
Table 3.19 Derived allele frequencies of immune-related DIND-significant SNPs in the Colla popula-
tion compared to other populations
Several genes shown in Table 3.19 are involved with immune response to viral infection.
ATF6 is involved in West Nile Virus replication via the inhibition of innate immune response
and the promotion of cell survival (Ambrose and Mackenzie, 2012). ASF1A is a histone
chaperone and participates in DNA replication and repair (Mousson et al., 2006). It has
been shown to play a role in the human antiviral immune response through regulation of
interferon-b (Liu et al., 2016b). IQCB1 is included in the HPIDB because it has been shown
to experimentally co-immunoprecipitate, or physically bind to, with the PA protein of the
Influenza A virus. Over 1,000 human genes are involved in an influenza infection (Watanabe
et al., 2014).
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CASR is a calcium-sensing receptor that has been implicated in a mouse model of colitis.
Knockout mice for this gene had compromised intestinal barrier functions, different makeup
of the intestinal microbiome, and were prone to inflammation in the intestine (Cheng et al.,
2014).
SYTL3 is also known as SLP3, or synaptotagmin-like protein 3. According to the HPIDB,
it is known to interact with bacterial pathogens. Along with Rab27a and kinesin-1, it is part
of a complex that plays a role in transporting lytic granules of cytotoxic T cells (CTLs) to the
immune synapse (where the CTL meets the target cell). CTLs defend against cells infected
by viruses, as well as cancerous cells. They act by attaching to the target cell and sending
out lytic granules, which contain perforin and other cytotoxic molecules such as granzymes
(Kurowska et al., 2012). This perforin helps granzymes to enter the target cell, which triggers
an apoptotic cascade and causes the target cell to die (Dieckmann et al., 2016).
rs148608573 (1:36638206) shows a striking difference in derived allele frequency in the
COL population compared to all others. MAP7D1 is a gene involved in cytoskeletal function
that is not referenced much in literature pertaining to immunity response, but it has been
shown to demonstrate alternative splicing after T cell activation (Martinez and Lynch, 2013).
This SNP also was found to be a high frequency allele having undergone pre-admixture
selection in the admixed American population by the FineMAV paper (Szpak et al., 2018).
Significant SNPs in the Mainland Southeast Asian population
Table 3.20 Derived allele frequencies of immune-related DIND-significant SNPs in the Mainland
Southeast Asian population compared to other populations
SLC15A2, or PEPT2, is a solute transporter that recognizes and moves peptides, including
bacterial peptides such as those present in the cell wall of Gram-negative bacterias, across
the lung and other epithelial tissues, activating the innate immune response. This transport is
proton-dependent, and the inflammatory acidification during a local infection may enhance
the efficacy of this process (Swaan et al., 2008).
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MAGI1 has been shown to induce promotion of interferon-b , via activation of IRF3
during an influenza infection. This suggests it plays a role in the immune response to viral
infection (Kumar et al., 2012).
Significant SNPs in the Island Southeast Asian population
Table 3.21 Derived allele frequencies of immune-related DIND-significant SNPs in the Island South-
east Asian population compared to other populations
DYNC2LI1 plays an important role in retrograde intraflagellar transport (IFT) and func-
tions in cilia biogenesis (Kessler et al., 2015; The UniProt Consortium, 2015). Among its GO
biological processes are antigen processing and presentation of exogenous peptide antigen
via MHC class II, cilium assembly, and ER to Golgi vesicle-mediated transport (The UniProt
Consortium, 2015). Retrograde IFT is the process by which proteins are carried from the
tip of the cilia back to the base. DYNC2LI1 interacts with DYNC2H1 to form the dynein-2
complex, which is necessary for retrograde IFT complexes. Knocking down this gene results
in reduced cilia length and altered cilia morphology, which are both suspected to affect
cilia function. This causes a number of severe skeletal and other diseases, since cilia play
important roles in development and organ function in growing and adult humans and are
present in most cells (Kessler et al., 2015). MHC molecules are assembled in the endoplasmic
reticulum, after which they are loaded into vesicles for transport to the Golgi apparatus and
the plasma membrane (Hewitt, 2003), so this is how it might relate to the immune process.
DYNC2LI1 has also been reported to be upregulated in patients with psoriasis, lichen planus,
and atopic dermatitis, all of which are autoimmune diseases of the skin (Li et al., 2013). This
reinforces an association with immune processes suggested by its antigen processing gene
ontology term.
3.3 Results of population differentiation-based analysis: di
As described in Section 2.3, di is a population differentiation statistic that is a function of
FST between a given population and all other populations. This means that it is best used to
detect local signals of selection that are not shared with other populations (Akey et al., 2010).
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Per population, each gene was assigned a di score based on the highest-scoring SNP in that
gene, allowing for a ranked list for enrichment analysis and listing the top scoring genes per
population.
3.3.1 Enrichment for immune function in genes with top di scores
In each population, genes were divided into the top one percent of di scores and the
bottom ninety-nine percent of di scores (correcting for gene size, see Section 2.4.2) in order
to see whether the top one percent of genes were enriched for immune genes compared to
neutral expectations. The results of these enrichment tests are shown in Table 3.22.
This table shows significant enrichments spread fairly evenly over the different categories
of immune genes, with more enrichments in the innate immunity and antigen processing and
presentation categories. The enrichments are spread between populations as well, with the
Central Siberian population being the only population without any enrichments.
Table 3.22 Enrichment of top one percent di results in each population for immune genes based on
GO DB and HPIDB compared with expected counts. The "exp" row gives the expected
number of immune genes in any given one percent of the data, and the counts in each cell
represent the number of immune genes of a given category in the top one percent of the
results. Light orange indicates significant enrichment at p = 0.05, dark orange at 0.01 in a
Fisher’s exact test with correction for multiple testing, as described in Chapter 2.
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A brief overview of the HLA
Because HLA genes are present in top selection (both positive and balancing) hits in
many populations, it is worth pausing for a condensed description of these genes.
HLA (human leukocyte antigen) genes are found in the MHC (major histocompatibility
complex), a region on chromosome 6 that contains a high concentration of polymorphic
immune genes. Genes in this region play a crucial role in the human adaptive immune
response and are also implicated in a large number of human diseases such as autoimmune
disease, as well as other processes such as maternal/fetal survival during pregnancy. In
general, the job of HLA genes is to present antigenic peptides to T cells in order for the
immune system to distinguish whether that peptide is self or non-self and mount an immune
response as appropriate. There are three classes of HLA genes, and the first two classes come
up most frequently in the results of this project. Class I HLA genes are HLA-A, -B, -C, -E,
-F, and -G, MICA, and MICB. Class I HLA genes are expressed on most nucleated cells, and
are recognized by CD8+ T cells or NK cells. Class II HLA genes are largely expressed on
antigen processing and presentation cells, and are recognized by CD4+ T cells. These consist
of HLA-D genes, such as HLA-DQA1 and HLA-DRB2, as well as other antigen processing
and presentation genes such as TAP1 and TAP2. As mentioned above, the majority of–though
not all–HLA genes are highly polymorphic, with over 15,000 class I and II alleles found
so far. Because of this, most individuals are heterozygous at MHC loci. High levels of
polymorphism are maintained by balancing selection, and in principle give a population
potential protection against a wide range of pathogens (see Janeway et al. (2001), review by
Dendrou et al. (2018), and review by Jeffery and Bangham (2000), and (Rajagopalan and
Long, 1999)).
Table 3.23 shows a subset of the genes responsible for driving significant signals of
enrichment, with a description of relevant genes below. Several genes have been described in
previous sections. The full version of Table 3.23 is in Appendix B.
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Table 3.23 Subset of immune-related genes driving significant di enrichment signals
In the GO.Bact category, STAT1 is important for the expression of interferon gamma-
induced genes in bacterial infection (Varinou et al., 2003). EPPIN and WFDC6 are part of a
group of proteinase inhibitor genes that is found at various levels of conservation between
mammals and is though to play a role in the innate immune response and have antimicrobial
effects (Clauss et al., 2005). EPPIN also plays a role in sperm motility (Yenugu et al.,
2004). FCER1G is a component of the immunoglobulin-E receptor. Immunoglobulin-E is
a mediator of allergic response (Garman et al., 2000). P2RX7 is involved in antimicrobial
innate immune response (Gavala et al., 2013). FZD5 contributes to the growth cycle of cells
that manufacture antimicrobial peptides in the small intestine (SCHMAUssER et al., 2004;
van Es et al., 2005). TNFSF8 is thought to play a role in the regulation of immune activation
(Collette et al., 2003).
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In the GO.Virus category, APOBEC3H is a member of the APOBEC3 cytidine deami-
nase gene family that has innate immune activity, through causing hypermutation, against
retroviruses. It it thought to have been under positive selection at certain times throughout
primate evolution. While APOBEC3H in other primates has strong antiviral effects, the
human version is expressed at low enough levels that it shows no antiviral activity. Two
potential reasons are given for this lack of function: the retrovirus APOBEC3H evolved to
combat went extinct and decreased the evolutionary pressure on the gene, or another member
of the APOBEC3 gene family now performs antiretroviral duties and human APOBEC3H is
no longer required to be functional. Under relaxed evolutionary pressure, it may be beneficial
to have fewer hypermutation-causing cytidine deaminase genes for the sake of the host
cell (OhAinle et al., 2006). CPSF interacts with the NS1 protein of the influenza A virus
(Nemeroff et al., 1998). FKBP8 is involved in hepatitis C virus replication (Okamoto et al.,
2006). IFNL1, or interferon-lambda 1 or IL29, is induced by viral infection and plays a
role in the antiviral innate immune response (Kotenko et al., 2002). ACY3 is a hepatitis C
virus core binding protein (Chen et al., 2009c). CXCL9 is a chemokine that is part of the
innate antiviral immune response (Thapa et al., 2008). LTBR, or lymphotoxin beta receptor,
is involved in epithelial cell innate immune response (Wang et al., 2010b).
In the T cell category, IFNG codes for interferon gamma, which is produced upon
activation of the innate immune response and stimulates inflammation and macrophage
action (Murray et al., 2009). LILRB is a leukocyte immunoglobulin-like receptor and is
involved in control of proliferation of T cells (Brown et al., 2004). LAG3 is associated
with lymphocyte activation and has been implicated in susceptibility to autoimmune disease
(Zhang et al., 2005). SPNS2 has been linked with humoral response to immunization (Nijnik
et al., 2012). RAB27A is part of a complex that plays a role in transporting lytic granules
of cytotoxic T cells (CTLs) to the immune synapse (referenced with SYTL3 in the Colla
section of DIND-significant SNPs above) (Kurowska et al., 2012).
In the B cell category, CD180 is important in B cell response to LPS (Ogata et al., 2000).
RAG1 is involved in VDJ recombination, in which lymphocytes generate a large range of
binding specificities (Oettinger et al., 1990).
In the innate immune category, ADCY9, or adenylyl cyclase type 9, is a gene that codes for
a protein that produces cyclic AMP (cAMP). Among its other functions, cAMP is produced
by T regulatory cells and plays a role in the downregulation of immune function. Through
this relationship, polymorphisms in this gene have been significantly associated with markers
of allergic reaction (Teixeira et al., 2017). C1QB is part of the C1q protein, which enables
the binding of the C1 complex to the antigen-antibody complex on the cell surface (Murray
et al., 2009). NLRC4 is involved in the detection of bacterial components (Miao et al., 2010b).
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TRIM32 is involved in a range of physiological processes, and one of them is in cellular
defense against influenza virus (Fu et al., 2015). COROA1 is a coat protein that is involved
in Mycobacterium leprae survival during infection (Tanigawa et al., 2009). C1QBP is the
binding protein of C1QB. HCK is a tyrosine kinase that is involved in the innate immune
response to bacteria (Ernst et al., 2002). LILRA5 is a receptor that plays a role in leukocyte
activation and has been associated with autoimmune disease (Borges, 2002; Mitchell et al.,
2008). C1s is another member of the C1 complex in the complement system (Murray et al.,
2009). NLRX1 is located on the outer membrane of the mitochondria and is involved in the
antiviral immune response (Moore et al., 2008). TRAFD1, or FLN29, is a negative regulator
of TLR immune response (Mashima et al., 2005).
In the antigen processing and presentation category, APIS3 has been associated with
the viral innate immune response via interaction with TLR3 signaling (Setta-Kaffetzi et al.,
2014). TLR3’s ligand is double stranded RNA from viruses (Murray et al., 2009). LILRB2,
like LILRA5, plays a role in regulation of T cell activity (Brown et al., 2009). PSMA7 is a
negative regulator of antiviral innate immunity (Jia et al., 2009).
In the adaptive immunity category, DUSP10, or MKP5, plays various roles in adaptive
and innate immune responses that can lead in some cases to better resistance to autoimmune
disease or harmful immune overreaction (Zhang et al., 2004).
3.3.2 Top-scoring genes per population based on the di statistic
In addition to looking at enrichment for various immune functions in the top di results, it
is also interesting to look at the highest scoring genes in each population. The 50 highest
scoring genes in each population are shown in Tables 3.24 and 3.25, with genes in the
immune gene lists presented in Chapter 2 highlighted in orange. As referenced in Chapter 2,
these results are divided into five equally-sized bins by gene length, so as not to skew results









Table 3.24 Top 50 genes by di score part 1, correcting for gene size by assigning genes according to length to 5 bins of equal size and taking the





Table 3.25 Top 50 genes by di score part 2, correcting for gene size by assigning genes according to length to 5 bins of equal size and taking the
top 10 genes from each. Orange highlights indicate the gene belongs to one or more of the immune gene categories.
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A subset of these top genes are presented below, based on whether a gene has a potentially
important immunological role based on a literature search. The genes highlighted in orange
are classified as immune-related genes based on the GO terms listed in Chapter 2. Table 3.26
shows the counts of how many times a given immune-related class of genes appears in the top
50 genes for that population. This can be used as a rough guide for comparing representation
of immune gene classes between the classes themselves and between populations. Table
3.26 shows that no class of immune gene, save for HP.Bact and HP.Virus (which could
be to do with the relative size of those gene categories), are obviously represented at a
higher level in Tables 3.24 and 3.25. However, many of the highlighted genes do not have
clear immunological function, and a good number of non-highlighted genes do appear to
play an important role. Therefore, the orange highlights help to show the concentration of
immune-related genes in the top results, but should not be used as a simple classifier. The
descriptions of these genes are organized by the population in which they appear and grouped
by general immune function. Some populations have more genes with clear immunological
function than others.
Table 3.26 Counts of number of genes in each immune gene category and population in the top 50
genes based on di score per population
West and Central Africa
The highest scoring gene in Bin 1 of the West and Central African di results is DARC.
DARC, or the Duffy blood group antigen, is the red blood cell receptor for Plasmodium
vivax. Individuals without this receptor are resistant to malaria (Horuk et al., 1993; Miller
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et al., 1976). Plasmodium vivax infects around 75 million people per year, largely in tropical
countries. Its prevalence means that it could potentially exert a measure of selective pressure
on genes with which it interacts (review by Allison (2009)). The DARC gene contains SNPs
known to be some of the most allele frequency differentiated SNPs in the HapMap dataset,
as well as those predictive for low white blood cell and neutrophil count in individuals with
African ancestry (Reich et al., 2009).
Two high scoring genes are involved in maturation and differentiation of immune cells.
LRG1 is expressed in neutrophils and involved in granulocyte differentiation (O’Donnell
et al., 2002). In mice, VAV2 knockout mice experience deficiencies in the humoral immune
response and B cell maturation. VAV2 is a guanine nucleotide exchange factor (Doody et al.,
2001).
CYP26B1 and ARPC1B are both involved in the development of inflammatory disease.
CYP26B1 is an enzyme that degrades retinoic acid, and when expressed prevents the ex-
pression of CCR9 on T cells. Knockout mice for this gene are protected from intestinal
inflammation caused by T cells (see review by Raverdeau and Mills (2014)). ARPC1B is part
of an actin-related complex and is expressed in the blood. Deficiencies in this gene cause
predisposition to inflammatory disease, such as eczema, eosinophilia, and elevated levels of
IgA and IgE, through platelet abnormalities (Kahr et al., 2017).
Two genes are involved with the immune response to LPS. PTP4A3 is a protein tyrosine
phosphatase that plays a role in LPS reaction. Mice treated with an analogous version of
this protein were protected from severe host reactions to LPS treatment (Tang et al., 2010).
MAP1LCDB, or LC3B, is an autophagic protein that is also involved in the immune response
to LPS (He and Klionsky, 2009; Nakahira et al., 2010).
CD226 is a protein involved in intercellular adhesion and white blood cell signaling.
Because of its expression in a range of immune cells (NK cells, monocytes, T cells, and B
cells), it is likely to be involved in a range of immune responses (Shibuya et al., 1996). One
study showed the importance of CD226 in the regulation of T-cell activation by demonstrating
that mice treated with anti-CD226 resulted in delayed onset and reduce severity of the mouse
model of MS (Dardalhon et al., 2005). This gene has been associated with risk for type 1
diabetes and MS, as well as possibly autoimmune thyroid disease and rheumatoid arthritis
(Hafler et al., 2008).
West Asia and Armenia
The top scoring genes in the West Asian and Armenian populations with clear immune
function based on the literature can be divided into several categories.
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One of these categories are genes involved in immune response to pathogens. RETNLB,
or resistin like beta, has been shown to be a part of the immune defense against helminths
(Artis et al., 2004b; Herbert et al., 2009). TNK1 is an antiviral host protein that works with
interferon-stimulated genes to suppress the life cycle of hepatitis C virus (Ooi et al., 2014).
TECPR1 plays a role in the targeting of pathogenic bacteria for selective autophagy (Ogawa
et al., 2011). ANXA2 is involved in various cellular activities and has also been associated
with HCV virus production (Backes et al., 2010; Gerke et al., 2005).
Another category of genes in top results is that of T cell function. SIGLEC10 is an
inhibitory receptor that is involved in T cell homeostasis and has anti-inflammatory effects
when acting in concert with other molecules (Bandala-Sanchez et al., 2013; Chen et al.,
2009a). PIK3IP1 is a transmembrane protein that is expressed on T cells and is thought to be
an inhibitor of T cell activation (DeFrances et al., 2012).
Several genes are also involved in inflammation and the balance between immune ac-
tivation and inactivation. AP1S3 knockouts result in increased IL1 signaling and IL36a
expression, which results in skin inflammation (Mahil et al., 2016). This gene plays a role in
autophagosome formation (Guo et al., 2012). ADAM17 is a metalloproteinase that cleaves
cell surface proteins and is involved in inflammation, immune response, and tissue regen-
eration (see review by Scheller et al. (2011)). MMP2 is a matrix metalloproteinase that is
thought to be involved in leukocyte recruitment and repair of inflammation and has various
pro- and anti-inflammatory roles in the immune system (see review by Parks et al. (2004)).
RORA is one of two retinoic acid receptors that play a role in Th17 cell differentiation and
therefore the balance between autoimmune disease and immune response (Yang et al., 2008).
SLC24A5 is a well known target of selection in European populations and is associated
with skin pigmentation (Voight et al., 2006a). Selection for skin pigmentation has been driven
by different levels of ultraviolet radiation in different environments, and has generally led to
darker sin at low latitudes to protect skin from radiation and lighter skin at higher latitudes,
potentially for vitamin D synthesis (review by Fan et al. (2016)).
Southwest Europe
Several top scoring genes in the Southwest European population were involved in immune
function. IL4 is involved in the Th2 immune response (Murray et al., 2009). It has also been
shown to have high levels of differentiation in the promoter region, suggesting this gene has
been under positive selection in different populations (Rockman et al., 2003). CLEC1A is a
C-type lectin receptor and is expressed on the cell surface of dendritic cells and endothelial
cells (see review by Sancho and Reis e Sousa (2012)). POU2F3 plays an important role in
the function of tuft cells, which are located in the intestine and involved in immune defense
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against parasites. Knockout mice have defective immune response to helminths (Gerbe et al.,
2016).
Several genes appearing in the top results are well known for being involved in hair
phenotype and skin pigmentation. PRSS53 is a protease that plays a role in hair growth
and keratinization and has been associated with hair shape at the scalp and hair curliness.
It has also been detected as being under selection in an East Asian population by the CMS
(Composite of Multiple Signals) statistic (Adhikari et al., 2016). OCA2 is associated with
pigmentation, especially in East Asian populations. The derived allele of interest here is
thought to have come into existence about six thousand years ago (Murray et al., 2015). The
OCA2 gene is associated with pH levels within the melanosome (Liu et al., 2013a) and has
been under positive selection in East Asian and European populations (Hider et al., 2013;
Lao et al., 2007).
Northeast Europe
Several of the top scoring genes in the Northeast European population fall into the
category of T cell function. TESPA1 plays a role in T cell signaling, selection, and maturation
(Wang et al., 2012a). TNFSF18, or GITRL, is a cytokine involved in the innate immune
reaction and T cell activation (see review by Shevach and Stephens (2006)). LAX1, or LAX,
is a negative regulator of T and B cell signialing (Zhu et al., 2005).
Other genes play a role in the function of other immune cells and barriers. ASPRV1, an
aspartic retroviral-like protease, is expressed by neutrophils and plays a role in the progression
of acute inflammation to chronic, causing diseases like multiple sclerosis and experimental
autoimmune encephalomyelitis (Hawkins et al., 2017). MFSD2A is a regulator of blood
brain barrier function (Ben-Zvi et al., 2014).
TLR1, TLR6, and TLR10 form a cluster of genes that has been previously shown to be a
target of selection in European populations (Barreiro et al., 2009). All are members of the
Toll-like receptor family of pathogen recognition receptors that play an important role in the
innate immune response to pathogen infection.
HERC2 is in the same genomic region as OCA2 (from the top results in the Southwest
European population) and is also involved in hair and eye pigmentation (Donnelly et al.,
2011; Sturm et al., 2008).
Volga Uralic
FCERIG is one of the top scoring genes in the Volga Uralic population. It encodes the
gamma subunit of FCERI, which is the receptor for immunoglobulin E. This receptor is
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upregulated in antigen-presenting cells of individuals with atopic dermatitis, underlining its
role in allergic response (Liang et al., 2011).
South Asia
Several of the top scoring genes in the South Asian population are involved in immune
response and tolerance. SMAD7 is an inhibitor of TGF-b 1 signaling. TGF-b 1 is thought
to be part of the mechanism that keeps T cells from attacking gut bacteria and prevents
development of inflammatory gut disease (see review by Monteleone et al. (2004b)). It is also
induced by interferon-g and upregulated in gastritis caused by Helicobacter pylori, preventing
TGF-b 1 from mitigating the immune response that causes tissue damage (Monteleone et al.,
2004a). PIK3CD is involved in allergic and immune response. Knockout mice were protected
from anaphylactic response, and from various types of cancer as well (Ali et al., 2004, 2014).
STX4 is a member of the SNARE family of proteins, which are involved in vesicle and
membrane function in various body systems, including the immune system (Stow et al.,
2006). Expression of STX4 is upregulated upon exposure to LPS (Pagan et al., 2003) and
can be found at the immunological synapse of some T cells (Das et al., 2004). PRSS8
modulates insulin sensitivity in the liver via interaction with TLR4 (Uchimura et al., 2014).
Its expression is also upregulated in psoriatic skin (Tsoi et al., 2012).
ITGAL is a subunit of the LFA-1 (lymphocyte-associated antigen-1) integrin (Zhang
et al., 2002). This molecule is expressed on white blood cells and plays a role in leukocyte
differentiation and maintenance (Meli et al., 2016).
KCNK2, or TREK1, is a top scoring gene in the South Asian population, and it also
contains a DIND-significant SNP in the Northeast European population. It is a potassium
channel that regulates immune cell entry into the central nervous system and is involved in
the function of the blood brain barrier (Bittner et al., 2013).
West Siberia
Several of the top scoring genes in the West Siberian population play roles in the immune
response to infection by bacteria and other pathogenic organisms. SPSB1 is regulated by
TLR actions and plays a role in the induction and regulation of NO (reactive nitrogen species)
production. NO kills invading pathogens and is an important part of the host immune response
(Lewis et al., 2011). KLRD1, or CD94, is a receptor expressed on NK cells and some T cells
which can act as an activator or inhibitor, and likely plays a role in the survival of those cells
and therefore immune response to pathogenic organisms (Gunturi et al., 2004). MFHAS1 is
a regulator of TLR-dependent signaling and has been found at elevated levels in the blood of
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individuals with sepsis (Ng et al., 2010; Zhong et al., 2015). SEMA4D is a semaphorin that is
expressed in T cells. It expressed at lower levels in B cells, though expression is upregulated
by LPS and CD40 antibody. Knockout mice have deficient antibody responses (see review
by Suzuki et al. (2007)).
TNFSF15 and TMEM258 are both involved in immune function in the intestine and bowel.
TNFSF15 is a member of the tumor necrosis factor superfamily, and has been associated
with inflammatory bowel disease in European and Japanese populations (Yamazaki et al.,
2005). TMEM258, part of an oligosaccharyltransferase complex, is associated with intestinal
homeostasis. Mice deficient in this gene suffered from intestinal pathology (Graham et al.,
2016). TMEM258 also appears in the top results for the Island Southeast Asian population.
South Siberia and Mongolia
Two of the top scoring genes in the South Siberian and Mongolian population are involved
in the innate immune response to infection. IFNG is the gene for interferon gamma, which is
produced upon activation of the innate immune response and stimulates inflammation and
macrophage action (Murray et al., 2009). CSRNP2 is a transcription factor that is induced
by lipopolysaccharide and is involved in cellular stress response or apoptosis (Eichelbaum
and Krijgsveld, 2014). This suggests it plays a role in bacterial infection, though it is unclear
exactly what that role is.
GINS and LILRB2 play roles in development of immune cells. LILRB2 plays a role in
regulation of T cell activity (Brown et al., 2009). Deficiencies in GINS lead to developmental
delays as well as deficiencies in neutrophils and NK cells (Cottineau et al., 2017).
Central Siberia
Two of the highest scoring genes in the Central Siberian population are involved with
immune function in the lungs and airways. NFKBIA is a negative regulator of NF-kappa B
and variants in this gene have been associated with different outcomes of childhood lung
diseases such as asthma and respiratory syncytial virus infections (Ali et al., 2013; Hayden
and Ghosh, 2008). BPIFB1, or bactericidal/permeability-increasing fold-containing B1, is
secreted from epithelial cells in the upper respiratory tract (Bingle et al., 2010; Shum et al.,
2013). It is thought to play role in innate immune response to Gram-negative bacterial
infections based on its structural similarity to other well known innate immune response
genes (Bingle, 2002). It has also been implicated in the immune response to Vibrio cholerae,
and its expression is upregulated in the airways of patients with cystic fibrosis (Bingle et al.,
2012; Shin et al., 2011).
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HAVC1R (human hepatitis A virus cellular receptor 1) plays a role in both the immune
response to the hepatitis A virus and allergic asthma (Feigelstock et al., 1998; McIntire et al.,
2003). It has been shown to have been under positive selection during primate evolution
and balancing selection in human populations (Kosiol et al., 2008; Nakajima et al., 2005).
This balancing selection is thought to be a good example of the tradeoff between adaptation
to pathogenic organisms and chronic disease (in this case, hepatitis A virus and asthma,
respectively) (Sironi and Clerici, 2010).
Several other genes are associated with immune surveillance, activation, and function.
SH2D4B and its homolog SH2D4A are T-cell-specific adapter proteins with relatively
unknown functions. This lack of knowledge is potentially due to significant overlap in
functions between these two proteins and others in the the T cell adapter protein family
(Lapinski et al., 2009). TNFSF8 is thought to play a role in the regulation of immune
activation (Collette et al., 2003). SGPL1, or sphingosine 1-phosphate-lyase, is an enzyme
responsible for the degradation of S1P (sphingosine 1-phosphate) (Saba et al., 1997). The
gradients of S1P mediated by the effects of SGPL1 play a role in the exit of lymphocytes
from lymphoid organs for the purpose of immune surveillance and function (Schwab, 2005).
EBF1 plays an important role in early B cell differentiation into different lineages (Vilagos
et al., 2012).
Northeast Siberia
Several top scoring genes in the Northeast Siberian population play a role in the immune
response to bacteria. CFB, or complement factor B, is part of the alternative complement path-
way, which plays a role in the human immune response against polysaccharide-encapsulated
bacteria, such as those involved in pneumococcal and meningococcal infections. Deficiency
in this protein can cause recurrent infections of these types (Slade et al., 2013). PDE4B is
a phosphodiesterase that plays a role in immune activation by LPS. Mice deficient in this
gene experienced a strong reduction in induction of TNF-alpha in response to LPS stimulus,
indicating a decreased sensitivity to LPS in the knockout mice (Jin and Conti, 2002). TCIRG1
modulates cell pH and plays a role in Mycobacterium tuberculosis infection (Lafourcade
et al., 2008; Singh et al., 2006a).
Several other genes are involved in antigen processing and presentation. HLA-DRA
and HLA-DQB1 are both members of the class II MHC. HLA-DQB1 has been associated
with susceptibility to leprosy/tuberculosis in a Cambodian population, as well as multiple
autoimmune diseases (see review by de Bakker et al. (2006)). RAG1, or recombination
activating gene 1, takes part in initiating the process of VDJ gene recombination, which is
responsible for the manufacture of a diverse set of antigen receptors in lymphocytes (Bassing
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et al., 2002). Mutations in this gene can cause defective assembly of antigen receptors and
lead to immunodeficiency disorders (Brauer et al., 2016).
MRGPRF is a G protein-coupled receptor that is part of a family of GPCRs that are
linked to nociception and is expressed in sensory neurons (Dong et al., 2001). In a mouse
model of intestinal inflammation, it has been shown to be downregulated in enteric neurons
(Avula et al., 2011). In a study on human macrophage differentiation, it has been shown to be
significantly upregulated in macrophages compared to monocytes. It is upregulated during
the monocyte to macrophage differentiation process, and downregulated by LPS in human
macrophages derived from monocytes. However, not much is known about this protein
(Hohenhaus et al., 2013).
GATA2 is another top scoring gene that plays a role in the immune system. It is important
in the regulation of haematopoiesis and mutations in this gene can cause immune disorders
such as autoimmunity as well as increased incidence of infection, among other disorders
(Collin et al., 2015).
CPT1A has previously been found to be under positive selection in this same Northeast
Siberian population included in the EGDP dataset (Clemente et al., 2014). This gene has
been under selection because of the role it plays in adapting to a cold environment or a diet
high in fat (Clemente et al., 2014).
Colla
Two of the top scoring genes in the Colla population are involved with immune response
to viruses. RABGGTA is a transferase activity marker that was significant in a study
of genes associated with adaptive immunity following a H1N1 influenza A vaccine. It
was significantly associated with both hemagglutination inhibition and virus neutralization
antibody (Ovsyannikova et al., 2016). NLRX1 acts as a negative regulator of antiviral
response in the mitochondria (Moore et al., 2008).
Two genes are involved in immune function in epidermal cells. TGM1 is upregulated in
psoriatic skin and is associated with aberrant organization and differentiation of epidermal
cells (Kulski et al., 2005). ABCC4 is an ATP-binding cassette transporter that is expressed
in dermal and epidermal dendritic cells, and plays a role in their migration as part of the
immune response (van de Ven et al., 2008).
Several other top scoring genes play a role in immune response and inflammation.
Variants in the TCF7L2 promoter have been associated with Crohn’s disease (Koslowski
et al., 2009). OPRM1 is an opioid receptor gene that has an influence on secretion of
proinflammatory cytokines from peripheral immune cells (Matsunaga et al., 2009). C1S
is one of three components of the first complement component, the binding of which to
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immune complexes initiates the classical pathway innate immune response (see review by
Fujita (2002)). ADRBK1, also known as GRK2, is a GPR kinase 2 that is associated with
downregulation of chemokine receptors and is induced by activation of TLR2 (Alves-Filho
et al., 2009). When this gene is inhibited by IL33, the chemokine CXCR2 sends a strong
signal to attract neutrophils to the site of infection. This was shown with a mouse model
of sepsis, in which mice treated with IL33 showed more efficient clearance of bacteria
(Alves-Filho et al., 2010; Mantovani et al., 2011).
Mainland Southeast Asia
Several of the top scoring genes in the Mainland Southeast Asian population were in-
volved susceptibility to and immune response to pathogenic organisms. RPLP0 is upregulated
upon bacterial challenge (Arbibe et al., 2006), and RAB10 is a GTPase that plays a role
in the activation of TLR4 in response to LPS (Wang et al., 2010a). TRAFD1, or FLN29,
has an inhibitory role in the innate immune response. Knockout mice for this gene were
hyperresponsive to LPS, and were more likely to develop septic shock (Sanada et al., 2008).
This gene also appeared in the iHS enrichment table in the Volga Uralic population. HLA-
DPA1 has been associated with clearance of hepatitis B in the Han Chinese (An et al., 2011).
Variants in MYBBP1A, a NF-kappaB transcription repressor, have been associated with risk
of developing pulmonary TB in a Han Chinese population (Cai et al., 2012; Owen et al.,
2007). KARS secretion induces immune response via activation of macrophages (Park et al.,
2005).
Island Southeast Asia
Two HLA genes appear in the top scoring genes in the Island Southeast Asian population.
Like other HLA genes, HLA-F is involved in antigen processing and presentation. It is also
involved in the surveillance of stressed cells by the innate immune system (Garcia-Beltran
et al., 2016), and is expressed in the tonsil, spleen, and thymus (Lepin et al., 2000). HLA-DP
has been associated with hepatitis B in Asian populations (Kamatani et al., 2009).
Several other genes are involved in immune activation. LGALS3BP, or 90K, has been
shown to stimulate the host immune response, including by cells such as natural killer cells,
and induce the production of IL2 (Ullrich et al., 1994). IL10RB is a co-receptor involved in
the activation of cytokines IL10, IL22, IL28, and IL29 (Kotenko et al., 2000, 1997; Sheppard
et al., 2002; Xie et al., 2000). Mutations in this gene have been associated with inflammatory
bowel disease, enterocolitis, and hepatitis B infection (Begue et al., 2011; Frodsham et al.,
2006; Glocker et al., 2009). POLR3E is part of the cytosolic RNA polymerase III complex
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and functions in an immune capacity by sensing non-self DNA in the cytosol (Lee et al.,
2012).
On the other hand, LAIR1 and IL17RD are negative regulators of immune function.
LAIR1, or leukocyte-associated Ig-like receptor-1, is a collagen receptor with inhibitory
action on immune activation (Lebbink et al., 2006). IL17RD, or IL17 receptor D, is a negative
regulator of TLR response and is also involved in neutrophil recruitment (Mellett et al., 2015,
2012).
Another gene, BLNK, or B cell linker protein, is involved in B cell development and
function, via linkage of B cell receptor-associated kinases with different signaling pathways




Balancing selection is another important mode of selection, and is the process by which
diversity is maintained at a certain locus because the diversity is more adaptive than one
allele being at high frequency. Whereas positive selection acts directionally (for example,
specific surface antigens on host cells (Van Blerkom, 2003)), balancing selection acts on
regions where diversity is adaptive. While resistance to some diseases is conferred by one
particular allele, in some cases disease resistance is best maintained by genetic diversity.
This diversity can result in heterozygote advantage or resilience against a greater variety of
diseases than would be possible with less diversity (review by Karlsson et al. (2014)). For
this reason, immune-related genes are a functional class of genes that may be expected to
undergo balancing selection.
4.1.1 Previous evidence of balancing selection in immune genes
The most famous example of selection for diversity is in the MHC, which is a region
associated with susceptibility to many different infectious and inflammatory diseases, as
mentioned in Chapter 3 (Karlsson et al., 2014; Key et al., 2014). Though various studies
have found different genes under balancing selection, immunity is consistently among the
biological functions most strongly represented and overrepresented in results (Andrés et al.,
2009; Key et al., 2014). Additionally, though many signatures of balancing selection are
shared across populations, many of those that are unique are found in immune-related genes
(Key et al., 2014).
In several studies, pathogen richness in a specific geographic region has been significantly
correlated with diversity at immune loci in populations living in that same region (review
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by Barreiro and Quintana-Murci (2010)). Blood group antigens (Fumagalli et al., 2009a),
interleukins and interleukin receptors (Fumagalli et al., 2009b), and HLA class I genes
(Prugnolle et al., 2005a) have all been correlated with pathogen diversity. These results
suggest that the balancing selection in these genes has been pathogen-driven.
4.2 Results of the HKA test
The results from the HKA analysis are organized into two main parts. Section 4.2.1 is
an enrichment analysis to show whether the top one percent of genes based on HKA score
contain more immune genes than would be expected in the absence of selection. It shows
which genes are present in significantly enriched windows, and how those selection signals
are shared between populations. Section 4.2.2 is a further description of top HKA results
in immune genes that may not have appeared in an enriched population but still warrant
attention. As a reminder, the HKA test is best suited to finding signals of balancing selection
younger than 250 kya (review by Sabeti et al. (2006)).
4.2.1 Enrichment of immune genes in top results
Table 4.1 shows the results for enrichment tests in each population and category of
immune gene based on the results of the HKA statistic. A Fisher’s exact test was used
with correction for multiple hypothesis testing, as described in Chapter 2. Orange coloring
indicates that significantly more immune genes appear in the top one percent of results for a
given population than would be expected under neutral conditions. The expected values of
how many genes per immune gene class in any one percent slice of the data is given at the
top of the table. The full table of genes responsible for the enrichment signals seen in Table
4.1 can be seen in Table B.10.
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Table 4.1 Enrichment of top one percent of HKA results in each population for immune genes
based on the GO DB and HPIDB compared with expected counts. The "exp" row gives
the expected number of immune genes in any given immunity category after randomly
choosing one percent of all protein-coding genes, and the counts in each cell represent
the observed number of immune genes of a given category in the top one percent of the
results. Light orange indicates significant enrichment at p = 0.05, dark orange at p=0.01 in
a Fisher’s exact test with correction for multiple testing, as described in Chapter 2.
There are several categories of immune genes that show notable patterns of enrichment
and lack of enrichment. Several categories show high levels of uniformity across many or
all populations, potentially suggesting old signals of shared selection on the same genes.
For example the T cell category and the antigen processing and presentation categories are
significantly enriched in every population, largely because of genes in the MHC. For this
reason, the enrichment analysis was done again after removing all genes in the MHC from
the complete list of protein-coding genes considered. The MHC was defined here as anything
overlapping with the region 6:28,866,528-33,775,446 (Gourraud et al., 2014). With MHC
genes removed, it is possible to see which categories and populations retain a significant
enrichment signal.
Table 4.2 shows the results of this enrichment analysis without MHC genes. All significant
enrichments in the antigen processing and presentation category, as well as the GO.Virus
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category, have disappeared. Interestingly, there are more GO.Bact and GO.Innate enrichments
than in the enrichment table including MHC genes.
Table 4.2 Enrichment of top one percent of HKA results in each population for immune genes based
on the GO DB and HPIDB compared with expected counts, with genes in MHC region
removed. The "exp" row gives the expected number of immune genes in any given immunity
category after randomly choosing one percent of all protein-coding genes, and the counts in
each cell represent the observed number of immune genes of a given category in the top
one percent of the results. Light orange indicates significant enrichment at p = 0.05, dark
orange at p=0.01 in a Fisher’s exact test with correction for multiple testing, as described in
Chapter 2.
Because of the potentially confounding results of the MHC genes in driving enrichments,
making other genes look as though they may be driving a signal of enrichment when really it
is MHC genes driving the signal, the description of the enrichment table for the HKA results
will be based on Table 4.2.
A subset, based on clear immunological function based on a literature search, of the
genes responsible for the enrichment signals shown in Table 4.2 are shown in Table 4.3, and
described in more detail below. The full table can be seen in Table B.11. This table shows
that genes driving enrichment signals are largely shared between populations, even those
that are widely geographically separated. However, there are no significant enrichments
in the West and Central African population after the removal of MHC genes from the
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analysis. Since other genes included in the enrichment table below are shared between
such geographically distant populations, the pattern of sharing potentially suggests sharing
between all non-African populations compared to the West and Central African population.
Table 4.3 Subset of genes driving significant HKA enrichment signals
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In the GO.Bacteria category, the populations with significant enrichments are character-
ized by sharing the same core of genes driving enrichment signals. These genes are DEFB1,
DMBT1, and PGLYRP4, though the South Asian and Mainland Southeast Asian populations
also share TLR6. DEFB1 and PGLYRP4 have been found to be targets of balancing selection
in previous a previous study, in both African and European populations and African popula-
tions, respectively (Bitarello et al., 2018). DEFB1 is a defensin, or antimicrobial peptide, that
has previously been shown to be under positive selection in primates (Hollox and Armour,
2008). Its promoter region has been shown to be under balancing selection by Cagliani
et al. (Cagliani et al., 2008). DEFB1 provides protection from a range of Gram-negative
bacteria (Goldman et al., 1997) and Candida species (Jurevic et al., 2003). It is expressed in
a range of epithelia and tissues (Singh et al., 1998; Valore et al., 1998; Zhao et al., 1996). It
is also expressed in milk and breast tissue of lactating mothers (Jia et al., 2001). This broad
variety of expression and antimicrobial activity against a wide range of microbes suggests
DEFB1 plays an important role in host defense. Certain variants of this gene have been
associated with allergic disease, susceptibility to sepsis, HIV, and Candida infection (Braida
et al., 2004; Cagliani et al., 2008; Chen et al., 2007; Jurevic et al., 2003; Leung et al., 2006).
DEFB1 is in the enrichments results of every population that is significantly enriched in the
GO.Bact category except for the Central Siberian population. It also appears in a number of
enrichments in the GO.Innate category. P2RX7 or P2X7 is a purinergic receptor that binds
to extracellular ATP. In mouse studies, it plays a role in the regulation of intestinal T cells
(Heiss et al., 2008). P2X7 plays an important role in tuberculosis infection. When infected
macrophages were exposed to ATP, the viability of the infecting mycobacterium was reduced
by ninety percent. When cells with a loss of function mutation in P2X7 were exposed to ATP,
there was no apoptosis or killing of mycobacteria (Saunders et al., 2003). P2RX7 is in the
enrichment results in the Southwest European, Central Siberian, and Mainland Southeast
Asian populations, and also appears in several populations in the GO.Tcell and GO.Innate cat-
egories. PGLYRP4 (see review by Dziarski and Gupta (2010)) is a peptidoglycan recognition
protein that is expressed in the skin, mucous membranes, the mouth, and the gastrointesti-
nal tract (Lu et al., 2005). Peptidoglycan is an element of bacterial cell walls (Royet and
Dziarski, 2007). PGLYRP4 has a bactericidal response against both Gram-negative and
Gram-positive bacteria (Lu et al., 2005). This gene has also been associated with psoriasis
(Kainu et al., 2009). TLR6 is a Toll-like receptor that is activated by bacterial and fungal
pathogens (Murray et al., 2009), and appears in the top results in this category in the South
Asian, South Siberia and Mongolian, Central Siberian, and Northeast Siberian populations.
DMBT1 plays an important role in the mucosal innate immune response via sensitivity to
bacterial cell wall antigens. In the intestinal epithelia, DMBT1 expression is upregulated
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upon exposure to LPS and may be implicated in Crohn’s disease (Rosenstiel et al., 2007).
DMBT1 is also expressed in saliva and expressed as salivary agglutinin, which binds to oral
bacteria (Bikker et al., 2002). DMBT1 copy number is correlated with population history
of agriculture, via increase in dietary carbohydrates and the associated dental carie-causing
bacteria Streptococcus mutans (Polley et al., 2015). DMBT1 is in the enrichment signals
of all populations that are significantly enriched in the GO.Bact category except for the
Southwest European population, and it also appears in several populations in the GO.Innate
category.
As in the GO.Bact category, the significant enrichments are largely driven by a core set
of genes shared between populations. CLC, or galectin-10, is related to mucosal damage and
number of phagocytic eosinophils (phagocytic cells involved in allergic response and defense
against parasites) at an infection site. It has also been associated with celiac disease and
allergic asthma (Chua et al., 2012; De Re et al., 2009; Murray et al., 2009). It appears in the
enrichment signals in all populations that are significantly enriched in the GO.Tcell category.
LGALS8, or bgalactoside-binding lectin, detects damage in host cells and marks them for
degradation via autophagy. It has been shown to play a role in both bacterial and viral
infections (Staring et al., 2017; Thurston et al., 2012). LGALS8 is in the enrichment results
in the West Asia and Armenian, Southwest European, Northeast European, West Siberian,
South Siberia and Mongolian, Central Siberian, Northeast Siberian, and Mainland Southeast
Asian populations, and has been found to be under balancing selection in populations in both
Africa and Europe (Andres et al., 2009; Bitarello et al., 2018). TESPA1 is a gene which plays
an important role in T cell selection and growth and is involved in T cell receptor signaling
and development (Wang et al., 2012a), and has been found to be under balancing selection
in African populations (Bitarello et al., 2018). TESPA1 is in the the enrichment signals
in every population with a significant enrichment signal in this gene category. UBASH3A
only appears in the enrichment signal of the West Asia and Armenian population and is a
negative regulator of T cell receptor signaling and is associated with multiple autoimmune
diseases (Carpino et al., 2009; Li et al., 2017). INPP5D, or SHIP, is involved in bacterial
immune response. Knockout SHIP mice were hyper-responsive to LPS (lipopolysaccharide,
or endotoxin, which is a component of Gram-negative bacterial membranes) and did not
display endotoxin tolerance upon a second exposure to LPS (Sly et al., 2004). This suggests
that SHIP plays an important role in regulating the initial and subsequent exposures to
endotoxin and modulating the immune response to Gram-negative bacteria. INPP5D is in the
enrichment signals in the Southwest European, Northeast European, South Asian, and South
Siberia and Mongolian populations. SIGLEC1, or CD169, is lectin protein expressed by
immune cells that binds to sialic acid, which is thought to be an important marker of self for
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immune tolerance (Chen et al., 2014). A lack of sialylation can mark cells for degradation
(Meesmann et al., 2010). Due to its immunosuppressive role, SIGLEC1 is thought to play
a role in sepsis, by inappropriately inducing endotoxin tolerance (Wu et al., 2016). This
induction of tolerance is thought to be an adaptation to persistent bacterial infections by
preventing the immune system from mounting an ultimately damaging reaction (Sly et al.,
2004). Macrophages expressing this protein play an important role in halting the spread of
pathogens via the lymphatic system, stimulating the innate immune system, and assist B
cells in recognizing antigens (Junt et al., 2007). SIGLEC1 is only in the enrichment signal in
the the Northeast Siberian population.
In the innate immune category, as in the others, a set of genes driving enrichment signals
is shared between almost all populations. APOBEC3H, as previously described in Chapter
3, is a member of the APOBEC3 cytidine deaminase gene family that has innate immune
activity, through causing hypermutation, against retroviruses. As mentioned in Chapter
3, it is thought to have been under positive selection at certain times throughout primate
evolution. While APOBEC3H in other primates has strong antiviral effects, the human
version is expressed at such low levels that it shows no antiviral activity. Two potential
reasons are given for this lack of function: the retrovirus APOBEC3H evolved to combat
went extinct and decreased the evolutionary pressure on the gene, or another member of
the APOBEC3 gene family now performs antiretroviral duties and APOBEC3H is no longer
required to be functional. Under relaxed evolutionary pressure, it may be beneficial to have
fewer hypermutation-causing cytidine deaminase genes for the sake of the host cell (OhAinle
et al., 2006). APOBEC3H appears in the enrichment signals in the West Asia and Armenian,
Southwest European, Northeast European, Volga Uralic, South Asian, West Siberian, and
Island Southeast Asian populations. PLSCR1, or phospholipid scramblase 1, is a calcium-
binding protein that amplifies the antiviral effects of the interferon response, since it is an
interferon-stimulated gene and its expression is associated with increased expression of other
interferon-stimulated genes (Dong et al., 2004). PLSCR1 is in the enrichment signal in the
Southwest European, Northeast European, Volga Uralic, West Siberian, Colla, Mainland
Southeast Asia, and Island Southeast Asian populations. IFI16 is an intracellular sensor of
exogenous double stranded DNA (present in DNA viruses and bacteria) and plays a role in
the induction of interferon-b (Unterholzner et al., 2010). IFI16 has been shown to be under
past positive selection during primate evolution as well as long term balancing selection in
Yoruban, European, and EastAsian populations from HapMap populations using the MLHKA
test (Cagliani et al., 2014). This gene also contains SNPs that have been associated with
both risk for and protection against various autoimmune diseases, suggesting antagonistic
pleiotropy as the cause of balancing selection (Cagliani et al., 2014; Zhernakova et al., 2011).
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C1qC is subunit of C1q, which is a member of the complement family and is a pattern
recognition molecule. C1q helps to clear pathogens and cellular debris, including apoptotic
cells. C1q deficiencies can cause autoimmune disease, potentially through the failure to
remove apoptotic cells and subsequent autoantigens (Bohlson et al., 2007; Taylor et al., 2000).
C1QC appears in the enrichment signals in the Central Siberian, Mainland Southeast Asian,
and Island Southeast Asian populations. IRGM is an immunity-related GTPase with an
interesting evolutionary history. Around 50 million years ago, most of the IRG gene cluster
was deleted. The IRGM gene’s open reading frame was disrupted by retrotransposition in the
anthropoid common ancestor but was reestablished in the the common ancestor to humans
and great apes due to disruption from an endogenous retrovirus insertion (Bekpen et al.,
2009). IRGM controls pathogens via autophagy and has been linked to resistance to a range
of pathogens (Bekpen et al., 2010; Singh et al., 2006b). In humans, it has been shown to
control levels of intracellular mycobacteria (Singh et al., 2006b). IRGM has also been linked
to Crohn’s disease susceptibility (Parkes et al., 2007). IRG appears in the enrichment signal
in the Island Southeast Asian population.
Despite that MHC genes were removed from the above enrichment analysis because they
were potentially skewing enrichment results because of their strong representation in several
gene categories, genes driving enrichment in the MHC are worth noting. The gene category
of antigen processing and presentation is especially driven by MHC genes, therefore a subset
of the genes driving the significant enrichments in Table 4.1 are shown in Table 4.4. The full
list of genes can be seen in Table B.10.
Table 4.4 Subset of genes driving significant HKA enrichment signals in the antigen processing and
presentation categorie
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Table 4.4 is largely made up of HLA genes. HLA-A, HLA-B, HLA-C, HLA-G, HLA-DF,
HLA-DQ, and HLA-DP have all been shown to be previously under balancing selection
(Andres et al., 2009; Bitarello et al., 2018; DeGiorgio et al., 2014; Sabbagh et al., 2013).
Supporting the idea that infectious disease is an important factor driving balancing selection at
these loci, HLA diversity has been correlated with pathogen richness (Prugnolle et al., 2005b).
It has also been shown through mouse studies that higher levels of heterozygosity in the
MHC have better survival outcomes when infected with multiple pathogens, suggesting again
that the high levels of polymorphism in the MHC may have evolved to provide protection
against pathogens (McClelland et al., 2003; Penn et al., 2002). MICA is a cell surface protein
in the MHC complex, which is an immune effector and upregulated upon infection (such
as with M. tuberculosis or cytomegalovirus) and other stress events (Das et al., 2001; Groh
et al., 2001). TAP1 and TAP2 are transporter subunits in the MHC (see review by Trowsdale
(2011)). For this analysis, TAP1 and TAP2 are considered to be part of the MHC, but in
future work it would be interesting to see whether the signal from these genes in coming
from TAP1 and TAP2 themselves or other genes in the MHC.
4.2.2 Top-scoring genes per population based on the HKA statistic
In addition to looking at genes that are driving significant enrichment signals, it is also
interesting to look at the top scoring genes in each population. As in the di results, the
genes have been divided into 5 bins based on gene size, so larger genes don’t have an unfair
skew toward higher scores compared to shorter genes (see Section 2.4.2 for more details
on dividing genes into bin sizes). In order to see generally the representation of immune
genes in these top scoring 50 genes in each population, all genes in any of the immune gene










Table 4.5 Top 50 genes by HKA score part 1, correcting for gene size by dividing into 5 bins and taking the top 10 genes from each. Orange






Table 4.6 Top 50 genes by HKA score part 2, correcting for gene size by dividing into 5 bins and taking the top 10 genes from each. Orange
highlights indicate the gene belongs to one or more of the immune gene categories.
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A subset of genes from Tables 4.5 and 4.6 are described below, based on clear immune
function from a literature search. Because many of the genes are shared between several
populations, the descriptions below will be divided by general immune function instead of by
population groups as in the positive selection chapter. While many genes are shared between
the top results of multiple populations, suggesting a potentially older or shared signal, some
of the genes appear in the top results of only one population, potentially suggesting a more
recent and specific signal. Table 4.7 shows the counts of how many times a given immune-
related class of genes appears in the top 50 genes for that population. This can be used as
a rough guide for comparing representation of immune gene classes between the classes
themselves and between populations. Table 4.7 shows that the T cell and antigen processing
and presentation gene categories are represented more strongly than other categories of
immune genes, which is not unexpected given the importance of MHC genes in these results.
Genes in the GO.Virus category are also well represented. Please note that not all of the genes
highlighted in orange had a clear connection to immune function based on the literature, and
so they were not included in the descriptions below. Similarly, some genes that were not
highlighted did have clear connections to immune function, and so they were included in the
gene descriptions below.
Table 4.7 Counts of number of genes in each immune gene category and population in the top 50
genes based on HKA score per population
Many of the genes with top HKA scores are involved in response to bacterial infection,
though this is not reflected well by Table 4.7. DEFB1 appears in the top results here, as well
as in the HKA gene enrichment table under the GO.Bacteria table, where it is described as an
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antimicrobial peptide that has been implicated in defense against bacterial infection. Unlike
many other genes in the top HKA results, this gene is a top hit only in the West and Central
African population, suggesting relatively localized balancing selection. However, DEFB1
was described as driving significant enrichment signals in the South Asian, South Siberia
and Mongolian, and Mainland Southeast Asian populations in the GO.Bact categories. It
has a high score in both the Mainland Southeast Asian and Southeast Asian populations,
though it doesn’t fall into the top 50 genes by score. Therefore, it seems likely that any
balancing selection signal in DEFB1 is not specific to any one population and may be fairly
widespread geographically. FCER2, or CD23, induces killing of bacteria and fungi via
induction of nitric oxide synthase immune cells (see review by Flemming (2017)). CD23
is also associated with allergic response, including T cell activation in response to allergen
exposure and IgE levels associated with specific allergen (Selb et al., 2017). It is in the
top results in the West and Central African, West Asia and Armenian, Northeast European,
Volga Uralic, South Siberia and Mongolian, Central Siberian, Northeast Siberian, Colla,
and Mainland Southeast Asian populations. As referenced in the HKA enrichment results,
PGLYRP4 is a peptidoglycan recognition protein that is expressed in various tissues and has a
bactericidal response against both Gram-negative and Gram-positive bacteria. It is in the top
50 genes in the Southwest European, Volga Uralic, South Siberia and Mongolian, Northeast
Siberian, Colla, Mainland Southeast Asian and Island Southeast Asian populations. LILRA2
is a leukocyte immunoglobulin-like receptor and is a negative effector of antimicrobial TLR
activity and a positive effector of eosinophils. It is also implicated in leprosy infection (see
review by Brown et al. (2004)). It is in the top results of the South Asian population. LGALS8
appeared in the HKA enrichment genes and is involved in host response to bacterial and viral
infections, marking damaged host cells for autophagy. It is a top scoring gene in the West
Siberian, South Siberia and Mongolian, and Northeast Siberian populations. DMBT1 appears
in the HKA enrichment tables, and plays a role in the mucosal innate immune response to
bacteria. It is a top scoring gene in the South Asian, South Siberia and Mongolian, Central
Siberian, Northeast Siberian, and Mainland Southeast Asian populations.
Defense against viral infection is another category of immune genes that is well repre-
sented in top HKA results, as shown in Table 4.7. TAP1 is part of the MHC and is involved
in antigen processing and presentation. It is also a virus-inducible negative regulator of the
innate immune response, and is induced by influenza A virus and human enterovirus 71 (Xia
et al., 2017). It is in the top results in the Northeast European, Southwest European, West
Siberian, and Northeast Siberian populations. TRIM40 is also in the MHC, and suppresses
the viral-RNA recognition by RLR receptors. A deficiency in this gene results in a stronger
antiviral immune response and decreased viral replication (Zhao et al., 2017). It is in the top
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results in the West and Central African, West Asia and Armenian, Volga Uralic, Northeast
European, Central Siberian populations. PSMB9, or LMP2, is a protein that is part of the
proteasome. The proteasome degrades intracellular proteins into peptides that are presented
by MHC class I molecules (Pierini and Lenz, 2018). Various proteasome genes appear in the
top balancing selection results for HKA and other tests, though not all play a clear role in
immune response based on the literature. The expression of PSMB9 is increased upon expo-
sure to interferon-gamma. This may make a proteasome that is better suited to processing
endogenous antigenic peptides (Akiyama et al., 1994). PSMB9 was in the top results in the
West Asia and Armenian, Southwest European, Northeast Siberian, West Siberian, Central
Siberian, Northeast Siberian populations. NUP54 appeared in the HKA enrichment genes
and plays a role in influenza replication (Tafforeau et al., 2011), and is a top result here in
the Colla population. PLSCR1 appeared in the HKA enrichment genes and is an amplifier
of interferon’s antiviral effects, and also appears here in the top results of only the Colla
population.
As would be expected, genes involved in antigen processing and presentation are also
among the genes with the highest HKA scores. HLA-C, HLA-DQA2, HLA-G, HLA-A, HLA-
B are all among the highest scoring genes. They have associations with susceptibility to
infectious and inflammatory disease, and appear in the top results of all populations. As seen
in the enrichment results, MICA is an immune effector and upregulated upon infection (Das
et al., 2001; Groh et al., 2001). TAP2 is part of the MHC and plays a role in the immune
response against various pathogens (see review by Trowsdale (2011)). It is in the top scoring
genes in the West and Central African and the West Asia and Armenian populations.
A number of genes in Tables 4.5 and 4.6 are involved in immune activation. SPHK1
(sphingosine kinase 1), along with SPHK2, produces S1P, which is an immune regulator that
was previously discussed in the di results section of the Central Siberian population (Spiegel
and Milstien, 2011). In summary, S1P gradients play a role in migration of immune cells.
The gene SPHK1 is in the top results of the Volga Uralic population. SELE, or E-selectin,
plays a role in the recruitment of leukocytes to the endothelium and has been studied in the
case of an individual with recurrent infections and impaired pus formation (DeLisser et al.,
1999). It is in the top results of the West Asia and Armenian, Southwest European, South
Asian, South Siberia and Mongolian, Northeast European, Volga Uralic and Central Siberian
populations. TNFRSF10D is a member of the tumor necrosis factor receptor superfamily,
whose members have important roles in immune response (see review by Collette et al.
(2003)). Transcription of TNFRSF10D is a result of stimulation with the intestinal pathogen
S. Typhimurium (Bruno et al., 2009), and this gene is found in the top results of the Island
Southeast Asian population. BTNL2 has been associated with inflammatory disease, and is
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involved in T cell activation (Nguyen et al., 2006). It is in the top results of all but the West
and Central African populations. As seen in the enrichment results, TESPA1 is involved in
T cell receptor signaling and T cell development. It is also in the top results of all but the
West and Central African populations. NQO2 plays a role in activation of chemokines and
NF-kappaB signaling. Knockout mice for this gene and NQO1 had impaired B cell function
and increased tendency toward autoimmune disease (Iskander et al., 2006). NQO2 is in the
top results of the West and Central African and Northeast European populations.
4.3 Results of the b test
Like the HKA results, the results of enrichment analyses in the b results are separated
into two parts: enrichment for immune genes in the top one percent of results, and a list of
the top 50 scoring genes in each population. As with the HKA results, the top results are
corrected for gene size as described in the Chapter 2. The b statistic is best powered to detect
balancing signals older than 100,000 generations, which is about 2.5 million years ago if a
generation time of 25 years is used (Siewert and Voight, 2017b).
4.3.1 Enrichment of immune genes in top results
The results of the enrichment test are shown below in Table 4.8. As with other tests,
the expected number of genes per immune category is shown in the row labeled "exp", and
light and dark orange colors represent statistically significant (with corrections for multiple
testing) enrichment at two different p values. The gene count for the number of genes in the
top one percent of results in a given population and gene category is given in each cell.
Most populations show a significant enrichment in genes associated with T cell function.
Interestingly, while the top results of many populations are enriched for genes involved with
response to bacteria, there are no significant enrichments for response to viral infection.
There is less of a strong enrichment in the antigen processing and presentation category than
there is in the HKA results. There are no significant enrichments in the HPI DB results.
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Table 4.8 Enrichment of top one percent of b results in each population for immune genes based on
the GO DB and HPIDB compared with expected counts. The "exp" row gives the expected
number of immune genes in any given immunity category after randomly choosing one
percent of all protein-coding genes, and the counts in each cell represent the observed
number of immune genes of a given category in the top one percent of the results. Light
orange indicates significant enrichment at p=0.05 and dark orange at p=0.01 in a Fisher’s
exact test with correction for multiple testing, as described in Chapter 2.
As with the HKA results, it is expected that genes in the MHC will be common among
top balancing selection targets and may skew enrichments in other categories. Therefore, the
enrichment analysis was performed again, excluding genes in the MHC. The results of this
are shown in Table 4.9. While the enrichment patterns have changed somewhat, these results
are much more similar to those including MHC genes than were the HKA results.
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Table 4.9 Enrichment of top one percent of b results in each population for immune genes based on the
GO DB and HPIDB compared with expected counts, with genes in MHC region removed.
The "exp" row gives the expected number of immune genes in any given immunity category
after randomly choosing one percent of all protein-coding genes, and the counts in each cell
represent the observed number of immune genes of a given category in the top one percent
of the results. Light orange indicates significant enrichment at p = 0.05, dark orange at
p=0.01 in a Fisher’s exact test with correction for multiple testing, as described in Chapter
2.
A subset of genes, chosen for their clear relation to immune function based on a literature
search, driving the enrichment signals seen above is shown below in Table 4.10. This table
shows that the shared signals of enrichment shown in Table 4.9 are often caused by the same
genes, though not always with perfect overlap. Most of the genes in Table 4.10 appear more
than once and often are shared between many populations. Unlike in the HKA results, there
are significant enrichments in the West and Central African population, and these genes are
shared more or less with all other populations in the analysis. This suggests shared signals
predating the split between modern African and non-African populations, which fits with the
timeframe for which the b statistic is optimally powered.
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Table 4.10 Subset of genes driving significant b enrichment signals
Many of the genes driving enrichments in the GO.Bact category are shared between
populations. One of the exceptions is CHIT1, or chitinase, an enzyme that digests chitin.
CHIT1 is enriching the GO.Bact signal in the West and Central African population. It
also was part of the enrichment signal in the Colla population in the nSL test. Chitin is a
polysaccharide that is a structural component of a variety of fungal, bacterial, and parasitic
(including malaria) pathogens but is not made by human cells. This enzyme plays a role
in the immune response to these organisms, and is also implicated in inflammatory disease
(see review by Di Rosa et al. (2016)). Several genes driving significant enrichments in
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the GO.Bact category are shared between almost all of the populations with significant
enrichment results. These are DEFB1, DMBT1, and PGLYRP4, all of which are involved
in defense against bacterial infection. These three genes also appear multiple times in the
enrichment signals in the GO.Innate category, also with widespread sharing of these genes
between populations. GNLY produces granulysin, which is an antimicrobial protein that has
cytolytic effects against bacteria (including tuberculosis), parasites, fungi, and malaria (see
review by Krensky and Clayberger (2009)). This gene drove significant enrichment in the
West Siberian and Island Southeast Asian populations, and has been suggested to be a target
of balancing selection in European populations by Bitarello et al. (2018).
In the GO.Tcell category, CD209 is an attachment factor for various viruses, bacteria, and
parasites including Mycobacterium tuberculosis, dengue virus, Leishmania, hepatitis C virus,
and others (Colmenares et al., 2002; Kooyk et al., 2003; Lozach et al., 2004; Sakuntabhai
et al., 2005). CD209 is part of the enrichment signal in the West and Central African and West
Asia and Armenian populations, both in the GO.Tcell category and the GO.Innate category.
CLC, involved in eosinophil function (De Re et al., 2009), is also shared between four of the
nine populations. It is part of the significant enrichment signal in both the West and Central
African and West Asia and Armenian populations. IRF1 is a transcription factor that is a
regulator of interferon expression (Miyamoto et al., 1988). IRF1 appears in the enrichment
results in all the significantly enriched populations, suggesting a widely shared signal. It also
appears in multiple populations in the GO.Innate category. SFTPD is a surfactant protein
that is important in the defense of lung tissue from bacterial and viral pathogens (Wright,
2005). SFTPD is driving enrichment in the West and Central African, Southwest European,
West Siberian, and South Siberia and Mongolian populations. TESPA1 is involved in T cell
receptor signaling and T cell development (Wang et al., 2012a), and is driving enrichment
signals in all the populations with significant enrichments in this gene ontology category.
TRPM4 is associated with calcium signaling and has been found to be important for survival
in a mouse model of sepsis (Serafini et al., 2012). TRPM4 is also shared between four
of the nine populations with significant enrichments in genes involved in T cell function.
VAV1 plays a role in the adhesion of T cells and antigen-presenting cells (Krawczyk et al.,
2002), and unusually only appears in one one enriched population in Table 4.10, the South
Siberia and Mongolian population. LGALS8 is part of the enrichment signal in the West Asia
and Armenian, Southwest European, Northeast European, West Siberian, South Siberia and
Mongolian, and Island Southeast Asian populations. It is involved in detecting damage in
host cells and plays a role in both bacterial and viral infections (Staring et al., 2017; Thurston
et al., 2012). INPP5D plays a role in regulating response to endotoxin (Sly et al., 2004).
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INPP5D appears only in the Northeast European enrichment signal in this gene ontology
category.
In the innate immune category, CLEC6a is a C-type lectin receptor, which is involved
in the immune response to fungi and mycobacteria (see review by Dambuza and Brown
(2015)). This gene is in the enrichment signals for the West and Central African, West
Asia and Armenian, Central Siberian, Mainland Southeast Asian, and Island Southeast
Asian populations. ZC3HAV1 is an antiviral protein that shows evidence of long-standing
balancing selection in several major human population groups, as well as trans-specific
polymorphism between humans and chimpanzees (Cagliani et al., 2012). It only appears in
the enrichment signal in the West Asia and Armenian population. C3 is another component of
the innate immune complement pathway (Murray et al., 2009), and appears in the enrichment
signals in the South Siberia and Mongolian, Central Siberian, and Mainland Southeast
Asian populations. KL, or klotho, is involved in aging, which is also reflected in its role
in T cell aging and autoimmune disease (Witkowski et al., 2007). It has been suggested to
be a target of balancing selection in European and African populations by Bitarello et al.
(2018). APOL1 provides innate resistance against the parasite Trypanosoma brucei, which
causes trypanosomiasis in African primates, humans, and other animals. However, functional
APOL1 has only been identified in humans and several other primates, which suggests that
this gene may have a fitness cost in other animals that outweigh this benefit. This fitness
cost may be related to the involvement of this gene in kidney disease in African American
populations (review by Limou et al. (2015)). APOL1 is in the enrichment signals in the West
Asia and Armenian, Southwest European, Volga Uralic, West Siberian, Mainland Southeast
Asian and Island Southeast Asian populations. APOBEC3H has appeared in the top HKA
results, as well as in top positive selection results, and is an antiviral gene that plays an
important role in other primates but seems to be less important in humans (OhAinle et al.,
2006). This gene is part of the enrichment signal in the Volga Uralic, Central Siberian,
Northeast Siberian, Mainland Southeast Asian, and Island Southeast Asian populations.
IFI16 is an intracellular sensor of viral DNA and has been shown to be under past positive
selection during primate evolution as well as long term balancing selection in Yoruban,
European, and EastAsian populations from HapMap populations using the MLHKA test
(Cagliani et al., 2014; Unterholzner et al., 2010). IFI16 was in HKA enrichment results in the
Volga Uralic population, and here is in the enrichment results in the West Asia and Armenian,
West Siberian, South Siberia and Mongolian, and Northeast Siberian populations.
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4.3.2 Top-scoring genes per population based on the b statistic
As in the presentation of the HKA results, the 50 genes with the highest b scores per
population are presented in Tables 4.11 and 4.12. Again, genes highlighted in orange show
that a given gene is in one of the immune gene classes described in Table 2.1. These are
divided into 5 bins based on gene size to avoid a bias toward higher scores for larger genes








Table 4.11 Top 50 genes by b score part 1, correcting for gene size by dividing into 5 bins and taking the top 10 genes from each. Orange highlights






Table 4.12 Top 50 genes by b score part 2, correcting for gene size by dividing into 5 bins and taking the top 10 genes from each. Orange highlights
indicate the gene belongs to one or more of the immune gene categories.
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A subset of these top genes are described below, based on their clear connection to
immune function based on a literature search. As in the description of the top scoring genes
from the HKA test, the gene descriptions will be grouped by broad immune function, since
many signals are shared between multiple populations. Table 4.13 shows the counts of
how many times a given immune-related class of genes appears in the top 50 genes for that
population. This can be used as a rough guide for comparing representation of immune gene
classes between the classes themselves and between populations. Table 4.13 shows that the
gene categories relating to bacterial and viral defense response, as well as T cell function,
are represented more strongly than other categories of immune genes. However, as with
the results of the di and HKA tests, genes assigned to these categories do not always have
a clear relation to immune function based on a literature search, and some genes that are
not highlighted to have a clear immune function based on a literature search. Therefore, the
genes highlighted below are grouped by immune function, and not by strict membership to
the gene ontology terms in Table 4.13.
Table 4.13 Counts of number of genes in each immune gene category and population in the top 50
genes based on b score per population
As Table 4.13 shows, a large number of the genes with top b scores are involved in defense
against bacterial pathogens. CD209 is a C-type lectin receptor expressed in phagocytic cells
that functions as a pathogen recognition receptor for a wide range of pathogens including
HIV, Mycobacterium tuberculosis, Helicobacter pylori, hepatitis C virus, Dengue virus,
certain strains of pneumonia bacteria, as well as parasites responsible for schistosomiasis and
leishmaniasis (see Barreiro et al. (2005) for review). Barreiro et al. undertook an extensive
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population genetic analysis of CD209 in a global context and found that it has been under
strong selective constraint. However, it does exhibit high levels of nucleotide diversity in
African populations. This, the authors conclude, is not due to balancing selection but rather
to ancient population structure within the larger African population. Time to most recent
common ancestor for this gene is one of the oldest reported, at around 2.8 million years
(Barreiro et al., 2005). This certainly fits with the older timeframe of the b test, which here
seems to have picked up not a signal of true balancing selection but rather an artifact of
population structure. IL37 is a suppressor of the immune response. Mice with transgenic
expression of this gene were less susceptible to LPS-induced shock and had fewer cytokines
and less activation of dendritic cells (Nold et al., 2010). DEFB1, an antimicrobial defense
gene, was in the top HKA results as well and here is seen in the top results for the Central
and West African, West Asia and Armenian, Southwest European, Northeast European,
Volga Uralic, South Asian, West Siberian, South Siberia and Mongolian, and Mainland
Southeast Asian populations. MRGPRX2 is expressed in mast cells and is a receptor for
LL-37, an antimicrobial peptide (Subramanian et al., 2011; Zanetti et al., 1995). It is in the
top results in the West Asia and Armenian, Southwest European, Northeast European, Volga
Uralic, South Asian, West Siberian, Central Siberian, and Northeast Siberian populations.
IL17RC is in the top results in the West and Central African population. IL17RC, along with
IL17RA, forms a heterodimer receptor IL17R, which is the ligand for IL17A and IL17F.
IL17RC is expressed mostly in non-immune cells, and is bound with higher affinity by
IL17F than IL17A. Both IL17A and IL17F play a role in immune response to bacteria and
fungi. IL17F is mostly involved in mucosal defense, and IL17A is involved in autoimmune
and allergic responses as well as immune responses (see review by Iwakura et al. (2011)).
PGLYRP4 appears here in the top results of the Southwest European and Northeast European
population populations, as well as in the top HKA results, and is a peptidoglycan recognition
protein that has a bactericidal response against both Gram-negative and Gram-positive
bacteria. As seen in the b gene enrichment results, GNLY produces the antimicrobial protein
granulysin, which acts against a wide range of pathogens. GNLY is a top scoring gene in
the West Siberian population. LGALS8 is in the top results for the West Asia and Armenian,
Southwest European, Northeast European, Volga Uralic, South Asian, Island Southeast Asian
populations, and it also appeared in the HKA top results. It is involved in detecting damage in
host cells and plays a role in both bacterial and viral infections (Staring et al., 2017; Thurston
et al., 2012). As mentioned in the gene enrichment results, TRPM4 is involved in calcium
signaling and has been implicated in sepsis survival. It is in the top results in the West Asia
and Armenian, Volga Uralic, West Siberian, and Island Southeast Asian populations. DMBT1
appears here again and also is in the top enrichment and individual HKA results. It plays an
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important role in the mucosal innate immune response via sensitivity to bacterial cell wall
antigens. In the b results, it is among the top scoring genes in the all but the West and Central
African and West Asia and Armenian populations.
Multiple top scoring genes are involved in defense against viral infection. IRF1 was in
the b enrichment results, and is a regulator of interferon expression, and here is in the top
results in the West and Central African, Northeast European, South Asian, and Mainland
Southeast Asian populations. APOBEC3H was also found in the HKA enrichment results,
and is an important antiviral gene in other primates but seems to be less important in humans
(OhAinle et al., 2006). Here it is in the top results in the Mainland Southeast Asian and
Island Southeast Asian populations. IL32, in the top results of the Northeast European
population, is a proinflammatory cytokine and plays a role in defense against DNA viruses,
RNA viruses, and Mycobacterium tuberculosis via induction of other inflammatory cytokines
and differentiation of monocytes into macrophage-like cells (Bai et al., 2010; Netea et al.,
2005, 2008; Zepp et al., 2011). TREML4, in the top results of the Central Siberian and
Northeast Siberian populations, is a positive regulator of TLR7 signaling. Mice deficient
in this gene showed decreased propensity to autoimmune disease and showed an inhibited
immune response to influenza virus. The TREM family of genes are receptors that amplify or
dampen TLR signaling to regulate immune response (Ornatowska et al., 2007; Ramirez-Ortiz
et al., 2015; Turnbull et al., 2006). Also seen in the window-based DIND results for the
Southwest European population, MSR1 binds to extracellular double-stranded RNA and
instigates the innate immune response to viral infection via activation of interferons via
interaction with TLR3 (Dansako et al., 2013; DeWitte-Orr et al., 2010). MSR1 is in the top
results of the South Siberia and Mongolian population.
IL36RN is also involved in the defense response against potentially pathogenic organisms,
though the organism in this case is not bacteria nor viruses but rather fungus. IL36RN is
the receptor antagonist of IL36 and acts against the inflammation-causing IL36 family of
cytokines. IL36 cytokines are thought to play a role in anti-fungal immune response, and
mutations in IL36RN have been associated with psoriasis (Blumberg et al., 2007; Gresnigt
et al., 2012; Marrakchi et al., 2011).
Several top scoring genes are involved in antigen processing and presentation, though
fewer in the b results than in the HKA results. Interestingly, whereas other HLA genes were
very common in top results for the HKA test, only HLA-DQA2 appears in the top b results,
and only in the West and Central African, Volga Uralic, South Asian, South Siberia and
Mongolian, Northeast Siberian, Colla, Mainland Southeast Asian and Island Southeast Asian
populations. MICA is also involved in antigen processing and presentation and appears in the
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top results in the South Siberia and Mongolian, Northeast Siberian, and Colla populations, as
well as in the top HKA results. It is a cell surface protein in the MHC complex.
A number of genes in the top b results are involved in T cell and immune activation
and inflammation. CLC, or galectin-10, is in the top West and Central African, Southwest
European, and Northeast European results and was also described in the HKA enrichment
results. It plays a role in eosinophil function and has been implicated in inflammatory
disease (De Re et al., 2009; Murray et al., 2009). CCL26 is a chemokine that plays a role
in allergic disease by attracting eosinophils, killer lymphocytes, and monocytes (Nakayama
et al., 2010). It is in the top results in the Southwest European, Volga Uralic, and Colla
populations. PDLIM2 is in the top results in the South Asian, Mainland Southeast Asian,
Island Southeast Asian populations and is involved in limiting the inflammation caused by
the immune response. Knockout mice for this gene were more likely to have EAE (Qu et al.,
2012). AP1M2 deficiency in mice causes immune impairment and chronic colitis, and the
gene is implicated in maintaining gut immune homeostasis. Human patients with Crohn’s
disease exhibit reduced expression levels (Takahashi et al., 2011). AP1M2 is in the top
results in the West Siberian and Colla populations. BTNL2 is in the top results in the West
Siberian, South Siberia and Mongolian, Northeast Siberian, and Mainland Southeast Asian
populations, as well as in the HKA top results, and is involved in T cell activation (Nguyen
et al., 2006). ISX is an intestinal transcription factor in the top Central Siberian, Mainland
Southeast Asian, and Island Southeast Asian results that has been identified as an important
part of maintaining vitamin A homeostasis that helps to maintain immune function tolerance
in the gut (Widjaja-Adhi et al., 2017). CD84 is in the top West and Central African results,
and is a stimulator for interferon-gamma production, and is involved in T cell activation
(Martin et al., 2001; Tangye et al., 2003). IL1RN, like IL36RN, is an interleukin receptor
antagonist. It binds to the IL1 receptor, as does IL1, but it does not initiate an inflammatory
response. Therefore, this gene acts as a way to limit immune and inflammatory response
(McIntyre, 1991). IL1RN is in the top results in the West and Central African, Southwest
European, Volga Uralic, South Asian, West Siberian, and South Siberia and Mongolian
populations. PTPN21, in the top results of the West Asia and Armenian, South Asian, West
Siberian, South Siberia and Mongolian, Central Siberian, and Colla population, is a negative
regulator of ICAM-1 in in skin cells, thus having a dampening effect on immune reactions in
the skin (Cho et al., 2017). ITGAE, or CD103, was a significant gene in the window-based
positive selection tests in the West and Central African population. It is involved in immune
homeostasis in both the intestine and the airways, and here is in the top South Siberia and
Mongolian results. KL was described in the b enrichment results, and is involved in aging,
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which is also reflected in its role in T cell aging and autoimmune disease. It is in the top
results in the Volga Uralic, Central Siberian, and Mainland Southeast Asian populations.
Another top result in the b results is EGLN1, which is not known for its immune in-
volvement, but is included here because it is a noted target of past positive selection in both
Tibetan and Andean populations as an adaptation to living at high altitude (Bigham et al.,
2010; Yi et al., 2010). It is a top result in both the West Asian and Armenian population and
the Volga Uralic population, suggesting that potentially the selection history of this gene may
be more complex than previously thought.
4.4 Results of the Tajima’s D test
As in the previous two sections, the results of enrichment analyses in the Tajima’s D
balancing selection results are separated into two parts: enrichment for immune genes in the
top 1% of results, and a list of the top 50 scoring genes in each population. Since Tajima’s
D was computed per 200 KB window, each gene did not have its own Tajima’s D score. In
order to rank individual genes, the gene with the highest mean minor allele frequency from
each of the top 50 genic windows was chosen. Those genes are listed in descending order
with the gene from the top window first. In some cases, a gene may appear multiple times in
one population. This is because that gene was in multiple windows and had the highest mean
minor allele frequency in each window. The Tajima’s D test is best powered to detect signals
between 50,000 and 250,000 years ago (Grossman et al., 2013; Sabeti et al., 2006). As is
discussed in the Discussion chapter of this thesis, it is likely that a window size of 200 KB is
likely far too large to be used to search for signals of balancing selection. However, the data
was available in 200 KB windows so it was repurposed in this analyses to see if it could be
used in multiple ways.
4.4.1 Enrichment of immune genes in top results
Compared to the other two tests of balancing selection, there are very few significant
enrichments for immune genes in top Tajima’s D balancing selection results. Also unlike
the other two tests, there is a (single) significant enrichment in a HPI DB category, here in
the Colla population in the HP.Bacteria category. The most enrichments are in the antigen
processing and presentation category, and there are two in the GO.Bact category.
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Table 4.14 Enrichment of top one percent of Tajima’s D and mean MAF results in each population
for immune genes based on the GO DB and HPIDB compared with expected counts. The
"exp" row gives the expected number of immune genes in any given immunity category
after randomly choosing one percent of all protein-coding genes, and the counts in each
cell represent the observed number of immune genes of a given category in the top one
percent of the results. Orange indicates significant enrichment at p = 0.01 in a Fisher’s
exact test with correction for multiple testing, as described in Chapter 2.
As with the HKA and b statistics, it is possible that MHC genes will skew the enrichment
results of the Tajima’s D test and suggest significant enrichments where there are none.
Because of this, the enrichment analysis was performed excluding the MHC genes. The
results of this analysis are shown in Table 4.15. Also as with the HKA and b results, the
pattern of significant enrichments is different when MHC genes are excluded. Notably, all
enrichments in the antigen processing and presentation category disappear save for that in
the South Asian population. All significant enrichments in the West and Central African
population disappear as well, as does the sole enrichment in the GO.Tcell category.
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Table 4.15 Enrichment of top one percent of Tajima’s D and mean MAF results in each population for
immune genes based on the GO DB and HPIDB compared with expected counts, excluding
genes in the MHC. The "exp" row gives the expected number of immune genes in any
given immunity category after randomly choosing one percent of all protein-coding genes,
and the counts in each cell represent the observed number of immune genes of a given
category in the top one percent of the results. Orange indicates significant enrichment at p
= 0.01 in a Fisher’s exact test with correction for multiple testing, as described in Chapter
2.
A subset of the genes responsible for the enrichment signals shown in Table 4.15 are
shown in Table 4.16, and described in more detail below.
Table 4.16 Subset of genes driving significant Tajima’s D balancing selection enrichment signals, not
including MHC genes
In the GO.Bact category and Volga Uralic population, NFKB1 is involved in the regulation
of a number of inflammatory responses (Borm et al., 2005). TLR2 is activated by both
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bacterial and fungal ligands and is an important part of the innate immune response to those
pathogens (Murray et al., 2009).
In the GO.Virus category in the West Siberian population, AP1S3 is necessary for
normal TLR3 endosomal translocation and downstream signaling, as well as normal IL1
and IL36alpha expression. Mutations in this gene can cause skin autoimmune disease and
inflammation (Mahil et al., 2016; Setta-Kaffetzi et al., 2014). This gene was also seen in the
di top results in the West Asia and Armenian population. DDX1 is an RNA helicase and
plays a role in coronavirus replication (Xu et al., 2010). DUOX2 was described in the nSL
enrichment results in the Northeast European population and plays a role in antiviral immune
response (Fink et al., 2013). RNASEL is an RNAse that sets of interferon production pathway
during a viral infection (Malathi et al., 2007). TRIM23 was in the Mainland Southeast Asia
nSL enrichment results, and plays a role in the TLR3 antiviral and innate immune response
(Arimoto et al., 2010).
In the adaptive immunity category and the Colla population, NLRP10 is important in the
initiation of the adaptive immune response (Eisenbarth et al., 2012).
4.4.2 Top-scoring genes per population based on the Tajima’s D statis-
tic
As in the HKA, b , and di results, it is interesting to look at individual top scoring genes
in the Tajima’s D balancing selection analysis as well as looking at enrichment signals.
However, Tajima’s D was run on 200 KB windows across the genome and not gene-wise, as
HKA, di, and b were. Therefore, in order to get gene-wise results to be comparable to the
other balancing selection statistics, the top 50 windows are represented in descending order
of Tajima’s D score, with the gene within that window with the highest mean minor allele
frequency representing that window. The rationale behind this system is that genes under
balancing selection would likely tend to have variants at intermediate frequency than variants
at high or low frequencies. Please see Chapter 2 (Section 2.3.1) for more information. As
with the previous sections, genes highlighted in orange have been classified as immune-
related genes according to Table 2.1 in Chapter 2. Not all highlighted genes have a clear
connection to immune function based on the literature, so not all are described. Some genes











Table 4.17 Part 1 of table showing the gene with the maximum mean MAF from each of the top 50 200 KB windows with the highest positive
Tajima’s D values, excluding windows not containing protein-coding genes. Orange highlights indicate the gene belongs to one or more






Table 4.18 Part 2 of table showing the gene with the maximum mean MAF from each of the top 50 200 KB windows with the highest positive
Tajima’s D values, excluding windows not containing protein-coding genes. Orange highlights indicate the gene belongs to one or more
of the immune gene categories.
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A subset of the top 50 genes by Tajima’s D score and minor allele frequency, included
in the descriptions below based on their clear involvement in immune function based on a
literature search, are listed below for each population and grouped by gene function. Two
categories of genes which are not overtly involved in immune function but that are well
represented in Tables 4.17 and 4.18 are olfactory receptors and solute carriers. It is interesting
to note that selection signals seem to be shared less in this statistic than in others. In the gene
descriptions below, many genes appear in the top results of multiple populations. However,
these are usually shared between two or a small number of populations. Sometimes these
populations are geographically close, or are likely to share a relatively recent common
ancestor population, but sometimes they are significantly geographically separated. Based
on these results, there doesn’t seem to be a pattern for which types of immune genes are
likely to be shared as top results between populations and which are not. Table 4.19 shows
the counts of how many times a given immune-related class of genes appears in the top 50
genes for that population. This can be used as a rough guide for comparing representation of
immune gene classes between the classes themselves and between populations. Table 4.19
shows relatively small numbers of immune-related genes in these results, and the highest
concentration of immune genes in the HP.Bact and HP.Virus categories. However, as with
the results of previous balancing selection statistics, genes assigned to these categories do
not always have a clear relation to immune function based on a literature search, and some
genes that are not highlighted to have a clear immune function based on a literature search.
Table 4.19 Counts of number of genes in each immune gene category and population in the top 50
genes based on Tajima’s D score and MAF per population
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Though this is not reflected by Table 4.19, a large number of top scoring genes are
involved in the defense response to bacterial infection, meaning that selection in these genes
could be an adaptation to bacterial pathogens. LGALS8 is in the top results in the West and
Central African and Island Southeast Asian populations and also appeared in top HKA and b
results. Between the three statistics, is appears in the top results of a wide variety of Eurasian
and Island Southeast Asian populations This suggests that balancing selection in this gene is
global and potentially very old. It is involved in detecting damage in host cells and plays a
role in both bacterial and viral infections (Staring et al., 2017; Thurston et al., 2012). TRPC6
is among the top results in the West Asia and Armenian population, and is a receptor-activated
calcium channel (see review by Dietrich et al. (2005)) that has also been associated with
vascular inflammation caused by endotoxin (LPS). LPS induces a TLR4 response, which
induces TRPC6 in endothelial cells. This in turn sets off a cascade that leads to increased lung
vascular inflammation and permeability via activation of NF-kappaB. This can cause acute
lung injury in individuals with sepsis (Tauseef et al., 2012). Also in the top results in the West
Asia and Armenian and Central Siberian populations, PELI2, or Pellino 2, is important for
TLR/IL1R-mediated post-transcriptional control. PELI2 knockout cells underwent decreased
expression of inflammatory genes usually induced by LPS or IL1 (Kim et al., 2012). APIP is
in the top results in the Northeast European population and the Northeast Siberian population.
Reduced expression of APIP, or apoptotic protease activating factor 1-interacting protein,
is associated with an increase of Salmonella-associated cell death and increased survival of
individuals with systemic inflammatory response syndrome during the course of a Salmonella
infection. The authors of this study suggest that the SNP associated with these outcomes has
been under selection in Europe and Asia, though not in the Americas, Oceania, or Africa,
due to earlier development of agricultural practices in the former regions (Ko et al., 2012).
ITLN1, or intelectin, is a lectin that binds to galactofuranose, which is a component of
bacterial cell walls, suggesting a role for this gene in the innate immune response (Tsuji
et al., 2001). ITNL1 is in the top results in the Northeast European population. NBR1, in the
top results in the Volga Uralic population, is an LC3-interacting adaptor protein that acts to
tag microbial and cytosolic material for autophagy, implying a role in the coordination of the
innate immune response (see review by Levine et al. (2011)). The SLC46 family of genes
has been shown to be involved in innate immune recognition of peptidoglycan, however the
role of SLC46A3 in this context has not been elucidated (Paik et al., 2017). SLC46A3 is in
the top results of the Volga Uralic population. Antimicrobial fragments of the skin protein
FLG2, or filaggrin-2, target the replication of the bacteria Pseudomonas aeruginosa. Healthy
skin is usually able to fight off infection, but when the skin barrier is compromised infection
can ensue (Hansmann et al., 2015; Yu et al., 2007). FLG2 is in the top results of the South
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Asian population. PADI4, or PAD4, plays an important role in the formation of neutrophil
extracellular traps, which are part of the innate immune response against bacteria. Knockout
mice for this gene are more susceptible to bacterial infection (Li et al., 2010b). PADI4 is in
the top results of the South Asian population. OLFM4, in the top results of the West Siberian
and Central Siberian populations, plays a role in H. pylori infection. Knockout mice had a
lower bacterial load and more inflammatory signaling that wild type mice (Liu et al., 2010).
PYDC2, or CPOP2, acts as a regulator of inflammasome and controls the manufacture of
IL-1beta. Its expression was also induced in response to LPS (Dorfleutner et al., 2006). It
is in the top results in the South Asian, South Siberia and Mongolian, Mainland Southeast
Asian, and Island Southeast Asian populations. The phagocyte receptor CEACAM3, in
the top results in the Northeast Siberian population, is expressed on granulocytes and is
involved in the recognition and response to several Gram-negative bacteria such as Neisseria
gonorrhoeae and Haemophilus influenzae, which can cause sepsis, meningitis, and infertility
(see review by Pils et al. (2008)). RASGEF1B expression is induced by microbial infection
and TLR activation and plays a role in the mediation of the innate immune response (Andrade
et al., 2010). RASGEF1B is in the top results of the Mainland Southeast Asian population,
and has been suggested as a target of balancing selection by Bitarello et al. (2018).
Several of the top scoring genes are involved in defense response against parasites.
FREM3 is in a region that has been shown to be under ancient balancing selection, potentially
because of its proximity to and LD with GYPE, GYPB and GYPA, which are implicated
in malaria infection (Leffler et al., 2013; Manjurano et al., 2015). FREM3 is in the top
results in the West Asia and Armenian, Southwest European, South Asian, Volga Uralic,
and Northeast Siberian populations. LEPR, or the leptin receptor, has been associated with
susceptibility to amebiasis and amebic colitis, and leptin has been associated in mice with
differential susceptibility to M. tuberculosis and Streptococcus pneumoniae. Thus leptin and
its receptor are important in the immune response, as well as in their perhaps better-known
role in appetite and metabolism (see review by Mackey-Lawrence and Petri (2012)). LEPR
is in the top results of the South Asian and West Siberian populations.
A number of top scoring genes are involved in defense response against viral infections.
XCR1 is in the top results in the Northeast European and South Asian populations, and
is the chemokine receptor of XCL1, a chemokine that is produced during immune and
inflammatory reactions. XCL1 has been associated with host response to viral, bacterial,
and parasitic pathogens. XCR1 is expressed by dendritic cells and is involved in antigen
presentation and the cytotoxic T cell response. The interaction of XCR1 and XCL1 also
plays a role in thymic selection and self-tolerance (see review by Lei and Takahama (2012)).
USP38 is in the top results in the Northeast European, South Asian, and Northeast Siberian
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populations, and is a negative regulator of type I interferon signaling (Lin et al., 2016).
It is also in the same region as FREM3, mentioned in the paragraph above. N4BP1, in
the top results of the Volga Uralic, South Asian, and West Siberian populations, has been
shown to inhibit interferon-beta production upon viral infection, however, it is not clear from
the literature how widespread this immunomodulatory effect is (Li et al., 2011). AP1S3
was described in the enrichment results in the West Siberian population, and is involved
in TLR3 function. It is in the top results in the West Siberian population. NUP54, in the
top results of the South Siberia and Mongolian and Mainland Southeast Asian populations,
also appeared in HKA results and is a nuclear transport protein that has been shown to be
necessary for influenza replication (Tafforeau et al., 2011). DAPK1, in the top South Siberia
and Mongolian population, is a regulator of the antiviral immune response via its interaction
with interferon-beta, IRF7, IRF3, INFB1, and RIG-1 (Zhang et al., 2014). As seen in the
Tajima’s D balancing selection enrichment results, NFKB1 is involved in the regulation of a
number of inflammatory responses including response to viral infection and innate immune
response, migraine, and the interaction between gut microflora and the immune system
(Hiscott et al., 2001; Lawrence et al., 2005; Nenci et al., 2007; Reuter et al., 2002). NFKB1
is in the top results for the Central Siberian and Northeast Siberian populations. WWP2, in
the top Colla results, is a negative regulator of the TLR3-mediated innate immune response
to double stranded viral RNA. Knockout mice produced higher levels of interferon-beta,
TNFalpha, IL6, and CCL5 in response to the activation of this response (Yang et al., 2013).
As with the results for other balancing selection statistics, there are a number of top
scoring genes involved in antigen processing and presentation. The top four results in the
West and Central African population are genes in the MHC, which is not surprising based
on the other balancing selection tests. However, it interesting to note that while results for
other populations do include HLA genes, none are at the very top of the results as they are in
the West and Central African population. HLA-A and HLA-DPB1 are in the top results in
the West and Central African and South Asian population. HLA-G is in the top results in the
West and Central African and Volga Uralic population. HLA-DRA and HLA-C are only in the
top results in the West and Central African population. HLA-DQA2 is in the top results in the
West and Central African and Northeast European populations. HLA genes are clearly less
often shared among top results than in other balancing selection statistics. RPP21 is among
the top results in the West and Central African population. Loci in this gene were found to
have significant effect on antibody response to HBV vaccine. These loci are though to have
some regulatory effect on the expression of various HLA genes (Yucesoy et al., 2013).
A number of genes in the top Tajima’s D results for balancing selection are those involved
with T cell and immune activation and function. PTPN21 in the West and Central African
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population was also in the top individual genes for the b results. It is is a negative regulator
of immune reactions in the skin. Among the top results in the Southwest European and
Northeast European populations are GIMAP7 and GRIP1. GIMAP7 is a GTPase of immunity-
associated protein that plays a role in lymphocyte survival (Schwefel et al., 2013). GRIP1 is a
regulator of innate immune reaction via its role as a coactivator of IRF3 (interferon regulatory
factor 3) (Reily et al., 2005), and has been suggested to be a target of balancing selection in
European populations by Bitarello et al. (2018). LANCL2, significant in the Volga Uralic
population, has been implicated in the regulatory response of T cells and macrophages during
infection with H. pylori (Leber et al., 2016). RUNX1, in the top results of the South Asian
population, has been associated with the control of regulatory T cell function, predisposition
to autoimmune disease, and hematopoiesis and T cell development (Helms et al., 2003; Ono
et al., 2007; Taniuchi et al., 2002; Tokuhiro et al., 2003). KLRG1 is expressed on T cells and
NK cells, and has a negative regulatory effect on numbers of NK cells (Blaser et al., 1998;
Wang et al., 2013a). KLRG1 is in the top results in the West Siberian and Northeast Siberian
populations. LRRFIP2, in the top results in the Colla population, is an inhibitor of NLRP3
inflammasome activation, which has been associated with immune and inflammatory disease
(Jin et al., 2013; Wen et al., 2012).
Though a pigmentation-related gene and not an immune-related gene, OCA2 appears
here in the top results in the Volga Uralic population. It is also in the top di results of several





The preceding chapters outlining the results of positive and balancing selection analysis
results contain lots of information, including results for enrichment for different types of
immune genes and individual top SNPs and genes. From the results of these analyses, we
can learn about not only what types of genes have been under which type of selection, but
also about global distribution of selection signals and gain insight into the methods used in
this thesis. This discussion chapter will be organized around the themes set out at the end of
Chapter 1: methodology, population selection histories, and selection targets.
5.1 Methodology
This thesis project used the nSL, iHS, Tajima’s D, and di statistics to look for evidence of
positive selection and the HKA, b , and Tajima’s D statistics to look for evidence of balancing
selection. Because each of these statistics is designed to look for specific qualities in a region
of the genome (for example, long haplotypes or groups of variants at mid-range frequencies),
each will return a unique set of results that doesn’t fully overlap with the results of other
statistics. Therefore, results reflect a variety of time frames and selection scenarios. The
extent to which the different statistics gave overlapping results was varied.
The following questions posed at the end of Chapter 1 are discussed in this section:
• How much do the results of each of the selection tests overlap with each other?
• How can a relatively large, window-based signal of selection be narrowed down to an
individual variant potentially driving the signal?
• How are the results influenced by the choice of which immune genes to examine for
evidence of selection?
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5.1.1 Sharing of top windows between populations and tests
Positive selection
The different proportions of overlap between the three window-based statistics can be
seen in Table 5.1, and a subset of the gene overlaps between the di and the window-based
positive selection results can be seen in Table 5.11. In the window-based tests of selection,
the results of the nSL and iHS tests overlapped the most, and Tajima’s D overlapped less
with both. Table 5.1 shows that around twenty or thirty percent of top one percent windows
are usually shared between the nSL and iHS tests, which makes sense because both are based
on haplotype homozygosity tests. Despite the levels of sharing of windows between the nSL
and iHS tests, it is interesting to note that the two tests are different enough that they rarely
pick up the same enrichment signal. In future work it would be interesting to look into why
this is the case, since both are based on measurements of haplotype homozygosity and would
therefore be expected to return similar results. This is shown in Figures 3.1 and 3.3. For
the most part, less than ten percent of top one percent windows are shared between either
haplotype homozygosity test and the Tajima’s D test, except in the South Asian population.
It is not clear why this population is an outlier in this respect. The results of the di statistic
did overlap to a small extent with the window-based test results. These overlapping results
would be in regions that display extreme differentiation in a given population compared to
all other populations as well as score high in a given window-based test.
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Pop. nSL:iHS nSL:TD TD:iHS
AFR 0.352 0.024 0.04
WAA 0.336 0.056 0.136
SWE 0.304 0.048 0.128
ENE 0.392 0.08 0.096
VOL 0.224 0.064 0.136
SOA 0.368 0.12 0.16
WSI 0.16 0.048 0.072
SSI 0.248 0.024 0.096
CSI 0.2 0.056 0.056
NSI 0.24 0.024 0.048
COL 0.312 0.008 0.048
SEM 0.368 0.072 0.152
SEA 0.304 0.08 0.056
Average 0.293 0.054 0.094
Table 5.1 Proportions of top 1% windows shared between different tests per population
Table 5.2 shows the extent to which top one percent window are shared between popula-
tions. The Tajima’s D test shows much more sharing of windows, whereas the nSL and iHS
tests have many more windows that only appear in one population or are shared between a
small number. This fits with Tajima’s D being used to measure more ancient selection, since
sharing signals between multiple populations hints at that type of selection history. The nSL
and iHS tests are used to measure recent selection, so it makes sense that those signals would
appear in individual, local populations.
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Num. pops. Count (TD) Count (nSL) Count (iHS)
1 378 1001 832
2 112 192 189
3 65 43 65
4 52 8 23
5 35 8 8
6 24 2 6
7 15 1 1
8 11 1 2
9 5 0 2
10 3 0 0
11 3 0 1
12 0 1 0
13 0 0 0
Table 5.2 Counts of top 1% windows shared between populations. There were 12554 windows total
for each population.
Balancing selection
As in the results of the positive selection tests, each statistic used to search for signals
of balancing selection is designed to pick up a different type of signal. This means that
each statistic produced a unique set of results. Of the three different measures of balancing
selection used in this project, the HKA is the only commonly used measure of balancing
selection. b is fairly newly developed, and Tajima’s D is not often used to measure balancing
selection. Many of the top results from the HKA statistic also appear in the top results of
the b statistic, giving confidence in the results of the b statistic. These include HLA genes,
DEFB1, and others. The results of the combination of Tajima’s D and minor allele frequency,
on the other hand, hardly overlap at all with either the HKA or the b results. This, along with
the conspicuous absence of HLA genes in the top results of any population save the West and
Central African population, marks the results of this test as perhaps less reliable than those
of the other two. However, given the large difference in window size between the Tajima’s D
test and the others, it is likely that the test itself is not to blame for lack of reasonable results
but rather the way in which it was applied. The extent to which the top 50 genes in each
population overlapped in each of the three tests can be seen in Table 5.3. HKA and b results
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overlap much more often than either does with the Tajima’s D statistic (except in the case of
the West and Central African population), again marking its results as somewhat different
from those of the other two tests.
Population HKA:b HKA:Tajima’s D Tajima’s D:b
AFR 0.18 0.10 0.04
WAA 0.16 0.00 0.00
SWE 0.20 0.02 0.00
ENE 0.10 0.04 0.00
VOL 0.14 0.00 0.02
SOA 0.20 0.00 0.00
WSI 0.16 0.00 0.02
SSI 0.18 0.02 0.02
CSI 0.18 0.02 0.00
NSI 0.28 0.00 0.00
COL 0.24 0.00 0.02
SEM 0.20 0.04 0.02
SEA 0.16 0.00 0.02
Average 0.18 0.02 0.01
Table 5.3 Proportion of overlapping results between the top 50 genes in each population in each of
the three balancing selection tests
Table 5.4 shows the extent to which top 50 genes are shared between populations in each
of the balancing selection tests. The HKA test shows the most sharing of genes between
populations all the way up to all thirteen populations. The b test shows an intermediate
amount of sharing of top genes between populations, with very few genes shared between
more than half of the populations. This is surprising, since b is supposed to be optimized
to detect selection signals that predate the split of all modern populations. In that case, it
would be expected for there to be a very high number of top b signals shared between a high
number of populations. Finally, the combination of Tajima’s D and minor allele frequency
produced the least amount of sharing of top hits between populations, with a high number of
top hits found only in one population and no sharing at all above nine populations.
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Num. pops. Count (HKA) Count (b ) Count (Tajima’s D)
1 51 95 230
2 20 52 84
3 15 24 24
4 9 16 8
5 13 10 8
6 7 10 8
7 11 4 2
8 3 8 3
9 5 2 2
10 3 2 0
11 4 5 0
12 5 1 0
13 7 0 0
Table 5.4 Counts of top 50 genes shared between populations in the balancing selection tests.
Of these three statistics, only HKA is widely used as of yet to look for signatures of
balancing selection. It is interesting to note the extent to which the other two, relatively
untested, statistics pick up the same signals, and to compare them to HKA in terms of sharing
of signals between populations.
The relative proportion of what are considered to be top results (here, one percent) to the
rest of the genome is also an important consideration. For example, if a larger proportion
of top results was used (for example, five percent), it is possible that there would be more
sharing of top results between populations. Also, one limitation of using the top one percent
of results for either balancing or positive selection is that is assumes the same amount and
strength of each type of selection in each population, which is unlikely to be true. For future
work, it could be useful to instead use an empirical approach based on p-values alone instead.
A note on window size of Tajima’s D used in balancing selection
The use of a window size of 200 KB was far too large for this purpose. This window size
was used because the data existed in this form for the positive selection analysis, so it made
sense to see if it could be reused for this purpose. However, future analyses should use a
much smaller window if using Tajima’s D to look for balancing selection.
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5.1.2 Narrowing down positive selection signals from windows to driver
SNPs
This project used a number of filters to move from a 200 KB window which was
highlighted as a top positive selection hit to a single SNP potentially driving that signal. This
involved using the DIND statistic to look for derived alleles at high frequency linked with
low-diversity sites, followed by using CADD to filter for variants predicted to be functionally
important. The combination of these two filters was effective in producing a list of SNPs that
could be driving a signal of selection in a top-scoring window, however, there are several
limitations to this method that could also be addressed with future work. One of these is that
CADD has somewhat limited functionality in regulatory regions (Nishizaki and Boyle, 2017),
meaning that potential targets in regulatory regions may have been inappropriately filtered
out from the results. Perhaps a further study could focus on selection in regulatory regions,
and try to find tools optimized for scoring functional importance in those regions. Another
limitation is that the DIND statistic discarded any SNP with a derived allele frequency above
ninety percent, thus screening out any SNPs that are near fixation. It is possible that a
beneficial allele under selection could reach such high frequencies, and this work would
have missed those variants. Regarding the iHS and nSL analyses, DIND was applied to top
windows in order to find driver SNPs, however, iHS and nSL are both SNP-based statistics.
In future work, it would be more efficient to use the top SNPs from the iHS and nSL statistic
without converting the scores into windows. Finally, there are many genes that were in
the top one percent of window-based and di results that appeared in the descriptions of the
enrichment tables but were eventually screened out via the DIND and CADD results before
the final smaller list of results was compiled and would be interesting for further inquiry.
5.1.3 Gene lists
This project also highlights some caveats and lessons with regards to the selection of
gene lists used to highlight selection in certain phenotypes:
• Using gene lists that are small is not ideal for enrichment tests. Examples of gene lists
that are potentially too small for such tests in this project were the lists for adaptive
immune genes, genes associated with amoebozoa infections, and genes associated
with protozoa infections. While those classes of immune genes are certainly worth
examining, any signals of enrichment in those classes should be interpreted with
caution, since a statistically significant enrichment could consist of a single gene in the
top results.
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• The database from which gene lists are taken has a large effect on the composition of
those gene lists. For example, there were overlaps between the bacteria and virus lists
in the GO database and the HPI database. However, the enrichment tests results did not
always match between the two gene lists. This shows that the way gene lists are curated
can have a large effect on the results of a selection study like this. Based on literature
searches for top hits, inclusion in the GO database gene lists often accompanied a
clearer connection to immune function than did inclusion in the HPI database gene
lists. For this reason, the results of this thesis more often focused on interpretation
of those results, especially in the discussion of genes driving significant enrichment
signals. If a study were looking to capture as many genes as possible that have been
associated with a certain type of pathogen, using a gene list from the HPI DB might be
better.
• Not all genes associated with important immunological function will be included in
gene lists designed to cast a wide immune-based net, such as the DARC gene. On
the other hand, not all genes included even in a gene ontology list will have a clear
connection with immune function based on a literature search. Many genes involved
in immune function also have other important physiological roles. This means that top
scoring genes should be double checked to see if they do have immune function based
on the literature.
5.1.4 Enrichment tests and use of outlier approach
The use of Fisher’s Exact test to ascertain whether certain classes of genes are overrepre-
sented in top scoring windows and genes rests on the assumption that genes and windows
are evenly distributed throughout the genome. However, it is possible that top scoring genes
and/or windows are clustered together, causing enrichments to appear where there are none.
This method does not take this bias into account, and future work might address this issue by
using a different method (for example, the Gowinda package (Kofler and Schlotterer, 2012))
as well as ascertain whether gene clustering unfairly biased enrichment test results.
The use of the outlier approach to find potential targets of selection is also problematic
in some instances. It is especially useful to look for enrichment of certain gene classes in
the top results. However, it is not necessarily fair to assume that all results in the top one
percent of statistic scores are actually under selection, or that every population has the same
proportion of their genome (one percent) under positive and balancing selection. Issues
with this outlier approach are highlighted in the balancing selection results with the removal
of MHC genes. When these genes are removed from the analysis, the enrichment results
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in this section change significantly. This suggests that the outlier approach can limit how
informative results are.
5.2 Population selection histories
Examining the geographical distributions of private and shared selection signals between
different regions and statistics can shed light on the regional specificity or lack thereof of
selection pressures. In order to place the results of this thesis in context with previous
work with regards to the distribution of global and local selection signals, it is useful here
to compare the results from this thesis with the published results of studies which have
used similar methodology. An exploration of these distributions and their implications are
included in the following sections.
The following questions posed at the end of Chapter 1 are discussed in this section:
• What is the distribution of global and local signals in the results of each selection
statistic, and how do those compare to the results of previous studies?
• Is there evidence of more selective pressure on immune genes in populations living in
lower latitudes, where pathogen richness is greater?
5.2.1 Positive selection
A summary of the sharing of top selection signals between three commonly included
broad continental regions in positive selection studies (Africa, East Asia, and Europe) are
shown in Table 5.5 and are based on several previously published analyses (Frazer et al.,
2007; Voight et al., 2006b). This table shows that across studies and selection statistics, the
majority of top positive selection signals are private to each of the three continental groups.
The number of private signals per region are fairly equal between the three different regions.
There are a small number of shared signals between continental groups, and rarely a global
shared signal.
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Study Voight et al. (2006b) Frazer et al. (2007) Frazer et al. (2007)
Selection statistic iHS LRH iHS
Continental No. of signals No. of signals No. of signals
region (% of total signals) (% of total signals) (% of total signals)
A 243 (0.34) 37 (0.33) 26 (0.26)
EA 232 (0.32) 38 (0.34) 35 (0.35)
E 223 (0.31) 30 (0.27) 27 (0.27)
EA, A 4 (0.01) 2 (0.2) 3 (0.03)
E, A 6 (0.01) 2 (0.2) 1 (0.01)
E, EA 9 (0.01) 2 (0.2) 5 (0.05)
A, EA, E 0 (0) 1 (0.1) 3 (0.03)
Total top signals 717 112 100
Table 5.5 Sharing of top signals between geographic groups in previous whole-genome, multi-regional
positive selection studies. Abbreviations: "A" = Africa, "EA" = East Asia, "E" = Europe.
Both analyses are based on Yoruba (YRI), north and western European origin (CEU), and
Han Chinese and Japanese (CHB + JPT) populations.
Table 5.6 shows the results from analyses in this thesis, and is designed to be as directly
comparable to the results from previous studies, as shown in Table 5.5, as possible. Therefore,
the same three continental regions are represented. The African continental region is repre-
sented by the West and Central African population, the European region by the Southwest
European population, and the East Asian region by the Mainland East Asian population.
Similarly to the distribution shown in Table 5.5, most of the top signals are specific to one
continental region in particular, with some shared between two continental regions and very
few appearing in all three. However, the Tajima’s D results show slightly different patterns
from the other two tests. Both the nSL and iHS results, like the results summarized in Table
5.5, show very similar numbers of private top selection hits. However, the Tajima’s D results
show more private results in the African continental region compared to the other two regions.
Also, results for non-African signals shared between Europe and East Asia contain several
times more signals than those of the nSL or iHS tests. This could reflect that the Tajima’s D
statistic detects older signals of selection than the nLS or iHS tests.
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Statistic nSL iHS Tajima’s D
Continental No. of top wins. No. of top wins. No. of top wins.
region (% of total top wins.) (% of total top wins.) (% of total top wins.)
A 119 (0.32) 107 (0.29) 106 (0.28)
E 116 (0.31) 110 (0.29) 86 (0.23)
EA 115 (0.31) 109 (0.29) 89 (0.24)
A, E 2 (0.01) 7 (0.02) 9 (0.02)
A, EA 3 (0.01) 8 (0.02) 6 (0.02)
E, EA 6 (0.02) 5 (0.01) 26 (0.07)
A, E, EA 1 (0.01) 3 (0.01) 4 (0.01)
Total top wins. 375 375 375
Table 5.6 The distribution of private and shared top positive selection results. Continental populations
were used to make this table as comparable to those based on previously published results
as possible. Abbreviations: "A" = Africa, "EA" = East Asia, "E" = Europe. The African
continental region is here represented by the West and Central African population, the
European region by the Southwest European population, and the East Asian region by the
Mainland Southeast Asian population. Total top windows here include only top widows
from the AFR, SWE, and SEM populations.
When comparing the overlap of top signals between the studies represented in Table
5.5 to the analogous distribution of signals in the results of the analyses in this thesis (5.6),
there was a small amount of overlap between the two. One reason for this may be that
the analyses are based on different populations. The populations (AFR, SWE, SEM) used
for comparison, while the closest matches in the EGDP dataset to those used in above the
previously published analyses, do not match perfectly with the YRI (Yoruba in Ibadan,
Nigeria), CHB (Han Chinese in Beijing, China) + JPT (Japanese in Tokyo, Japan), and
CEU (Utah Residents (CEPH) with Northern and Western European Ancestry) HapMap
populations used in the Voight et al. (2006b) and Frazer et al. (2007) analyses. Therefore, the
comparison between Tables 5.5 and 5.6 is potentially most useful in looking at the relative
quantitative distribution of signals between continental regions, instead of looking at overlap
of specific top selection hits.
There were no overlaps of significant, globally shared windows between the analyses
represented by these two tables. In the Frazer et al. (2007) study shown in Table 5.5, all
three global signals (one is significant in both the iHS and the LRH tests) are all in non-genic
regions. Genes in the three global windows in the iHS analysis from this thesis are NDUFB3,
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ORC2, CFLAR, and FAM126B; VPS13B; and PIH1D2, SDHD, C11orf57, TIMM8B, DLAT,
and DIXDC1. Genes from the one significant global window in the nSL analysis are CROCC,
FAM231A, and FAM231C. Genes from the four significant global windows in the Tajima’s
D results are PHKB and ITFG1; and DACH1. None of these genes were highlighted in the
results or discussion of this thesis as being especially relevant in immune function.
When discussing global distribution of shared and local selection signals, it is also
interesting to look at signals that are specific to the African continental regions compared to
potential "Out-of-Africa" (OOA) signals–those found in non-African regions and not found
in African regions. As is clear from Tables 5.5 and 5.6, there are many more top signals that
are specific to the African continental region than those shared between European and East
Asian populations. Of signals specific to the African continental region, six 200 KB windows
from this thesis overlap with top regions in the Frazer et al. (2007) analysis, and the only
gene represented in those windows is TMEFF2. One 200 KB window overlaps with a top
window in the Voight et al. (2006b) analysis, containing the gene TNKS.
OOA signal overlaps between the results from this thesis and the Frazer et al. (2007)
analysis are sparse. One window, in the top results of both the nSL and iSH tests, overlaps
with a top hit in the Frazer et al. (2007) analysis, but this region is non-genic. There are
no overlaps in OOA signals between the Voight et al. (2006b) analysis and the results of
this thesis. The most recognizable OOA signal from the results of the analyses in this thesis
is the window containing EDAR. As noted in Chapter 1, the grouping of West and Central
Africa into one population could have diluted real signals that are present in either population,
and could account for the lack of overlapping results with other studies. Additionally,
differentiation between populations could look like a false signal of balancing selection.
Other continental-specific overlaps are well-known selection hits as well, especially in the
European continental region. In the European continental region, LCT and the surrounding
region appear both in the top results of this thesis and of the Voight et al. (2006b) analysis, as
well as TYRP1 (Wilde et al., 2014). Both of these genes also appear in the top results of the
Frazer et al. (2007) analysis.
5.2.2 Balancing selection
Similarly to the positive selection above, Table 5.7 provides a set of selection signal
distributions with which to compare the results from this thesis. The studies represented in
the table below are both whole-genome scans for balancing selection, as are the analyses
performed in this thesis (Andres et al., 2009; Bitarello et al., 2018). Both of these studies
looked at two main broad continental regions of ancestry: Africa and Europe. Table 5.7 shows
different relative distributions of top signals between the two studies. The Bitarello et al.
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(2018) study shows relatively even numbers of signals between the African and European
populations, with the largest number of signals being shared between the two populations.
Conversely, the Andres et al. (2009) paper shows the most top signals in the European
American population.
Study Bitarello et al. (2018) Andres et al. (2009)
Selection statistic NCD2 HKA + MWU
Continental No. of outlier wins. No. of extreme genes
region (% of total outlier wins.) Population (% of total extreme genes)
A 79 (0.29) AA 15 (0.25)
E 84 (0.31) EA 32 (0.53)
A, E 102 (0.38) AA, EA 13 (0.21)
Total signals 265 60
Table 5.7 Sharing of top signals between geographic groups in two previous whole-genome, multi-
regional balancing selection studies. Abbreviations: "A" = Africa, "E" = Europe, "AA" =
African American and "EA" = European American.. Populations making up the African
population in the Bitarello et al. (2018) paper are LWK (Luhya in Webuye, Kenya) and
YRI (Yoruba in Ibadan, Nigeria), and those making up the European population are TSI
(Toscani in Italia) and GBR (British in England and Scotland) 1000 Genome populations.
Table 5.8 shows the distribution of private and shared signals between broad continental
regions based on the top 50 gene results for each of the balancing selection statistics in this
thesis. It includes the East Asian region as well for ease of comparison with positive selection
results. Each of the statistics shows a somewhat different distribution of signals between
the three continental regions, though in each statistic the majority of signals are local to one
region. The HKA results have the most shared signals, with a relatively high number of
global signals. The b results have relatively fewer shared signals, though still more than the
Tajima’s D results, which show no globally shared signals.
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Statistic HKA b Tajima’s D
Continental No. of top wins. No. of top wins. No. of top wins.
region (% of total top wins.) (% of total top wins.) (% of total top wins.)
A 22 (0.14) 32 (0.21) 42 (0.28)
E 23 (0.15) 31 (0.20) 36 (0.24)
EA 16 (0.01) 28 (0.18) 37 (0.22)
A, E 4 (0.02) 5 (0.03) 4 (0.02)
A, EA 11 (0.07) 8 (0.05) 3 (0.02)
E, EA 10 (0.06) 9 (0.06) 9 (0.06)
A, E, EA 13 (0.08) 5 (0.03) 0 (0)
Total top wins. 150 150 150
Table 5.8 The distribution of private and shared top balancing selection results from this thesis.
Abbreviations: "A" = Africa, "EA" = East Asia, "E" = Europe. The African continental
region is here represented by the West and Central African population, the European
region by the Southwest European population, and the East Asian region by the Mainland
Southeast Asian population. Total top windows here include only top widows from these
three populations.
There were a relatively high number of top signals from the Andres et al. (2009) and
Bitarello et al. (2018) studies that also appeared in the top results of the HKA, b and Tajima’s
D balancing selection results. However, the distribution of sharing between populations and
the populations in which a signal was significant did not often match.
Genes appearing in all three global regions in the HKA results were HLA-G, HLA-
A, CDSN, TRIML1, HLA-B, PSORS1C1, ZNF766, MUC22, IGFBP7, CSMD1, RBFOX1,
KRT40, and CLDN16. In the b results, globally shared gene signals were DEFB1, SMPDL3A,
TESPA1, PSMG4, and CSMD1. Several of these signals did appear as top hits in both the
European and African populations in the Bitarello et al. (2018) analysis: HLA-B, HLA-G,
CDSN, PSORS1C1, RBFOX1, and CSMD1.
Examining the sharing of balancing selection signals between continental regions high-
lights the utility of using multiple statistics for whole-genome scans. Several signals that
appear to be either African-only or non-African only in one statistic are proved not to be
by the results of another statistic. For example, based on the West and Central African,
Southwest European, and Mainland Southeast Asian results of the HKA test, DEFB1 appears
to be an African-only signal. However, it appears in all three of those populations in the b
results. TESPA1 appears to be a non-African only signal based on the HKA results, but it
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is a global signal in the b results. This suggests that signal sharing is likely more common
than the results for each individual statistic as shown in Table 5.8 would suggest. Because of
this, it is somewhat complex to say which signals are specific to a single region or shared
between multiple regions, because the geographical distributions of signals rarely are similar
between the different statistics. It should be noted that these sorts of comparisons depend on
the somewhat arbitrary nature of choosing the cutoff percentage for top hits and non-top hits.
Therefore, a gene that doesn’t appear in the top results in one test may be outside, though
near, the cutoff–therefore just because a gene is not significant in one population does not
mean it is unique as a selection hit to another.
5.2.3 Comparison of distribution of selection signal sharing between
positive and balancing selection results
The comparison of the distributions of sharing signals in Tables 5.6 and 5.8 highlights
two points. First, in both types of selection, the majority of signals are local to the three
continental regions. This suggests very broadly that the majority of adaptations potentially
represented by these signals are relatively local adaptations. Second, the balancing selection
signals, at least in the HKA and b results, are more highly shared in general than any of
the positive selection signals. This could suggest similar selection pressures acting on
widely geographically separated populations, or, more parsimoniously, older shared signals
of selection that predate population splits into the populations we see today.
Note:
A graphical summary for each population of all significant enrichment signals from each
selection statistic can be found in Appendix D.
5.2.4 Pathogen-driven selection and latitude
In order to address the question of whether populations at lower latitudes experienced
more pathogen-driven selection, we can look to see whether the selection patterns of those
populations appear to be different from those of populations at higher latitudes. The pop-
ulations at the lowest latitudes are the West and Central African, South Asian, Mainland
Southeast Asian, and Island Southeast Asian populations (please refer to Figure 1.6 for a
map). The Northeast European and Northeast Siberian populations are high latitude popu-
lations for contrast. When comparing the enrichment results for these populations, neither
set appears to have a defining set of characteristics, or have more total enrichments than
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the others (for an overview of the total significant selection enrichments in every test in
these populations, please see the tables corresponding to these populations in Appendix D).
Therefore, based on the results of this thesis, no evidence for more pathogen-driven selection
at lower latitudes was found. However, it should be noted that this approach focuses on the
number of significant enrichments in immune gene categories, and not the magnitude of
the selection. For example, one population may have experienced strong selection in only
one immune gene category, whereas another might show weak selection signals in multiple
gene categories. It is possible that future work focusing on this question might go about
it another way and find a clear differentiation. However, tying pathogen concentration to
latitude is complicated, since the richness of pathogen species is more closely correlated with
variation of precipitation around the mean, according to Guernier et al. (2004). The authors
suggest that disease dynamics are affected by not only the pathogen, but by any vectors and
other hosts, complicating the picture further, and that additionally, this type of environmental
prediction applies largely to pathogens with an external phase of the lifecycle, which are
likely to be parasites. Many evolutionarily important pathogens lack an external phase of
their lifecycle, and so are less influenced by the environment (Guernier et al., 2004).
Several other studies by Fumagalli et al., have examined the relationship between
pathogen richness, selection, and geography, but have not found any correlation between
variants under selection and latitude (Fumagalli et al., 2009a, 2010, 2009b, 2011).
5.3 Targets of selection
Past selection on genes and variants associated with disease resistance and the immune
response helped populations survive their epidemiological environments and are still rel-
evant today. In instances where disease pressures remain constant (for example, malaria
in regions where it is endemic) these adaptations can still be beneficial. In other instances
where the prevalence of selection-causing epidemics can be controlled with vaccines and
other interventions, a more immediate effect of past adaptations can be their influence on
inflammatory and autoimmune disease. Either way, looking for past adaptations can help us
to better understand modern disease and find new variants that can shed more light on our
complex immunological relationship with our environment. This can include finding host
pathways important in infections and screening findings of other studies (review by Heyer
and Quintana-Murci (2009)). Including diverse populations in future selection studies will
be important in order to capture variants that could otherwise be missed and to build a more
complete picture of human adaptation.
The following questions posed at the end of Chapter 1 are discussed in this section:
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• Do different classes of immune genes show different selection histories (positive vs.
balancing vs. none)?
• Do different classes of immune genes show different ages of selective pressure (ancient
vs. recent)?
• What are some of the most striking targets of positive and balancing selection?
5.3.1 Discussion of targets of positive selection
Positive selection has shaped much of the human genome, and immune-related genes
are often among the top hits in selection studies. However, there is a need for such results
from populations that have not often been included in these studies. This thesis gave positive
selection results for some populations that have been included previously, and some that
have not, shedding new light on how pathogens and disease have shaped positive selection in
human populations.
The synthesis of the results of the nSL, iHS, Tajima’s D, and di tests allows broad conclu-
sions to be drawn about the signatures of positive selection left in the thirteen populations
included in this study. First, it is useful to compare the extent of positive selection on
immune-related genes to that of genes in other functional categories. In the Supplementary
Materials of Pagani et al. (2016), which included the same populations as this thesis (save the
Colla), six different functional categories were considered for enrichment in top selection sig-
nals: pigmentation, thermoregulation, fatty acid metabolism, vasoconstriction/vasodilation,
bacterial genes, and innate immune genes. The proportions of significant enrichments to
non-significant enrichments based on the results of those enrichment analyses are 0.027,
0.083, 0.083, 0, 0.027, and 0.055, respectively. Based on these results, the two immune gene
categories are neither the categories with the most enrichments nor the fewest. This suggests
that immune genes are an important part of the results of those analyses, but not necessarily
the most significant category of genes.
Table 5.9 shows how the results of each of the three window-based positive selection
enrichment test results overlap. It shows that in most gene categories there is significant
enrichment in many populations in at least one test. However, there are many fewer categories
with significant enrichment in more than one test. Only several categories show significant
enrichment in all three tests, such as the GO.Virus category in the Colla population and the
antigen processing and presentation category in the Southwest European population. The
HP.Bact category shows the most agreement between selection tests. Significant enrichment
in multiple tests may be less likely to be a false positive result and potentially indicates real
enrichment for positive selection in a given category of immune genes and population.
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Table 5.9 Overlap of window-based positive selection enrichment test results. Pale orange shows
significant enrichment in one test, medium orange in two tests, and maroon in all three
tests.
The enrichment results can also be used to examine time frames of potential past selec-
tion categories at low resolution, since the Tajima’s D statistic finds selection signals that
are relatively ancient (older than 50,000 years) compared to those found by the iHS and
nSL statistics (younger than 30,000 years) (Grossman et al., 2013). Table 5.10 shows the
division between statistics that find relatively ancient (Tajima’s D) versus relatively positive
selection signals (nSL and iHS), with grey columns representing ancient and white columns
representing recent selection. Some gene categories show a difference in the number of
significant enrichments between these two categories. For example, GO.Bact shows more
ancient significant enrichments than recent ones. GO.Tcell, GO.Bcell, GO.Adapt., and
HP.Virus show more recent significant enrichments than ancient ones. Other categories show
similar numbers of enrichments between the two time frames.
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Table 5.10 Ancient versus recent positive selection enrichment results. Ancient signals are represented
by the grey columns and shows Tajima’s D results. Recent signals are represented by
white columns, and shows nSL and iHS results. An "x" signifies significant enrichment in
that category.
The genes driving significant enrichment signals, seen in Tables 3.2, 3.4, 3.6, and 3.23,
show that while genes driving significant enrichment signals are sometimes shared between
populations, more often enrichment signals in an immune gene category are driven by
different genes in each population. This suggests population-specific adaptations to particular
environments, rather than shared adaptations either through common ancestry or convergent
evolution. It may also be suggestive of polygenic adaptation, in that a number of genes,
varying between populations, contribute to overall adaptation in a certain category. Because
of this, future work might look more explicitly for evidence of polygenic selection in this
dataset as it likely plays an important role in adaptation in the immune system.
A number of the genes that emerged as top selection targets in this study have been
previously found to be top targets in other studies, though not always in the same populations.
These include EDAR (Sabeti et al., 2007), ITGAE (The International HapMap Consortium,
2005), IL1A (Tang et al., 2007), IL4 (Rockman et al., 2003), CXCR4 (Tang et al., 2007),
ARPC1B (Kimura et al., 2007), RAG1 (Kelley, 2006), CD5 (Carnero-Montoro et al., 2011),
DUOX2 (Kelley, 2006), ITGAL (Kimura et al., 2007), and MSR1 (Kimura et al., 2007).
It is important to note here that references to malaria, a very strong selection pressure
throughout human history, have been largely absent from results of this thesis. Even the
HPI database list of genes associated with protozoa infections in humans was very short.
This is surprising. It is highly likely that malaria’s selective pressure is represented in the
results of this thesis, but not classified as such because of the lack of enrichment in the genes
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classified as interacting with that particular pathogen. However, there are several references
to individual genes associated with malaria in both the positive and balancing selection
results.
Summary of top SNP results for further study from window-based selection tests
The population-specific SNP tables in the window-based selection results contain a large
number of genes, many of which have interesting immune function. However, many of the
genes that appeared in the top one percent enrichment tables did not pass through the DIND
and CADD filters into the individual top SNP results. This may be for several reasons. DIND
discards SNPs with frequencies below forty percent and above ninety percent. Therefore,
any SNPs at very high frequency or relatively low frequency will have been filtered out by
this statistic. Additionally, the CADD filtering step likely filtered out some regulatory SNPs,
since it has been shown to underperform on scoring regulatory variants (Gulko et al., 2015).
Finally, a top window signal could have been driven by a SNP in a different, non-immune
gene, or by demography and for this reason did not pass through the DIND filter.
Of the SNPs that did make it through the filters, several appear particularly interesting for
further study based on derived allele frequency, CADD score, VEP consequence, absence or
relative absence from previous selection studies, and immune function based on the literature.
These SNPs are in the following genes:
• IL27 in the Northeast Siberian population: This gene is of further interest for
several reasons. It appears as a significant target of positive selection in a population
that has seldom been included in genetic studies, and based on the results of a literature
search this gene has not previously been reported to have been under selection in any
human population. Finally, it has an important role in immune response to infection
by a range of pathogenic organisms, a number of which that have had the potential to
significantly shape human populations (for example, hepatitis C and influenza A). It
also plays a role in modern inflammatory diseases such as asthma and inflammatory
bowel disease. These associations point to IL27 being a prime candidate for a gene
that was target of past selection driven by infectious disease that has modern health
implications relating to inflammatory or autoimmune disease. This SNP, rs181206,
is at middling frequency in all European and Siberian populations, as well as in the
Colla and South Asian populations, and is at relatively low frequency in the Mainland
Southeast Asian and Island Southeast Asian populations.
• MAGI3 in the West and Central African population: Because of its involvement in
intestinal immunity and inflammation, MAGI3 would make an interesting target for
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further investigation. Based on a literature search, rs7543189, the SNP highlighted in
the West and Central African population table above, has not been associated with any
particular disease.
• MAST2 in the West Asia and Armenian population: Despite middling allele fre-
quencies across most populations, MAST2 would be an interesting gene for follow up
study because of its role in TLR signaling and immune response to infection, as well
as its role in inflammatory disease such as Crohn’s disease and rheumatoid arthritis.
Based on a literature search, it is unclear what role the missense SNP rs1707336 plays
in an infection. Because of similar allele frequencies across populations, it is likely
that this particular SNP doesn’t confer a region-specific benefit.
• CEP63 in the South Siberian and Mongolian population: Because rs1127826 is
a stop gain mutation, and because the derived allele frequency is relatively low in
most populations and relatively high in only the South Siberia and Mongolian, Cen-
tral Siberian, Northeast Siberian, and Colla populations, as well as its role in viral
infections, CEP63 and rs1127826 would be good candidates for further study.
• SYLT3 in the Colla population: SYTL3 is an interesting candidate for follow-up
study because of its role in the movement of lytic granules to the immune synapse and
its relatively high frequencies in Siberian, Asian, and Colla populations compared to
other populations. The missense SNP represented here, rs901363, does not have any
associations with disease at this time based on a literature search.
• SLC15A2 in the Southeast Asia Mainland population: Because of the role of
SLC15A2 in the immune response to bacteria, especially airborne infections, this
gene would make an interesting candidate for further study. It shows particularly high
derived allele frequency in the Mainland Southeast Asian population and relatively
low to middling derived allele frequencies in all other populations. rs2257212, the
missense SNP, has been studied as a drug ADME (absorption, distribution, metabolism,
excretion) SNP (Li et al., 2010a). Polymorphisms in this SNP are predicted to have a
potential effect on drug action (Pinsonneault, 2004).
Summary of top results for further study from di test
Immune genes are well-represented in the top 50 genes in each population in the di results,
not to mention in the results from the enrichment analysis. There are many immune-related,
potentially interesting genes to choose from for future work. Perhaps the most straightforward
way to narrow down this impractically long list of genes is to look for genes which appear in
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the top selection results of window-based tests as well, and which appear from the literature
to have relevant immune functions. These are shown in Table 5.11:
Test Gene Pop. Immune Category
nSL, iHS IL4 SWE GO.Bcell
nSL, iHS ADRBK1 COL GO.Innate
nSL, iHS RPS6KB2 COL GO.Innate
nSL KARS SEM GO.Virus
nSL NRG1 SSI GO.Innate
nSL TAB1 SSI GO.Innate
nSL KIF3C SSI GO.APP
nSL HLA-F SEA GO.APP
iHS RPL6 SEM GO.Virus
iHS PTPN11 SEM GO.Tcell
iHS PDCD6IP WSI GO.Virus
iHS PSMB2 MIE GO.APP
iHS TYRO3 COL GO.Innate
Table 5.11 Gene overlaps between top results of window-based selection tests and top di results with
relevant immune function based on a literature search
Of the genes above, several are especially interesting for follow-up study, based on their
clear involvement in immune functions. These are:
• ADRBK1 in the Colla population: As referenced in the Colla di results, ADRBK1
is induced by TLR2 activation and is associated with downregulation of chemokine
receptors, resulting in impaired neutrophil recruitment and more severe sepsis in a
mouse model. Based on this downregulation, this gene appears to have an important
role in the balance of an immune reaction between being strong enough and not too
strong.
• HLA-F in the Island Southeast Asian population: As mentioned above, HLA-F is
involved in antigen presentation, as well as surveillance of stressed cells by the innate
immune system. Based on a literature search, there are few known associations with
susceptibility to either infectious or inflammatory disease associated with this gene.
• TYRO3 in the Colla population: As described in the iHS enrichment section, TYRO3
is an immunoregulatory receptor tyrosine kinase that is important for preventing
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autoimmunity in mice. TYRO3 also plays an inhibitory role in type 2 immunity,
helping to control the magnitude of the immune reaction. It has been suggested as a
drug target–for example, blocking TYRO3 could lead to improved helminth expulsion,
or activating TYRO3 could lessen allergic response (Chan et al., 2016).
The genes listed above are very few compared to those in the top one percent results per
population, including those highlighted in the description of the enrichment table. Again,
there are too many there to practically follow up on, but very likely at least some of those
are worthy of further study as well. For example, a number of complement genes were
represented in those results, and it would be interesting to further investigate extreme
differentiation in those genes between populations.
Future work on positive selection targets
Future work could focus on the genes listed in the above sections on the top hits from
the window-based and di results. The most straightforward results to follow up on would be
specific SNPs, such as those stemming from the DIND analysis, since those can more easily
be studied than an entire gene. However, since the di analysis was originally performed on
SNPs, it would be fairly straightforward to select SNPs with high scores from that analysis
for further research. There are two main types of future work stemming from these SNPs that
would be interesting to pursue. The first is to ascertain whether any of the most promising
SNPs from the analyses in this chapter are associated with immune phenotypes through
genome-wide association studies. If there are significant associations between a SNP and
an immune phenotype, it would give credence to the idea of that SNP having evolutionary
importance in that phenotype. The other type of analysis to pursue would be functional
analysis to find out what effect, if any, any of the SNPs chosen for further study have on a
given protein and downstream phenotypes. This could take the shape of computer-based
protein structure modeling or studies in model organisms.
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5.3.2 Discussion of targets of balancing selection
Table 5.12 Overlap of significant balancing selection enrichment signals. Pale orange shows one
significant enrichment, medium shows two, and dark orange shows significant enrichments
in all three statistics.
Table 5.12 shows which classes of immune gene appear to be most targeted by balancing
selection. Every single population is significantly enriched in at least one, and often two or
even three, selection tests in the categories of T cell and antigen processing and presentation
genes. These are likely driven by the very strong representation of HLA genes in the results.
In particular, the West and Central African population is enriched in both of these categories
in all three tests. These categories make sense as targets of balancing selection, since diversity
in antigen processing and presentation cells allows for the immune system to mount an attack
against a wider range of pathogens. There are several immune gene categories, such as
GO.Bact, GO.Virus, and GO.Innate, that show varied levels of enrichment among populations
instead of the unanimous enrichment in the GO.Tcell and APP categories. This may suggest
that evolutionary pressures causing balancing selection act less often or strongly on these
categories of genes. There is a notable absence of enrichments in the gene classes defined by
the HPIDB. It is not clear why this is the case.
Enrichment tests were completed for each balancing selection statistic with and without
the inclusion of MHC genes. The overlap of significant enrichment signals excluding MHC
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genes can be seen in Table 5.13. Just as the enrichment signals for individual statistics were
different when the MHC was excluded, the pattern of significant enrichments looks different
in this table than it does in Table 5.12.
Table 5.13 Overlap of significant balancing selection enrichment signals, not including genes in the
MHC. Pale orange shows one significant enrichment, medium shows two, and dark orange
shows significant enrichments in all three statistics.
Most glaringly, all but one of the enrichment signals in the antigen processing and
presentation category have disappeared. This is a category that was enriched in every single
population in at least one test with the inclusion of MHC genes, showing the importance of
those genes in the balancing selection results. The enrichments in the genes associated with
T cell function have largely remained, as have those in the GO.Bact category. There are in
fact more significant enrichments in the GO.Innate category when MHC genes are excluded
from the analysis.
In general, many of the top gene results in each of the three selection tests were shared
between populations to a large degree. This is also reflected in some gene classes in the
enrichment results summarized in Table 5.12. This sharing of signals could either reflect
similar selection pressures in all populations, ancient signals in ancestral groups that then
split into the modern groups seen here, or some combination of both phenomena. Certainly
with the ideal timeframe given by the authors of the b statistic, the results of that test may
well suggest selection on a population that predates splits into modern continental groups. It
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is most parsimonious to assume that signals shared between a large number of populations,
especially populations that are separated by large geographical distances, are those that
predate the split of those populations. Signals shared by a small number of populations that
are geographically near may reflect a more localized selection pressure.
Several of the top results from this study confirm previous findings from other studies.
Among these are HLA-B (Andres et al., 2009), DEFB1 (Cagliani et al., 2008), TLR6 (Ferrer-
Admetlla et al., 2008), CDSN (Andres et al., 2009), and LGALS8 (Andres et al., 2009). A
fair number of genes in the top results of this study appear not to have been previously found
as targets of balancing selection, and may be interesting for future inspection. Several of
these are listed below:
• PGLYRP4: PGLYRP4 was in the top one percent of results for both the HKA test (in
all populations but West and Central Africa) as well as in the b test (in all populations
save West and Central Africa, Colla, Mainland Southeast Asia, and Island Southeast
Asia). PGLYRP4 is a peptidoglycan recognition protein that is expressed in the skin,
mucous membranes, the mouth, and the gastrointestinal tract (see review by Dziarski
and Gupta (2010)). It has a bactericidal response against both Gram-negative and
Gram-positive bacteria (Lu et al., 2005). Given the wide range of populations in which
this gene was a top balancing selection target, it is likely that this gene was under
selection in ancestral populations in response to pressure from bacterial infections.
• PGLYRP2: PGLYRP2 was in the enrichment results for the West and Central African
population in the Tajima’s D test, though not in the top 50 genes for that population or
any other. It was also not in the top one percent of results for any population in the
HKA or the b test. It is an amidase that digests peptidoglycan (Gelius et al., 2003). It is
constitutively expressed in the liver (Liu et al., 2001), but is expressed in keratinocytes
and corneal epithelial cells upon their exposure to both Gram-positive and -negative
bacteria, as well as cytokines. It is thought that the digestion of peptidoglycan could
lead either to reduction of the proinflammatory nature of peptidoglycan, via PGLYRP2
acting as a scavenger for this molecule, or to enhanced antimicrobial defense (Wang
et al., 2005). Despite its similar name to the gene above, PGLYRP2 is located on
chromosome 19, whereas PGLYRP4 is located on chromosome 1.
• GNLY: GNLY, or granulysin, was in the enriched GO.Bact results for the b statistic
in the Island Southeast Asian population and was in the top 50 results for the b
statistic in the West Siberian population. It is not in the top one percent of results
for any population in the HKA test. GNLY releases bactericidal granzymes into the
cytoplasm of infected cells (Walch et al., 2014), and has been suggested as a measure
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of overall cellular immunity (Ogawa et al., 2003). In one study, individuals with latent
tuberculosis had lower levels of serum granulysin than healthy individuals (Thuong
et al., 2016).
• DMBT1: DMBT1 was in the top 50 results in the South Asian, South Siberia and
Mongolian, Central Siberian, Northeast Siberian, and Mainland Southeast Asian
populations in the HKA test, and was in the top one percent of results in the Volga
Uralic, West Siberian, Colla, and Island Southeast Asian population in the HKA test. It
was in the top 50 results of the Southwest European, Northeast European, Volga Uralic,
South Asian, West Siberian, South Siberia and Mongolian, Central Siberian, Northeast
Siberian, Colla, Mainland Southeast Asian, and Island Southeast Asian populations in
the b results, and in the top one percent of results for all other populations. DMBT1 is
involved in the mucosal innate immune response via sensitivity to bacterial cell wall
antigens. In the intestinal epithelia, which is an important tissue in terms of being an
immunological barrier to pathogenic organisms, DMBT1 expression is upregulated
upon exposure to LPS and may be implicated in Crohn’s disease (Rosenstiel et al.,
2007). There are two other variants of DMBT1. DMBT1gp340 is the variant of DMBT1
involved in respiratory defense and DMBT1SAG, or salivary agglutinin, is the variant
involved in oral defense (Ligtenberg et al., 2001). DMBT1SAG binds a variety of
bacteria, including Staphylococcus aureus, E. coli, and H. pylori (Bikker et al., 2002).
DMBT1 copy number is correlated with population history of agriculture, via increase
in dietary carbohydrates and the associated dental carie-causing bacteria Streptococcus
mutans (Polley et al., 2015). This gene also plays a role in epithelial differentiation
(Mollenhauer et al., 2000).
• TLR2: TLR2 is in the enrichment results for the Tajima’s D test in the Volga Uralic
population. It did not appear in the top one percent of results in any population in
either the HKA or the b results. TLR2 is a Toll-like receptor that can recognizes a
broad range of pathogenic organisms including Gram-positive and -negative bacteria,
mycobacteria, spirochetes, trypanosomes, fungi, and more (see review by Takeda et al.
(2003)). TLR2 has been associated with susceptibility to tuberculosis (Ogus et al.,
2004).
The individual genes listed above are potential new contributions to the field of knowledge
of immune genes that have been under balancing selection in humans. All are involved
in not only the immune response but also have been implicated in various inflammatory
diseases. These dual associations highlight the delicate balance that must be struck by
the immune system in terms of when and how much of a response to mount. This theme
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also applies to appropriate calibration of an immune response during an infection–if the
immune system gives too small a response, the infection won’t be cleared, but if it gives
an overreaction, it leads to damage to the host. One of the conditions that came up many
times in the literature search in association with top balancing selection hits was sepsis. This
is a condition in which the inflammation caused by the immune system to clear a bacterial
infection becomes dysregulated and causes tissue damage and can lead to death (Cohen,
2002; Thimmulappa, 2006). Not all of the host factors involved in the development of this
condition are understood (Cohen, 2002; Thimmulappa, 2006). It is possible that studies
such as this one, based on finding immune genes that appear to have been evolutionarily
important in response to infection, could be helpful in further elucidating the mechanisms of
such conditions that rely on appropriate balance of inflammation and tolerance. Since sepsis
and other inflammatory/autoimmune diseases were strongly associated with the top results
from the three selection tests used in this project, in future it could be interesting to assemble
a gene list for a set of conditions of interest (such as sepsis and inflammatory disease) and
look for evidence of stronger balancing selection on the set of genes as whole compared to
sets of genes associated with conditions/diseases of other etiology.
5.3.3 Comparison of targets of positive versus balancing selection
We can look at Tables 5.9, 5.12, and 5.13 to compare overall enrichments in different
gene categories. Perhaps the most striking difference between enrichments in positive
and balancing selection are those in the GO.Virus category. There are many significant
enrichments in this category in the positive selection results, but far fewer in the balancing
selection results. This is in contrast to the GO.Bact category, which is significantly enriched
in the results of both types of selection. This suggests that both single variants and diversity
at a locus have been adaptive in defense against bacterial pathogens, but that single adaptive
variants have been more under selection due to pressure from viral infections.
Another significant difference between the enrichments results of the positive and bal-
ancing selection results are those in the antigen processing and presentation category. In the
positive selection results, there are enrichments in the West and Central African, West Asia
and Armenian, and Southwest European populations, but most of the populations in the rest
of the Eurasian continent show no enrichment. On the other hand, in the balancing selection
results that include MHC genes (Table 5.12), every single population is significantly enriched
for genes in this category. As Table 5.13 shows, these enrichments are almost completely
driven by genes in the MHC. These results are suggestive of the significance of this class of
immune genes as targets of balancing selection.
5.3 Targets of selection 159
Some temporal patterns of selection between the different gene categories can also been
seen from the enrichment results. In the positive selection results (see Table 5.10), using
Tajima’s D as a measure of ancient selection and nSL and iHS as a measure of recent
selection, the GO.Bact category shows more ancient significant enrichments than recent ones.
The GO.Tcell, GO.Bcell, GO.Adapt., and HP.Virus categories show more recent significant
enrichments than ancient ones. Using b as a measure of extremely ancient selection, again
the GO.Bact category is enriched in 12 of 13 populations, and the T cell category is enriched
in 11 of 13 (enrichments not including MHC genes). Together, these results suggest that
disease caused by bacteria likely exerted more early evolutionary pressure on humans than
did viruses. This conclusion supports the knowledge that the major viral epidemics that have
shaped human immunity require relatively large population groups, which did not exist until
recently, after the first epidemiological transition in the Neolithic.
In terms of targets of selection, in future work it could be of interest to include negative
selection in a study like this in order to see the contrasts between which genes have been
under each type of selection. It would also be interesting to focus more on selection in
regulatory regions, since they are likely to play an important role in immune response.
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Appendix A
Full lists of genes in each class of
immune genes
A.1 Genes from the Gene Ontology Database
A.1.1 GO.Bact genes
CATSPER4, TEKT2, ISG15, HIST2H2BE, S100A9, S100A12, S100A8, S100A14,
SLAMF8, FCER1G, IL10, LYST, TNFRSF14, IL22RA1, IL23R, CD160, S100A7, IL6R,
SELP, MR1, PLA2G2A, FGR, PGLYRP3, PGLYRP4, CRP, CD1D, CHIT1, BCL10, DRC1,
FZD5, DNAH7, NLRC4, RAB1A, GNLY, SLC11A1, CCL20, REG3G, ITGAV, STAT1,
VIL1, LTF, WNT5A, DNAH1, CAMP, TLR9, STAB1, PRKCD, TMF1, MYD88, IL12A,
PLD1, CCR4, CD47, MECOM, GPX1, TLR2, TLR6, TLR1, DEFB131, RBPJ, HTN3,
HTN1, PPBP, CXCL13, ANXA3, PLAC8, TLR3, ADH7, NFKB1, IL8, CXCL2, ROPN1L,
DNAH5, CATSPER3, LEAP2, IL12B, F2RL1, ERAP1, CD14, DNAH8, HIST1H2BC,
HIST1H2BE, HIST1H2BF, HIST1H2BG, HIST1H2BI, HIST1H2BJ, HIST1H2BK, TNF,
DEFB133, DEFB114, DEFB113, DEFB110, DEFB112, LTA, HLA-DRB1, TNFAIP3, CD36,
DNAH11, NOD1, NCF1, VGF, IL6, SERPINE1, ASIC3, BAIAP2L1, WASL, DEFB1,
DEFA6, DEFA4, DEFA1, DEFA1B, DEFA3, DEFA5, DEFB4B, DEFB103B, SPAG11B,
DEFB104B, DEFB106B, DEFB105B, DEFB107B, DEFB107A, DEFB105A, DEFB106A,
DEFB104A, DEFB103A, DEFB4A, DEFB136, DEFB135, DEFB134, DEFB130, RIPK2,
IFNB1, IFNE, SYK, TLR4, TNFSF8, CARD9, LCN2, MBL2, PARG, DMBT1, MMP7,
TIRAP, DNHD1, CATSPER1, DYNC2H1, SPA17, PRG2, DEFB108B, NLRP10, NLRP6,
RELA, LRRC32, TNFRSF1A, LALBA, DCD, IFNG, LYZ, STAB2, CD4, IL23A, KLRK1,
TBK1, P2RX7, IRG1, DNAAF2, NEMF, RNASE3, RNASE7, CEBPE, CTSG, GPX2,
CATSPER2, B2M, DNAH3, CCDC135, SPN, NOD2, HP, IRF8, PYCARD, IL27, DNAH2,
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DNAH17, NLRP1, NOS2, SPACA3, CCL2, PPM1D, BAIAP2, CABYR, MALT1, CATSPERD,
ELANE, HAMP, BCL3, AZU1, MYO1F, ACP5, IL27RA, PGLYRP2, PGLYRP1, C5AR1,
IRF3, DEFB125, DEFB126, DEFB127, DEFB128, DEFB129, DEFB132, MAVS, CST11,
DEFB115, DEFB116, DEFB118, DEFB119, DEFB121, DEFB123, DEFB124, ROMO1,
BPI, WFDC12, EPPIN-WFDC6, EPPIN, LBP, HCK
A.1.2 GO.Virus genes
ISG15, IFNLR1, IFI44L, GBP3, GBP1, POLR3C, ADAR, IFI16, RNASEL, PTPRC,
TRIM11, LYST, NLRP3, USF1, TNFRSF14, SPEN, EPHA2, UBR4, EIF4G3, LCK, HDAC1,
PSMB2, KDM4A, GTF2B, VCAM1, PRMT6, RBM15, MAGI3, PSMB4, SNAPIN, CRTC2,
FDPS, CD1D, SLAMF1, F11R, PVRL4, APOA2, FCGR2B, CD247, IVNS1ABP, CD46,
TARDBP, JUN, PROX1, IL23R, AIM2, PPIE, PPIH, NR5A2, TCEB3, ARF1, ENO1,
STMN1, FGR, IFI44, LAMTOR5, XCL1, TNFSF4, XPR1, BATF3, NFIA, RPL22, RPL11,
RPS8, RPL5, RPS27, HNRNPR, RAVER2, PRPF3, RCC1, TAF12, GFI1, TAF13, PSMA5,
PSMD4, TPR, NUP133, CD55, BCL2L11, IFIH1, RSAD2, EIF2AK2, CD207, CD8A,
STAT1, XRCC5, XPO1, CENPA, VRK2, PDCL3, BUB1, BIN1, ERCC3, CCNT2, CXCR4,
ITGB6, DYNC1I2, ITGAV, HSPD1, CFLAR, CASP8, CREB1, SP110, SP100, ACKR3,
PPM1B, CD28, POLR2D, CD8B, AP1S3, ODC1, DDX1, APOB, PRKRA, RPS7, RPS27A,
RPL31, RPL37A, HNRNPLL, SNRNP200, FSIP2, PSME4, CHMP3, RANBP2, PSMD14,
NUP35, PSMD1, EIF2AK3, HYAL2, CD86, PLSCR1, ABCF3, KPNA1, SATB1, KAT2B,
DYNC1LI1, FBXL2, PDCD6IP, WDR48, CX3CR1, CCR3, CCR2, CCR5, RHOA, DAG1,
RBM15B, VPRBP, CD200R1, CD80, GTF2E1, EIF4G1, EIF4A2, CLDN1, TFRC, PAK2,
DLG1, ZNF639, POLR2H, NCBP2, AP2M1, MYD88, MST1R, HYAL3, HYAL1, DHX36,
IL12A, UBP1, CXCR6, RPL32, RPL15, RPSA, RPL14, RPL29, RPL24, RPL35A, THOC7,
NUP210, PSMD6, CHMP2B, PSMD2, CXCL9, CXCL10, HERC5, ELMOD2, DDX60,
TLR3, CTBP1, PDGFRA, KDR, ANKRD17, EIF4E, GYPA, ABCE1, FBXW7, CENPU,
SLC25A4, REST, LEF1, PPID, NELFA, POLR2B, IL15, IL8, ERVMER34-1, RPL9, RPL34,
RPS3A, HNRNPD, LARP1B, NUP54, F2RL1, POLR3G, IRF1, TMEM173, IL12B, DDX41,
XRCC4, ITGA2, IL6ST, TRIM23, PIK3R1, TNPO1, VDAC1, CAMLG, CDC25C, HAVCR1,
NPM1, GNB2L1, TNIP1, CDK7, GTF2H2, CCNH, DOCK2, CCT5, MEF2C, RPL37,
RPS23, RPS14, RPL26L1, THOC3, NUP155, TAF9, SKP1, MB21D1, HMGA1, TAP2,
TAP1, DYNLT1, NUP153, HLA-A, HLA-C, HLA-B, MICB, PSMB8, PSMB9, DAXX,
SRPK1, CUL7, LMBRD1, SYNCRIP, RNGTT, FYN, MAP3K5, ULBP3, PSMB1, TBP,
TRIM38, TNF, TAF11, GTF2H4, NELFE, TNFAIP3, HS3ST5, IFNGR1, ERVFRD-1,
DEK, RPS18, RPS10, RPL10A, RPS12, DDX39B, VTA1, NUP43, HSPA1A, HSPA1B,
IL6, CRCP, TRIM56, IRF5, ZC3HAV1, PPIA, CPSF4, RNF216, RALA, CDK13, EIF4H,
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COPS6, PILRA, PSMC2, MDFIC, CAV1, SND1, HIPK2, CLEC5A, ZYX, CUL1, SRPK2,
POLR2J, RAC1, ELMO1, AP1S1, PSMA2, HSPB1, CDK6, CHRM2, ERV3-1, ERVW-
1, NUPL2, POM121, VPS37D, TAF6, NUP205, DEFA1, DEFA1B, DEFA3, POLR3D,
BNIP3L, OPRK1, EXOSC4, DERL1, SLC20A2, ATP6V1H, LYN, TRAM1, TCEB1,
WWP1, SCRIB, TCEA1, POLR2K, USP17L2, CLU, IKBKB, RPS20, RPL7, RPL30,
RPL8, VPS37A, CHMP7, GTF2E2, CHMP4C, VPS28, SLC52A2, DDX58, IFNB1, IFNW1,
IFNA21, IFNA4, IFNA7, IFNA10, IFNA16, IFNA17, IFNA14, IFNA5, IFNA6, IFNA13,
IFNA2, IFNA8, IFNA1, IFNE, IFNK, CARD9, PSIP1, CREB3, MPDZ, RRAGA, NFX1,
HNRNPK, SYK, C9orf156, AMBP, PSMB7, RXRA, C9orf69, NCBP1, CDK9, NELFB,
CCL19, LCN2, LRSAM1, RPS6, PCSK5, RPL35, RPL12, RPL7A, CHMP5, PSMD5,
NUP188, NUP214, PRF1, DDIT4, POLR3A, IFIT2, IFIT3, IFIT1, IFIT5, GPAM, DMBT1,
BNIP3, ZMYND11, KIN, VIM, ITGB1, CUL2, SIRT1, WAPAL, IDE, BTRC, GBF1,
TAF5, PDZD8, IL2RA, IFIT1B, GATA3, CXCL12, DDX21, ACTA2, CHUK, CTBP2,
RPS24, HNRNPH3, NMT2, BAD, IFITM2, IFITM1, IFITM3, TRIM5, TRIM22, FAM111A,
RELA, UNC93B1, FADD, BANF1, IRF7, CD81, NUP98, HPX, IPO7, COPB1, TSG101,
HTATIP2, PSMC3, CCDC86, DDB1, NXF1, RTN3, KAT5, SF3B2, PACS1, ACY3, PAAF1,
MMP1, CUL5, NLRX1, PVRL1, HSPA8, POU2F3, POLR2L, GTF2H1, SSRP1, POLR2G,
RSF1, TSPAN32, AP2A2, EEF1G, CFL1, FOSL1, CREBZF, NCR3LG1, RPLP2, RPL27A,
RPS13, FAU, RPS3, RPS25, PSMD13, TAF10, PSMA1, NUP160, VPS37C, CASP12,
APOBEC1, KCNJ8, ABCC9, PCBP2, IL23A, STAT2, TBK1, IFNG, POLR3B, OAS1,
OAS3, OAS2, OASL, BICD1, CD4, RAN, TNFRSF1A, LTBR, ATF7IP, DDX11, CCNT1,
KRT7, KRT8, KRT18, SP1, ATF7, CBX5, HNRNPA1, ITGA5, NACA, MDM2, UNG,
RPLP0, DYNLL1, SCARB1, HMGA2, TARBP2, GTF2H3, IRAK3, RPS26, RPL41,
RPL6, AAAS, NUP107, NUP37, HCFC2, PSMD9, VPS37B, UBC, HSP90B1, ITGB7,
DNAJC3, LIG4, GAS6, RB1, KPNA3, IPO5, EFNB2, CUL4A, GTF2F2, DCLK1, TPT1,
RPL21, NUPL1, IRF9, DICER1, PABPN1, PSMB5, AP1G2, NFKBIA, C14orf166, PSMA3,
SNW1, RCOR1, KLC1, SIVA1, PACS2, SUPT16H, MNAT1, TRAF3, NPC2, RPS29,
HNRNPC, PSMB11, PSME1, PSME2, CHMP4A, PSMA6, PSMC6, GTF2A1, PSMC1,
PML, ISG20, SMAD3, UBE3A, NEDD4, GTF2A2, PSMA4, IL16, MFGE8, ANPEP,
CRTC3, NTRK3, SIN3A, B2M, DUOX2, CYP1A1, RPL4, RPLP1, RPS17, RPS17L, FU-
RIN, SNRPN, SNRPA1, POLR3K, POLR3E, PYCARD, ITGAX, NLRC5, UBE2I, E4F1,
ATP6V0C, KCTD5, CREBBP, UBN1, USP7, MAPK3, SRCAP, PSMB10, WWP2, VAC14,
KARS, TFAP4, TCEB2, POLR2C, IL27, SPN, AP1G1, RPS15A, CCL22, IST1, RPL3L,
RPS2, RPL13, THOC6, NUP93, PARD6A, VPS4A, PSMD7, SLFN11, DHX58, BECN1,
TRIM25, UNC13D, KPNB1, YWHAE, PSMB6, C1QBP, EIF4A1, TP53, EFNB3, SUPT6H,
RAB11FIP4, PSMB3, KRT19, KAT2A, STAT3, ITGB3, KPNA2, GRB2, ALYREF, INPP5K,
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CCL5, CCL3, CCL4, BTBD17, TOP2A, PFN1, POLR2A, SUPT4H1, AP2B1, DDX5,
SPACA3, CCL11, CCL8, IFI35, TBX21, CCL2, RPL26, RPL23A, RPL23, RPL19, RPL27,
RPL38, NUP88, UBB, PSMD11, CCL1, PSMD3, PSME3, NMT1, CALCOCO2, PSMC5,
PSMD12, NUP85, CHMP6, SLC52A1, PMAIP1, BCL2, TYMS, NEDD4L, CTDP1, SER-
PINB3, RPL17-C18orf32, RPL17, THOC1, SEH1L, RNMT, PSMA8, TAF4B, VPS4B,
TGFB1, PVRL2, TICAM1, ILF3, BST2, LSM14A, IFNL3, IFNL2, IFNL1, EXOSC5, IRF3,
ZNF175, LILRB1, CD209, CLEC4M, USF2, POLR2E, SGTA, ICAM1, CARM1, LDLR,
RAD23A, GADD45GIP1, BRD4, AP1M1, FKBP8, CRTC1, CEBPA, PVR, ERCC2, BAX,
SMARCA4, HPN, IL12RB1, GTF2F1, ELL, POLR2I, SUPT5H, CD37, AP1M2, AP2S1,
AP2A1, CCDC130, URI1, HNRNPUL1, BCL3, INSR, ZNF571, RPS15, RPL36, RPS28,
RPL18A, UBA52, RPS16, RPS19, RPL18, RPL13A, RPS11, RPS9, RPL28, RPS5, HN-
RNPL, PSMD8, PSMC4, NUP62, CHMP2A, SLC1A5, BCL2L1, MAVS, POLR3F, ITCH,
SAMHD1, CD40, RBCK1, TBC1D20, CD93, HCK, RBL1, SRC, TOP1, PLCG1, ACOT8,
VAPB, TAF4, PSMA7, UCKL1, SLPI, NELFCD, RPS21, PSMF1, CHMP4B, RAE1, CX-
ADR, IFNAR1, MX2, MX1, ADARB1, IFNAR2, IFNGR2, APOBEC3A, APOBEC3B,
APOBEC3C, APOBEC3D, APOBEC3F, APOBEC3G, APOBEC3H, POLR3H, XRCC6,
MAPK1, SMARCB1, IL2RB, RBX1, EP300, ZC3H7B, FBLN1, POLR2F, AP1B1, RPL3,
THOC5, SNRPD3, RANBP1, NUP50
A.1.3 GO.Tcell genes
TGFB2, RPL22, RORC, CD247, TNFSF4, WNT4, RC3H1, TNFRSF14, XCL1, PTPN22,
VTCN1, TNFAIP8L2, LAX1, PTPRC, GLMN, IL10, IL23R, ITPKB, LCK, BCL10, S100A7,
MR1, VCAM1, CD1D, SPTA1, ZP4, ZBTB7B, CD2, ECM1, TNFSF18, PIK3CD, DDOST,
CD48, CD1C, PSEN2, FASLG, MTOR, CDC42, LGALS8, SEMA4A, LYST, S1PR1, TN-
FRSF4, NCSTN, THEMIS2, PDE4B, ENAH, RSAD2, CD8A, POU3F3, IHH, CTLA4,
PELI1, ZC3H8, ZAP70, CD28, IGFBP2, PAX8, HSPD1, ADAM17, IL1RL2, IL36B,
GLI2, IL1B, NCK2, CD8B, DPP4, CASP8, ICOS, PDCD1, SLC11A1, BCL11A, SP3,
NHEJ1, ZFP36L2, FZD7, FZD5, BCL2L11, FKBP1B, CXCR4, RPS27A, CACNB4,
INPP5D, SATB1, EOMES, CBLB, BTLA, TIGIT, CD86, APOD, IL20RB, DLG1, CCR2,
CD80, IL12A, TGFBR2, CD47, WNT5A, SELK, NCK1, HES1, TRAT1, BCL6, CTNNB1,
PIK3CA, PAK2, PIK3CB, LEF1, IL15, CASP3, PDE5A, TXK, IL2, CXCL13, IL21,
PPP3CA, RHOH, KIT, ADD1, NFKB1, DOCK2, TCF7, IRF1, IL4, CD74, IL7R, ND-
FIP1, ITK, IL12B, AP3B1, PRELID1, IL6ST, SPINK5, CAMK4, PRLR, F2RL1, RICTOR,
PIK3R1, EGR1, XRCC4, APC, FYB, PDE4D, LCP2, BTN3A1, FYN, STX11, MICB,
BTN2A2, HLA-G, HLA-DRB1, THEMIS, CD83, MAP3K7, HLA-DMA, VNN1, HFE,
HLA-F, HLA-A, HLA-E, HLA-C, HLA-B, TAP2, TAP1, AIF1, SRF, HLA-DOA, IRF4,
A.1 Genes from the Gene Ontology Database 217
TREML2, RIPK1, HLA-DRA, HLA-DRB5, HLA-DQA1, HLA-DQA2, HLA-DQB2, HLA-
DPA1, HLA-DPB1, SOX4, RUNX2, MICA, RAET1E, BTN3A2, BTN3A3, GNL1, CCND3,
CRIP3, TAB2, SHH, GLI3, GIMAP5, IKZF1, CARD11, AZGP1, IL6, ZP3, ZNHIT1,
PIK3CG, RAC1, CAV1, GIMAP1, CDK6, IDO1, PAG1, RIPK2, IL7, KIF13B, LYN,
CHD7, PRKDC, IKBKB, ANXA1, STOML2, FUT7, TNFSF8, CCL19, CCL21, CDKN2A,
SLC46A2, IFNB1, IFNA2, NRARP, CD274, PDCD1LG2, PHPT1, SYK, TRAF2, SIT1,
MAPKAP1, IL2RA, FAS, NKX2-3, SRGN, GPAM, PRKCQ, PPP3CB, SFTPD, PAX2,
GATA3, ADAM8, ADK, ZEB1, MAP3K8, FZD8, CHST3, CXCL12, PTEN, CHUK, INS,
CD3E, CD3D, CD3G, AMICA1, NLRP10, LRRC32, FADD, RAG1, SCGB1A1, PTPRJ,
THY1, IGF2, IL18, SART1, TRAF6, BAD, CD59, CD5, PAK1, RAG2, MPZL2, CTSC,
CD151, RELA, PTPN6, IFNG, LAG3, CD27, DTX1, PAWR, IL23A, IGF1, NCKAP1L,
CD4, TESPA1, P2RX7, ABCB9, CLEC7A, KLRK1, PTPN11, WNT1, CACNB3, UBE2N,
UBC, ELF1, HSPH1, TNFSF11, TNFSF13B, FLT3, LCP1, LIG4, SIVA1, AKT1, BCL11B,
JAG2, BMP4, PNP, ZBTB1, RIPK3, PSEN1, ZFP36L1, PPP2R3C, RNF31, NFKBIA, BLM,
RAB27A, CD276, PDCD7, ADAM10, B2M, CHRNA7, NEDD4, SMAD3, CSK, CCNB2,
CTSH, ITGAL, ITGAM, ITGAD, DNAJA3, SPN, NOD2, PYCARD, CORO1A, LAT, IL27,
MLST8, PDPK1, PSMB10, BCAR1, PLCG2, NCOR1, CCR7, CCL2, ERBB2, DUSP3,
CCL5, FOXJ1, MINK1, STAT5B, STAT5A, FOXN1, CD7, CCL3, GRB2, TBX21, TP53,
JMJD6, SPNS2, UBB, SKAP1, BCL2, PTPN2, SOCS6, MALT1, YES1, PMAIP1, LILRB1,
IFNL1, JAK3, TGFB1, NFKBID, LILRB2, TNFSF9, IL12RB1, EBI3, AP3D1, LGALS16,
TNFSF14, KCNN4, PRKD2, STK11, CLC, TRPM4, CLPTM1, CD209, PVR, PVRL2,
VAV1, ICAM1, TCF3, BAX, ZBTB32, PIK3R2, UBA52, VASP, PAX1, PRNP, ITCH, ADA,
SIRPG, SIGLEC1, FKBP1A, SLA2, SRC, MAFB, RBCK1, PLCG1, UBE2V1, LIME1, CX-
ADR, UBASH3A, ICOSLG, SOD1, IFNAR1, PKNOX1, MYH9, ADORA2A, TNFRSF13C,
LGALS1, GRAP2, PATZ1, MAPK1
A.1.4 GO.Bcell genes
PIK3CD, TXLNA, CHRNB2, LAX1, CR2, BCL10, VCAM1, GON4L, NTRK1, PTPRC,
IL10, LCK, VAV3, MNDA, NOC2L, RC3H1, HES5, TNFSF4, XCL1, TNFRSF4, WNT3A,
PTPN22, ZAP70, HSPD1, CASP8, HDAC4, BCL2L11, ADAM17, MSH2, BCL11A, SP3,
ITGA4, NHEJ1, CTLA4, INPP5D, ID2, INHA, PELI1, CD86, POU1F1, BCL6, PRKCD,
KLHL6, BTLA, HES1, TGFBR2, FOXP1, GCSAM, BANK1, CXCL13, RBPJ, CASP3,
LEF1, CD38, TEC, KIT, IL2, TNIP2, IL21, GAPT, IL4, PFDN1, PIK3R1, MEF2C, IL7R,
CD180, FNIP1, CD74, IL5, IL13, XRCC4, MZB1, BAK1, TRAF3IP2, MYB, TNFAIP3,
PRDM1, CDKN1A, SOX4, HDAC9, SKAP2, LAT2, POLM, IKZF1, FZD9, GIMAP1,
SH2B2, INHBA, IL6, CARD11, AHR, TPD52, IKBKB, LYN, PRKDC, BLK, PTK2B,
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SFRP1, IL7, IFNB1, SHB, TLR4, SYK, CDKN2A, NOTCH1, LRRC8A, KLF6, DCLRE1C,
ITGB1, HHEX, BLNK, NKX2-3, FAS, PLEKHA1, PTEN, MS4A1, CXCR5, RAG1, RAG2,
CLCF1, ATM, LPXN, BAD, TIRAP, AICDA, NCKAP1L, PTPN6, PAWR, CD27, GAS6,
TNFSF13B, FLT3, GPR183, IRS2, PCID2, LIG4, ZBTB1, TSHR, PPP2R3C, HIF1A,
PRKCH, CHRNA7, ONECUT1, MEF2A, PRKCB, PLCG2, CD19, BCAR1, NOD2, IKZF3,
HDAC5, SPNS2, TNFRSF13B, TP53, CD79B, FOXJ1, AURKB, STAT5B, STAT5A, FLCN,
MALT1, PTPN2, BCL2, BST2, CD79A, BAX, TCF3, LYL1, JAK3, CEBPG, IL11, BCL3,
POU2F2, TICAM1, CD40, CHRNA4, SLA2, LIME1, NFATC2, ADA, ICOSLG, SAMSN1,
TNFRSF13C, NFAM1, MAPK1, MIF
A.1.5 GO.Innate genes
IFI16, AIM2, ISG15, PIK3CD, MASP2, MTOR, CASP9, DDOST, CDC42, C1QA,
C1QC, C1QB, RPS6KA1, FCN3, WASF2, FGR, LCK, AGO4, AGO1, AGO3, C8A,
C8B, JUN, PRKACB, BCL10, VAV3, CSF1, CAPZA1, MOV10, NRAS, SIKE1, TXNIP,
POLR3GL, POLR3C, FCGR1A, CTSS, CTSK, TNFAIP8L2, THEM4, PGLYRP3, PG-
LYRP4, S100A9, S100A12, S100A8, S100A7, ADAR, SHC1, CD1D, FCER1A, FCER1G,
FCGR2A, FCGR3A, CD247, DHX9, NCF2, ARPC5, CFH, IKBKE, MAPKAPK2, C4BPB,
C4BPA, CD55, CR2, CR1, CD46, TLR5, NLRP3, SH2D1B, PTPN22, DUSP10, NLRC4,
RSAD2, ADCY3, EIF2AK2, SOS1, PRKCE, CALM2, RPS27A, PELI1, ACTR2, PPP3R1,
ACTR3, MARCO, TANK, IFIH1, WIPF1, ATF2, PDE1A, NCKAP1, CASP10, CASP8,
CD28, CREB1, ERBB4, XRCC5, ARPC2, ATG9A, IRS1, LRRFIP1, ITPR1, ARPC4,
BRK1, IRAK2, PPARG, RAF1, MYD88, CTNNB1, CCR2, TREX1, NCKIPSD, PRKAR2A,
UBA7, MST1R, MAPKAPK3, DUSP7, TLR9, PRKCD, PROS1, TRAT1, CD80, GSK3B,
CD86, ADCY5, PIK3R4, NCK1, PIK3CB, DHX36, PIK3CA, POLR2H, MASP1, NRROS,
PAK2, LTF, PLSCR1, SPON2, FGFR3, TLR10, TLR1, TLR6, KLB, TEC, PDGFRA, KIT,
EREG, BTC, FGF5, MAPK10, HERC5, PPP3CA, NFKB1, UBE2D3, CFI, EGF, FGF2,
GAB1, TLR2, DDX60, TLR3, TMEM173, ADCY2, FAM105B, MYO10, RICTOR, C9,
C7, C6, FGF10, MAP3K1, CD180, PIK3R1, NAIP, F2RL1, MEF2C, POLR3G, CAMK4,
TICAM2, ATG12, UBE2D2, NRG2, HBEGF, CD14, FGF1, CSF1R, PDGFRB, IRGM, ITK,
CYFIP2, LCP2, FGF18, FGFR4, F12, DDX41, MAPK9, IL4, ERAP1, IRF1, MB21D1,
RIPK1, LY86, C2, CFB, C4A, C4B, AGER, ITPR3, SRPK1, MAPK14, CDKN1A, TREML1,
TREM2, TREM1, NCR2, CNPY3, PPP2R5D, POLR1C, HSP90AB1, CRISP3, AKIRIN2,
MAP3K7, ATG5, FOXO3, FYN, VNN1, MAP3K5, TNFAIP3, TAB2, RPS6KA2, CCR6,
PDGFA, PRKAR1B, GPER1, CARD11, ACTB, RAC1, TAX1BP1, WIPF3, NOD1, PDE1C,
ELMO1, ADCY1, EGFR, CRCP, LIMK1, LAT2, NCF1, CD36, ARPC1A, TRIM56, SRPK2,
PIK3CG, PRKAR2B, CAPZA2, WASL, ZC3HAV1, CLEC5A, DEFB1, DEFA6, DEFA4,
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DEFA1, DEFA1B, DEFA3, DEFA5, DEFB4B, DEFB103B, DEFB103A, DEFB4A, CTSB,
FGF20, LZTS1, FGF17, POLR3D, CLU, DUSP4, NRG1, FGFR1, IKBKB, PRKDC, LYN,
LY96, RIPK2, POLR2K, ADCY8, AGO2, PTK2, TLR4, IFNB1, IFNA21, IFNA4, IFNA7,
IFNA10, IFNA16, IFNA17, IFNA14, IFNA5, IFNA6, IFNA2, IFNA8, IFNA1, DDX58,
PRSS3, PRKACG, CTSL, SYK, TXN, TRIM32, C5, DAB2IP, MAPKAP1, LCN2, ABL1,
VAV2, FCN2, FCN1, CARD9, TRAF2, C8G, IFNK, ADAM8, PRKCQ, ABI1, MAPK8,
MBL2, UBE2D1, CDK1, PPP3CB, POLR3A, SFTPD, PTEN, IFIT5, CHUK, FGF8, NFKB2,
PPAPDC1A, FGFR2, DMBT1, DOCK1, TRIM5, HRAS, IRF7, POLR2L, CHID1, TOL-
LIP, ART1, TRIM21, NLRP10, SAA1, LGR4, CD59, TRAF6, UBE2L6, SERPING1,
DTX4, MS4A2, DAK, BAD, MAP4K2, RELA, CFL1, ADRBK1, RPS6KB2, UNC93B1,
FGF19, FGF4, FGF3, FADD, LRRC32, PAK1, GAB2, PANX1, MRE11A, BIRC3, BIRC2,
CASP1, CD3G, NLRX1, TIRAP, APOA4, TBK1, FGF23, FGF6, CD4, C1S, C1RL,
CLEC4C, CLEC4A, CLEC6A, CLEC4D, KLRG1, CLEC7A, KLRD1, KLRK1, KLRC2,
CDKN1B, KRAS, ITPR2, IRAK4, ADCY6, ATF1, NR4A1, PCBP2, PDE1B, ERBB3,
IL23A, STAT6, MDM2, FRS2, KITLG, DUSP6, UBE2N, HSP90B1, POLR3B, ARPC3,
PTPN11, P2RX7, UBC, IRAK3, TRAFD1, FGF9, POLR1D, HMGB1, KL, FOXO1, SUGT1,
IRS2, IRG1, RNASE7, ADCY4, RIPK3, PRKD1, NFKBIA, LGALS3, PELI2, ZBTB1,
FOS, CALM1, RPS6KA5, LGMN, HSP90AA1, TRAF3, AKT1, SIN3A, RASGRP1, B2M,
FGF7, MAP2K1, NRG4, PSTPIP1, MEF2A, TYRO3, PYCARD, NOD2, POLR3K, MSRB1,
TSC2, MLST8, PDPK1, MEFV, CREBBP, ADCY9, POLR3E, TNRC6A, IL27, CD19, LAT,
MAPK3, CORO1A, PYDC1, ITGAM, ADCY7, CYLD, NLRC5, NFATC3, IL34, PHLPP2,
PLCG2, CYBA, CRK, MYO1C, PLD2, C1QBP, NLRP1, CLEC10A, MYH2, MAP2K4,
UBB, MAPK7, MAP2K3, VTN, RNF135, ERBB2, WIPF2, DHX58, DUSP3, TBKBP1,
TRIM25, PRKCA, PRKAR1A, MAP2K6, CD300LB, CD300E, GRB2, TNRC6C, BAIAP2,
ACTG1, NOS2, CCL5, COLEC12, YES1, RNF125, PIK3C3, SIGLEC15, MALT1, PHLPP1,
BCL2, NFATC1, GZMM, FGF22, CFD, POLR2E, CACTIN, MAP2K2, TICAM1, C3, VAV1,
CD209, CLEC4M, MAP2K7, PIN1, PRKCSH, ECSIT, PRKACA, PGLYRP2, BST2, JAK3,
PIK3R2, UBA52, TYROBP, NFKBIB, AXL, GSK3A, PGLYRP1, CALM3, IRF3, AKT1S1,
SIGLEC14, PRKCG, LILRA5, SSC5D, NLRP4, MYO1F, MAVS, DEFB127, TRIB3,
SIRPB1, POLR3F, DEFB118, BCL2L1, HCK, BPIFB3, BPIFA1, ITCH, SAMHD1, SRC,
LBP, PLCG1, YWHAB, ELMO2, UBE2V1, NFATC2, ZBP1, APP, MX1, ITGB2, ADARB1,
S100B, MAPK1, IGLL5, MIF, APOL1, POLR2F, PLA2G6, APOBEC3A, APOBEC3B,
APOBEC3C, APOBEC3D, APOBEC3F, APOBEC3G, APOBEC3H, PDGFB, TAB1, GRAP2,
TNRC6B, EP300, POLR3H, XRCC6, MAPK11
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A.1.6 GO.Adapt genes
PIK3CD, BCL10, CTSS, TNFSF4, DUSP10, ZAP70, TXK, ITK, IL6ST, IRF1, TRIM27,
PIK3CG, RIPK2, IFNB1, CTSL, SYK, SIRT1, RAG1, JAM3, NLRP10, FADD, IRF7, IFNG,
RIPK3, NEDD4, CTSH, PYCARD, ALOX15, TNFRSF11A, TGFB1, SAMSN1
A.1.7 GO.APP genes
CTSS, CD1A, CD1E, MR1, RAB4A, PSMB2, PSMA5, FCGR1B, FCGR1A, PSMD4,
PSMB4, FCER1G, NCF2, KIF2C, KIFAP3, CTSE, ARF1, CD1D, CD1C, CD1B, CD8A,
PSME4, RPS27A, CD207, PSMD14, ITGAV, PSMD1, KIF3C, DYNC2LI1, DCTN1,
ACTR1B, DYNC1I2, AP1S3, SLC11A1, PSMD6, ITGB5, SEC61A1, PSMD2, SEC13,
KIF15, RAB7A, AP2M1, SEC31A, CENPE, SEC24B, SEC24D, AP3B1, CD74, ERAP1,
ERAP2, LNPEP, KIF2A, KIF3A, SAR1B, SEC24A, DCTN4, KIF4B, CANX, HFE, HLA-
F, HLA-G, HLA-A, HLA-E, HLA-C, HLA-B, MICA, MICB, HLA-DRA, HLA-DRB5,
HLA-DRB1, HLA-DQA1, HLA-DQB1, HLA-DQA2, HLA-DQB2, HLA-DOB, TAP2,
PSMB8, PSMB9, HLA-DMB, HLA-DMA, HLA-DOA, HLA-DPA1, HLA-DPB1, RAET1E,
RAET1G, ULBP2, ULBP1, RAET1L, ULBP3, TAP1, TAPBP, PSMB1, AZGP1, PSMA2,
SEC61G, NCF1, CD36, PSMC2, DYNC1I1, AP1S1, NOD1, DCTN6, CTSL, SEC61B,
PSMD5, PSMB7, SH3GL2, DCTN3, CLTA, CTSV, CCL19, CCL21, SEC61A2, SEC24C,
KIF11, ACTR1A, CCDC67, PSMD13, PSMA1, PSMC3, AP2A2, CTSD, KIF18A, TRAF6,
KLC2, CTSF, SPTBN2, DYNC2H1, IFNG, PSMD9, UBC, RACGAP1, DCTN2, KIF5A,
DYNLL1, TPP2, PSME1, PSMB5, PSMB11, PSME2, PSMA6, PSMC6, PSMA3, PSMC1,
SEC23A, LGMN, DYNC1H1, KLC1, KIF26A, CTSH, PDIA3, B2M, PSMA4, KIF23,
THBS1, PSMB10, PSMD7, CYBA, DCTN5, KIF22, DYNC1LI2, AP1G1, PYCARD,
NOD2, PSMB6, UBB, PSMD11, PSMB3, PSMD3, PSME3, PSMC5, PSMD12, RILP,
AP2B1, KIF2B, DYNLL2, CLTC, BLMH, NPEPPS, CCR7, PSMA8, OSBPL1A, AP3D1,
CD209, CLEC4M, RELB, FCGRT, CALR, IFI30, UBA52, PSMD8, PSMC4, AP1M2,
DNM2, AP1M1, AP2S1, AP2A1, LILRB2, ICAM1, PROCR, PSMF1, PSMA7, KIF3B,
NCF4, AP1B1
A.2 Genes from the Host-Pathogen Interaction Database
A.2.1 HP.Bact
SEPT2, SEPT7, A1CF, AAMP, AATF, ABCA2, ABCA7, ABHD3, ABHD5, ABI1, ABI3,
ACADM, ACAP1, ACBD6, ACKR3, ACLY, ACSF2, ACSL1, ACSL5, ACSM1, ACTB,
A.2 Genes from the Host-Pathogen Interaction Database 221
ADAT2, ADCK3, ADCY4, ADH1B, ADK, ADNP, ADNP2, ADPGK, AEBP1, AES, AFF1,
AGFG2, AHDC1, AHR, AIP, AKAP6, AKAP9, AKNA, ALDH2, ALDOA, ALDOB, ALG3,
ALG9, AMBP, AMPD3, AMY2B, ANK2, ANO6, ANXA1, ANXA2, ANXA5, ANXA6,
ANXA7, AP1B1, AP1G1, AP1G2, AP2A2, AP2B1, AP3B1, AP3D1, AP3M1, APBA1,
APBA2, APLP2, APOA1, APOBR, APOE, APOL3, AQP3, ARAP2, AREG, AREL1,
ARF1, ARF6, ARID2, ARL1, ARL4A, ARPC2, ARPC3, ARPC4, ARRB1, ARRB2, ARSA,
AS3MT, ASB3, ASCC2, ASCC3, ASH1L, ASH2L, ASPG, ASTE1, ASXL1, ASXL2, ATF2,
ATF6B, ATG10, ATG13, ATG2A, ATM, ATN1, ATR, ATRN, AUP1, AUTS2, AXIN1,
AZI2, BACH2, BAG1, BAG2, BAG6, BANK1, BAP1, BCL2, BCL6, BDP1, BECN1,
BFAR, BICD2, BIN2, BIRC2, BIRC6, BLK, BLVRB, BMS1, BNIP2, BOC, BRD2, BRD7,
BRD8, BRI3, BRK1, BRPF1, BRPF3, BRWD1, BSCL2, BSDC1, BST2, BTAF1, BTBD1,
BTBD2, BTBD3, BTBD9, BTF3, BUB3, BZW1, C1QA, C1QB, C1S, C4BPA, C5AR2,
CAB39, CALD1, CALR, CAMLG, CAP1, CAPS2, CAPZB, CARD8, CASP1, CASP4,
CASP8, CASP9, CAV1, CBLC, CBWD5, CBX3, CBX5, CBY1, CCAR1, CCAR2, CCDC9,
CCL14, CCL21, CCL4, CCL5, CCM2L, CCNC, CCNF, CCNH, CCNI, CCNL1, CCNT2,
CCPG1, CCR1, CCSAP, CCZ1B, CD1C, CD22, CD320, CD34, CD36, CD4, CD44, CD48,
CD59, CD5L, CD6, CD63, CD68, CD69, CD7, CD79B, CD81, CD83, CD8A, CD97,
CDC16, CDC23, CDC27, CDC37, CDC42, CDC5L, CDC73, CDIP1, CDK12, CDK14,
CDK2, CDK7, CDK9, CDKL1, CDPF1, CEBPG, CELF2, CENPH, CENPJ, CEP44, CEP57,
CEP63, CEP85, CEP89, CEPT1, CERS2, CFLAR, CHD1L, CHD4, CHD6, CHD8, CHD9,
CHP1, CHRD, CHTOP, CIAO1, CIB1, CIC, CINP, CIR1, CIRBP, CISD1, CIZ1, CKAP5,
CLCC1, CLCN3, CLIC1, CLIP1, CLIP2, CLK1, CLN5, CLOCK, CLPB, CLPX, CLU,
CMC1, CNN1, CNN3, CNOT1, CNOT2, CNOT3, CNOT8, CNPY2, CNPY3, CNR2, CNST,
CNTRL, COA6, COG2, COG3, COG4, COG5, COG8, COPA, COPB2, COPE, COPG1,
COPZ1, COX20, CPEB4, CPED1, CPNE8, CPSF2, CPSF6, CPT1A, CPVL, CR1, CR2,
CRBN, CREB1, CREG1, CRIM1, CRIPT, CRLF3, CRP, CRYAB, CSDE1, CSF1, CSF1R,
CSTF3, CTCF, CTDP1, CTGF, CTIF, CUL1, CUL2, CUL5, CUL9, CUTA, CUTC, CUX1,
CWC15, CWC22, CXCR2, CXCR4, CXCR5, CYLD, CYR61, CYTIP, CYYR1, DAAM1,
DAB2, DAD1, DAG1, DAXX, DBR1, DCAF6, DCTN2, DCTN3, DCTN5, DDAH1, DDIT4,
DDX17, DDX23, DDX24, DDX28, DDX41, DDX42, DDX46, DDX47, DDX5, DDX50,
DDX56, DDX6, DDX60, DEK, DESI1, DFFA, DGKA, DGKD, DGKZ, DHCR7, DHRS3,
DHRS7, DHX15, DHX32, DIDO1, DLG2, DLG5, DMPK, DMTF1, DNMT1, DOCK5,
DOCK8, DOK3, DPEP2, DPM1, DPP4, DPY30, DPYD, DRAM2, DRG2, DSCR4, DTNA,
DTNB, DUT, DVL2, DVL3, DXO, DYM, DYSF, E2F2, E2F4, E2F5, EAF2, EAPP, ECD,
ECE1, ECH1, ECI2, ECM1, EDC4, EDEM1, EDF1, EDRF1, EEA1, EED, EGFL7, EGFR,
EGLN1, EGR1, EHBP1, EHD3, EHD4, EHMT1, EID1, EIF1, EIF2A, EIF3A, EIF3B,
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EIF3C, EIF3D, EIF3G, EIF3M, ELF1, ELF2, ELL, ELMO1, EMC2, EMC4, EMC6, EMID1,
ENAH, ENKD1, EOMES, EP300, EPAS1, EPHB6, EPN1, EPS15, EPS8, ERAP1, ERAP2,
ERCC3, ERI3, ERP29, ERP44, ESR1, ESYT1, ETFA, ETFB, ETHE1, ETS1, ETS2, ETV6,
EVA1C, EVI2A, EVI5, EXOC1, EXOC2, EXOC3, EXOC4, EXOC7, EXT1, EXT2, FADD,
FAF1, FAIM3, FAM3C, FANCF, FARP2, FBLN1, FBLN2, FBN1, FBRS, FBXL3, FBXL4,
FBXL5, FBXL7, FCAR, FCGBP, FCHO1, FCHO2, FCRLA, FEM1B, FES, FEZ2, FFAR2,
FGF1, FGR, FHL2, FHL5, FIZ1, FKBP2, FKBP4, FKBP5, FKBP8, FLI1, FLII, FLOT2,
FMO2, FMOD, FNBP1, FNTA, FOPNL, FOS, FOSB, FOXJ2, FOXK1, FOXK2, FOXP1,
FOXP4, FPR1, FRMD3, FRY, FRYL, FSD1L, FSTL1, FUBP1, FUS, FUT8, FXR1, FXYD6,
FYB, FYCO1, FYN, G2E3, G3BP2, GALE, GAS6, GAS7, GATA2, GATA6, GATM, GBA2,
GBF1, GBGT1, GBP1, GBP2, GBP3, GCC1, GCC2, GDE1, GDPD5, GET4, GGA1,
GGA2, GGT1, GGT6, GHITM, GIPC1, GIPC2, GIT1, GIT2, GLI3, GLTP, GLYR1, GMFG,
GMPR2, GNA11, GNA12, GNAI3, GNPTG, GNS, GOLM1, GOPC, GP1BB, GPER1,
GPN1, GPS2, GPX3, GRAP, GRASP, GRB2, GRN, GSDMD, GSTA1, GSTM1, GSTP1,
GTF2I, HAT1, HAUS3, HAUS6, HAX1, HBB, HBS1L, HCAR3, HCFC2, HCLS1, HCST,
HDAC1, HDAC2, HDAC3, HDAC4, HDAC9, HEBP1, HELB, HELLS, HELQ, HELZ,
HERC1, HES1, HFE, HGS, HHEX, HHLA2, HID1, HIF1A, HINT1, HIPK2, HIPK3, HLF,
HMCN1, HMGB1, HMGB2, HMGCL, HMGN2, HMGN3, HMGN4, HMHA1, HMOX1,
HMOX2, HNF1B, HOOK2, HPS1, HRG, HSDL1, HSF1, HSF2, HSPB1, HSPB6, HSPB8,
HTRA1, HTRA2, HTRA3, HYAL2, IBTK, ICAM2, ICAM3, ID3, IDH3A, IER2, IFI27,
IFI44, IFIT3, IFT20, IFT57, IFT80, IGF1R, IGJ, IGSF6, IKZF1, IKZF3, IL16, IL1R2,
IL2RB, IL32, ILF3, ILK, IMP3, IMPA2, INADL, INF2, ING4, ING5, INSR, IPO13, IPO4,
IPO5, IPO8, IQCB1, IREB2, IRF2, IRF4, IRF8, IRF9, ISCA1, ISOC1, IST1, ITCH, ITFG2,
ITM2B, ITPA, ITPR1, ITPR2, ITPR3, ITSN1, ITSN2, IVD, IWS1, JADE1, JADE2, JAG1,
JAG2, JAK1, JMJD4, JPH4, JTB, JUN, JUNB, KANK3, KAT6B, KCNRG, KDM2A,
KDM6B, KDM7A, KEAP1, KIF17, KIF1B, KIF1C, KLC2, KLF10, KLF11, KLF15, KLF6,
KLHL2, KLHL5, KLRB1, KMT2B, KMT2C, KMT2D, KMT2E, KRCC1, KRI1, KRIT1,
KSR1, KYNU, LACE1, LAG3, LAMA5, LAMP1, LARP1, LARP7, LCK, LCMT1, LCP2,
LDB1, LDB2, LDHA, LDHB, LENG8, LHX4, LIMA1, LIMD1, LIMD2, LIME1, LIMK2,
LIPE, LIX1L, LMAN1, LMNA, LMNB1, LMNB2, LMO4, LPAR6, LPIN2, LPXN, LRBA,
LRCH1, LRCH4, LRIF1, LRIG1, LRIG2, LRMP, LRP1, LRP10, LRP4, LRP5, LRRK2,
LSM1, LTBP4, LUC7L, LUZP1, LY75, LY9, LYN, LYST, MACF1, MADD, MAF, MAGI1,
MAGI2, MAML2, MAML3, MAP4, MARK2, MARK3, MATR3, MBD5, MBNL1, MBNL2,
MCFD2, MCM9, MCRS1, MDFIC, MDM2, MDM4, MDN1, MED21, MED23, MED24,
MED28, MED4, MEF2D, MEGF8, MEIS1, MEIS2, MEOX1, MERTK, MET, MEX3C,
MFAP4, MFN1, MFSD6, MGA, MGLL, MGMT, MIA3, MIB2, MIIP, MKL1, MKNK2,
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MKRN1, MLF2, MLH1, MLXIP, MMP19, MMP2, MMP9, MMRN1, MMS19, MNDA,
MOAP1, MOB1B, MON2, MPDZ, MPEG1, MRC1, MS4A7, MSH6, MSL1, MSL2, MT1G,
MTBP, MTMR2, MTMR3, MTO1, MTOR, MTSS1, MTUS1, MUC1, MUC4, MVP, MX1,
MYCT1, MYD88, MYH10, MYH14, MYH9, MYL6, MYL9, MYLK, MYO1D, MYO1G,
MYO5A, MYO9B, MYOZ2, MYPOP, N4BP2, NAA25, NAB1, NACA, NADK, NAGA,
NAGK, NAMPT, NANP, NARF, NASP, NAT8, NBAS, NBEA, NBPF1, NBPF8, NBR1,
NCALD, NCAM1, NCBP2, NCF2, NCF4, NCK1, NCOA1, NCOA2, NCOA3, NCOA4,
NCOA5, NCOA6, NCOA7, NCOR1, NCOR2, NDE1, NDEL1, NDRG1, NDRG3, NEK7,
NELFE, NELL2, NEO1, NETO2, NEXN, NFAT5, NFE2, NFKB1, NFYC, NGRN, NID1,
NINJ1, NIPBL, NIT2, NKD2, NKTR, NLRP1, NMI, NNAT, NOA1, NOB1, NOC2L, NOD1,
NOL7, NOL8, NOS3, NOXA1, NPAT, NPC2, NPDC1, NPHP3, NQO2, NR1D1, NR1H2,
NR1H3, NR1I3, NR2C1, NRCAM, NRF1, NRG1, NRIP1, NRP1, NSA2, NSD1, NSUN2,
NUDT3, NUDT5, NUMBL, NUP62, NUP98, NUPL2, NXF1, NXNL2, OBSCN, ODF2L,
OLFM4, ORAI2, ORC3, ORC4, OS9, OSCAR, OSER1, OSMR, OSTF1, OTUB1, OTUD1,
OTUD4, P2RX4, P2RX5, PA2G4, PAF1, PAIP1, PAK1, PALLD, PALMD, PAN2, PAPD5,
PARP1, PARP4, PARVA, PATL1, PAX5, PBX2, PCBP1, PCBP2, PCBP3, PCCA, PCF11,
PCGF5, PCID2, PCM1, PCSK6, PDCD4, PDCD5, PDCD6, PDE2A, PDE4D, PDE6D,
PDE7A, PDE8A, PDGFB, PDIA3, PDIA5, PDIA6, PDK4, PDP1, PDS5B, PEAK1, PEAR1,
PEG10, PENK, PEPD, PER3, PEX14, PEX2, PEX26, PEX5, PGAM1, PGM1, PGS1,
PHC1, PHC3, PHF1, PHF11, PHF12, PHF14, PHIP, PHKG2, PHTF2, PI4KA, PIAS3,
PIBF1, PIGH, PIGQ, PILRA, PILRB, PINK1, PJA2, PKN1, PLAG1, PLCG2, PLD1, PLD3,
PLEC, PLIN2, PLIN3, PLK2, PLRG1, PLS1, PLVAP, PMP22, PNKP, PNMA1, PNRC1,
POGZ, POLH, POLK, POMP, POMT1, PPCS, PPIB, PPIG, PPM1A, PPM1G, PPRC1,
PPT1, PPWD1, PRDM1, PRDM2, PRDM4, PRDX1, PRDX3, PRDX6, PRELP, PREX1,
PRKRA, PROSC, PRR12, PRR22, PRR3, PRRC1, PSD3, PSMD1, PSMD2, PSMD3,
PSMD4, PSMD7, PSMD9, PSME1, PSME2, PTAR1, PTBP1, PTBP3, PTEN, PTGDS,
PTGR1, PTH1R, PTK7, PTN, PTPRA, PTPRB, PTPRC, PTPRH, PTPRM, PUF60, PUM1,
PUM2, PWP1, PXDC1, QKI, QPCT, RAB10, RAB18, RAB1A, RAB1B, RAB34, RAB37,
RAB5A, RAB5C, RAB6C, RAB7A, RAB8A, RABL3, RAC1, RAC2, RAD21, RAD50,
RAF1, RAI1, RAI14, RAP1B, RARB, RASA1, RBBP6, RBL2, RBM12, RBM22, RBM25,
RBM27, RBM33, RBM38, RBM39, RBM4, RBM45, RBM47, RBM6, RBP2, RBPMS,
RCN3, RDH11, RECK, RER1, RERG, REXO4, RFTN1, RFWD2, RFWD3, RFX5, RGL3,
RGP1, RGPD1, RGS19, RGS3, RHOA, RHOC, RHPN1, RIC8A, RIF1, RILP, RIN1, RIN3,
RING1, RINT1, RITA1, RND3, RNF11, RNF31, RNF4, RNF41, RNF44, RNF8, RNH1,
ROBO2, ROGDI, RPAP3, RPE, RPN1, RRAGC, RRAS, RREB1, RRS1, RSAD1, RSF1,
RTEL1, RTF1, RTKN, RTN1, RTN2, RTN3, RTN4, RTTN, RUFY2, RUFY3, RUNX3,
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RYR2, RYR3, SAAL1, SAE1, SAMD8, SAMD9, SAP18, SARNP, SART3, SATB1, SAV1,
SBDS, SBNO1, SBNO2, SCIMP, SCLT1, SCLY, SCOC, SCRIB, SCYL2, SDC1, SDC2,
SDHA, SDK2, SDPR, SEC13, SEC63, SENP1, SENP6, SEPP1, SERF2, SETD2, SF3A1,
SF3B1, SF3B2, SFI1, SFPQ, SFRP4, SGK3, SGTA, SIDT1, SIKE1, SIL1, SIX5, SKI, SKP1,
SLFN5, SLIRP, SLIT2, SLK, SLMAP, SLTM, SLU7, SMAD4, SMAP2, SMC3, SMC4,
SMC6, SMG1, SMG7, SMG9, SMOC1, SMTN, SNAI3, SND1, SNIP1, SNRK, SNX1,
SNX2, SNX25, SNX29, SNX33, SNX5, SNX6, SNX7, SNX9, SOGA1, SON, SOS1, SOS2,
SP1, SP110, SP140, SP3, SPAG5, SPAST, SPG20, SPG21, SPHAR, SPHK2, SPI1, SPIB,
SPIN1, SPOPL, SRCAP, SREK1, SRF, SRGN, SRP14, SRP19, SRP54, SRP68, SRRM2,
SRRT, SRSF1, SRSF2, SRSF3, SRSF5, SRSF6, SSBP2, SSFA2, SSUH2, ST5, STAB1,
STAG1, STAG3, STAM2, STAT1, STAT2, STAT3, STAT4, STAT6, STAU1, STAU2, STIP1,
STK11, STK16, STMN1, STON1, STRN, STT3A, STT3B, STX16, STX17, STX3, STX8,
SUGP2, SULF2, SUMF1, SUMO1, SUMO2, SUN1, SUN2, SUSD1, SUSD2, SVEP1,
SYCP2, SYNC, SYNE1, SYNJ1, SYNPO, SYPL1, SYTL1, SYTL3, SYVN1, SZRD1,
TAB1, TAB2, TACC1, TADA3, TAF11, TAF4B, TAF6, TAF7, TAF9, TANK, TAOK2,
TAOK3, TAP1, TBCB, TBK1, TBRG1, TBX2, TBX6, TCAIM, TCEA1, TCF21, TCHP,
TCL1A, TEF, TES, TET2, TET3, TEX2, TFEB, TFG, TFPT, TGFB1, TGS1, THADA,
THAP5, THAP8, THOC3, THRB, THSD1, THSD4, THTPA, TIA1, TIAM1, TINF2, TIPIN,
TIPRL, TIRAP, TJAP1, TKT, TLE1, TLE3, TLE4, TLK1, TLR2, TLR4, TLX1, TMCC1,
TMCC3, TMCO1, TMED2, TMEM2, TMF1, TMTC2, TMUB2, TMX1, TMX3, TNIP1,
TNPO1, TOX4, TPP1, TRA2A, TRAF3, TRAF5, TRAF6, TRAF7, TRAK2, TRAM1,
TRAP1, TRIM3, TRIM7, TRIM8, TRIP4, TRIP6, TRNT1, TRPC1, TRPS1, TSC1, TSC2,
TSNAX, TTC1, TTC19, TTC24, TTC3, TTC7A, TTC9C, TTLL3, TTYH3, TWF2, TXLNA,
TXNIP, TXNL1, TYW1, U2AF1, UBC, UBE2K, UBE2N, UBXN4, UCK1, UCKL1, UCP2,
UFC1, UFL1, UIMC1, ULK1, UPP1, URM1, USB1, USF1, USF2, USMG5, USO1, USPL1,
UTP20, UTP6, UXS1, VAC14, VAMP2, VAPA, VAPB, VASP, VDAC2, VEGFA, VEGFB,
VHL, VMAC, VMP1, VPS11, VPS16, VPS18, VPS25, VPS29, VPS35, VPS39, VPS52,
VPS53, VTA1, VWCE, VWF, WAC, WBP11, WDFY4, WDR1, WDR33, WDR41, WDR43,
WDR59, WDR6, WDR72, WDR88, WIPF1, WIPF2, WIPI2, WISP2, WIZ, WLS, WNK1,
WNK2, WRN, WSB1, WWC2, WWP1, WWTR1, XAF1, XPC, XPO1, XPO5, XRCC3,
XRCC5, XRCC6, XRN1, XRN2, YAF2, YIF1A, YIPF2, ZAP70, ZBED4, ZBED5, ZBTB1,
ZBTB5, ZC3H3, ZEB1, ZEB2, ZFHX3, ZFR, ZHX1, ZHX2, ZHX3, ZMIZ1, ZMYM2,
ZMYM4, ZNF24, ZNF26, ZNF3, ZNF84, ZNF91, ZNFX1, ZNRF2, ZW10, ZYX, ZZZ3
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A.2.2 HP.Virus
SEPT1, SEPT8, SEPT9, SEPT10, AAAS, AAK1, AATF, ABCA1, ABCB6, ABCD3,
ABCE1, ABCF1, ABCF2, ABHD5, ABL1, ABR, ABT1, ACACA, ACAD9, ACADM,
ACAP2, ACBD5, ACKR3, ACLY, ACOT8, ACSL1, ACSL3, ACTB, ACTN1, ACTN2,
ACTN4, ACY1, ACY3, ADAM9, ADCK2, ADCK3, ADCK4, ADCY6, ADCY9, ADNP,
ADRM1, AEBP1, AES, AFF1, AFF4, AGAP3, AGFG1, AGGF1, AGK, AGO1, AGO2,
AGR2, AHR, AHSA1, AICDA, AIDA, AIMP1, AIMP2, AIP, AKAP1, AKAP8, AKAP9,
AKIP1, AKT1, ALDH2, ALDOA, ALDOB, ALG1, ALG5, ALMS1, AMBP, AMFR,
AMPD2, AMPH, ANK2, ANK3, ANO10, ANO6, ANO8, ANXA1, ANXA2, ANXA3,
ANXA5, ANXA6, ANXA7, AP1B1, AP1G1, AP1M1, AP1M2, AP2A1, AP2A2, AP2B1,
AP2M1, AP2S1, AP3B1, AP3D1, AP3M1, AP4M1, AP5S1, APEX1, APH1A, API5, APLP2,
APMAP, APOA1, APOA2, APOA5, APOB, APOE, APOH, APOL3, ARAP1, AREG,
ARF1, ARF3, ARF4, ARF5, ARID2, ARL1, ARL16, ARL2, ARL4D, ARL8A, ARL8B,
ARMC4, ARMC5, ARMC6, ARMC8, ARMC9, ARNT, ARPC4, ARRB2, ARV1, ASAP1,
ASCC2, ASF1B, ASPH, ASPM, ASXL1, ATAD1, ATE1, ATF1, ATF2, ATF3, ATF4, ATF5,
ATF6B, ATF7, ATG12, ATG4C, ATG5, ATG9A, ATM, ATN1, ATP5E, ATP5H, ATP5I,
ATP5J, ATP5L, ATP9A, ATR, ATRIP, ATRN, AUP1, AURKA, AURKB, AXIN1, AXIN2,
AZI2, BACE2, BACH1, BAD, BAG1, BAG2, BAG3, BAG4, BAG5, BAG6, BANK1,
BANP, BAP1, BASP1, BATF3, BAX, BAZ1A, BAZ1B, BBC3, BBX, BCAM, BCAR1,
BCAT2, BCL10, BCL2, BCL6, BCR, BECN1, BEND4, BEND5, BEND7, BET1, BICC1,
BICD1, BICD2, BID, BIK, BIN1, BIN3, BIRC6, BIRC7, BLCAP, BLM, BLNK, BM-
PER, BMS1, BNIP2, BNIP3, BOLA1, BOLA2, BPHL, BPTF, BRAT1, BRCA1, BRD2,
BRD3, BRD4, BRD8, BRMS1, BROX, BSCL2, BSPRY, BST2, BTAF1, BTBD1, BTBD2,
BTF3, BUB1, BUB3, BUD13, BZW1, BZW2, C1D, C1QA, C1QBP, C2CD5, CALD1,
CALR, CALU, CAMLG, CAND1, CAND2, CANT1, CAP1, CAP2, CAPS2, CAPZB,
CARD9, CARM1, CASC3, CASC5, CASP1, CASP3, CASP4, CASP6, CASP7, CASP8,
CAV1, CAV2, CAV3, CBL, CBR1, CBS, CBWD1, CBWD6, CBX1, CBX3, CBX4, CBX5,
CBY1, CCAR2, CCDC8, CCL1, CCL17, CCL2, CCL21, CCL25, CCL26, CCL28, CCNA1,
CCNA2, CCNB1, CCNB2, CCNC, CCND1, CCND2, CCND3, CCNE1, CCNE2, CCNG1,
CCNG2, CCNH, CCNL2, CCNO, CCNT1, CCNT2, CCNY, CCPG1, CCR5, CD14, CD209,
CD248, CD320, CD4, CD44, CD47, CD59, CD5L, CD63, CD68, CD80, CD81, CD82,
CD86, CD97, CDC16, CDC20, CDC23, CDC27, CDC37, CDC42, CDC45, CDC5L, CDC6,
CDC73, CDCA2, CDCA7, CDCP1, CDIPT, CDK1, CDK13, CDK19, CDK2, CDK3,
CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, CDR2, CDR2L, CDS2, CEBPA, CEBPB,
CEBPG, CELF1, CENPA, CENPB, CENPC, CENPH, CENPJ, CENPU, CEP44, CEP55,
CEP57, CEP63, CEP68, CEP70, CEP76, CEP85, CEP89, CEPT1, CERS1, CERS2, CERS4,
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CERS6, CGNL1, CHD1, CHD3, CHD4, CHD5, CHD6, CHD8, CHERP, CHMP6, CHP1,
CHPF2, CHPT1, CHTOP, CIAO1, CIB1, CIC, CIDEB, CINP, CIR1, CIRBP, CIZ1, CKAP4,
CKAP5, CLCC1, CLCN7, CLGN, CLIC1, CLIC4, CLIP1, CLIP4, CLK1, CLK2, CLN6,
CLPB, CLPP, CLPX, CLU, CMC1, CMC2, CNBP, CNIH4, CNN1, CNN2, CNN3, CNOT1,
CNOT2, CNOT3, CNOT6, CNOT7, CNOT8, CNPY2, CNTLN, CNTRL, COA3, COA7,
COG1, COG2, COG3, COG4, COG5, COG6, COG7, COG8, COIL, COMT, COPA, COPB2,
COPE, COPG1, COPG2, COPZ1, COQ5, COX15, COX17, COX20, COX5A, COX5B,
COX6C, COX7C, COX8A, CPNE3, CPSF1, CPSF2, CPSF3, CPSF4, CPSF6, CPSF7,
CPT1A, CPT2, CPVL, CRADD, CRBN, CREB1, CREB3, CREM, CRIM1, CRIP2, CRK,
CRKL, CRTC1, CRTC2, CRTC3, CRX, CRYAB, CSDE1, CSF1R, CSK, CSN2, CSN3,
CSPG4, CSPP1, CSRP1, CSRP2, CSTF1, CSTF3, CTBP1, CTBP2, CTDP1, CTGF, CTR9,
CTRL, CUBN, CUL1, CUL2, CUL3, CUL4A, CUL5, CUL7, CUL9, CUTA, CWC15,
CXCL3, CXCR4, CXXC1, CYB5B, CYLD, CYR61, DAAM2, DAB2, DAD1, DAG1,
DAXX, DCAF6, DCAF7, DCAF8, DCD, DCP1A, DCTN1, DCTN2, DDA1, DDAH2,
DDB1, DDB2, DDIT3, DDR2, DDX1, DDX11, DDX17, DDX18, DDX20, DDX21, DDX23,
DDX24, DDX25, DDX28, DDX4, DDX42, DDX46, DDX47, DDX49, DDX5, DDX54,
DDX55, DDX56, DDX58, DDX6, DEAF1, DEDD2, DEK, DERL1, DERL2, DEXI, DFFA,
DGAT1, DHCR7, DHRS7, DHX15, DHX29, DHX30, DHX34, DHX36, DHX37, DHX58,
DHX8, DHX9, DIP2A, DIP2B, DIRC2, DKK3, DLG1, DLG4, DLG5, DLK2, DLX2,
DMAP1, DMBT1, DMRT3, DNAL1, DNM1L, DNMT1, DOCK2, DOCK3, DOCK5,
DOCK7, DOCK8, DOCK9, DOHH, DOK1, DPF1, DPM1, DPM3, DPPA2, DPY30, DRG1,
DSC3, DSCR3, DSG1, DTD1, DTX3, DTX3L, DUOX1, DUS1L, DUT, DVL1, DVL2,
DVL3, DYM, DZIP3, E2F1, E2F2, E2F3, E2F4, E2F5, E2F6, E2F7, E4F1, EAF1, ECD,
ECE1, ECI2, EDC3, EDC4, EDEM3, EDF1, EED, EFHD2, EFNB2, EFNB3, EGFL7,
EGFR, EGLN1, EGR1, EGR2, EGR3, EHD2, EHMT1, EHMT2, EI24, EID1, EIF1, EIF2A,
EIF3A, EIF3B, EIF3C, EIF3D, EIF3E, EIF3F, EIF3G, EIF3H, EIF3I, EIF3K, EIF3L, EIF3M,
ELF1, ELF2, ELF3, ELMO1, ELMO2, ELMO3, ELOF1, ELP4, EMC1, EMC10, EMC2,
EMC7, EMC9, EME1, EMP2, ENAH, ENKD1, ENPP1, ENY2, EP300, EP400, EPHA2,
EPHB2, EPHB4, EPN1, EPN2, ERBB2, ERBB3, ERCC1, ERCC2, ERCC3, ERCC6, ERG,
ERH, ERI1, ERP29, ERP44, ESRP1, ESYT1, ESYT2, ETAA1, ETFA, ETFB, ETS1, ETV4,
EVA1A, EVA1B, EVL, EXD2, EXOC1, EXOC2, EXOC4, EXOC5, EXOC6, EXOC7,
EXOC8, EXPH5, EXTL3, EZH2, FABP5, FADD, FADS1, FADS2, FAF2, FAHD1, FAM3C,
FANCA, FANCG, FANCI, FARP1, FAS, FAT1, FBF1, FBLN1, FBLN2, FBLN5, FBN1,
FBN2, FBN3, FBXL2, FBXW7, FCN1, FCN2, FES, FEZ1, FGF12, FGFR4, FGL1, FHL2,
FHL3, FIBP, FIS1, FITM2, FKBP2, FKBP4, FKBP5, FKBP6, FKBP7, FKBP8, FKBP9,
FLCN, FLII, FLNB, FLNC, FLOT1, FLOT2, FMNL1, FNBP4, FNDC1, FNIP1, FOS,
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FOSL2, FOXC1, FOXF1, FOXK1, FOXK2, FOXM1, FOXP1, FRG1, FRMD1, FRS3,
FRYL, FUBP1, FUBP3, FURIN, FUS, FUT8, FXR1, FXR2, FXYD5, FXYD6, FYB,
FYCO1, FYN, FZD2, FZD6, FZD7, G2E3, G3BP1, G3BP2, GAB1, GAK, GALE, GALK1,
GANAB, GAS6, GATA3, GATC, GATM, GBF1, GBP2, GBP6, GCC1, GCDH, GCSH,
GDAP1, GDPD1, GEM, GET4, GFAP, GFPT1, GFPT2, GGA1, GGA2, GGA3, GGT7,
GID4, GID8, GIN1, GIPC1, GKAP1, GLI2, GLI4, GLMN, GLRB, GLRX3, GLRX5,
GLTP, GLYAT, GLYR1, GMCL1, GMDS, GMEB1, GNAI2, GNAI3, GNAT3, GNAZ,
GNL3, GNPAT, GNPTG, GNS, GON4L, GOPC, GOSR1, GPAA1, GPC1, GPD1L, GPM6A,
GPN1, GPN3, GPR1, GPR27, GPR62, GPR87, GPS2, GPX1, GPX2, GPX4, GPX8, GRB2,
GREB1, GREM1, GRHPR, GRN, GRSF1, GRWD1, GSK3A, GSK3B, GSTA4, GSTK1,
GSTM1, GSTM2, GSTO1, GSTO2, GSTP1, GTF2I, GUF1, GYS1, HAT1, HAUS4, HAUS5,
HAX1, HBB, HBD, HBEGF, HCAR1, HCFC2, HCK, HDAC1, HDAC2, HDAC3, HDAC4,
HDAC5, HDAC7, HDAC9, HDDC2, HECW1, HELLS, HELQ, HELZ, HELZ2, HERC2,
HERC5, HGS, HIC2, HIF1A, HINT3, HIPK2, HIRA, HKDC1, HLTF, HM13, HMGA1,
HMGA2, HMGB1, HMGB2, HMGN2, HMGN3, HMOX2, HNF4A, HOMEZ, HOOK1,
HPS6, HRG, HSBP1, HSDL1, HSDL2, HSPB1, HSPB2, HSPB6, HSPB8, HTRA2, HYOU1,
ICAM1, ICAM2, ICAM3, ICMT, ID1, IDE, IDH3A, IDH3B, IFI27, IFIH1, IFIT1, IFNA1,
IFNG, IFRD2, IFT81, IFT88, IGJ, IGLL1, IKZF1, IKZF3, IL17B, IL18, IL1B, IL23R,
IL32, IL8, ILF2, ILF3, ILVBL, IMPA1, IMPA2, INCA1, INF2, INSR, IP6K2, IPO11,
IPO4, IPO5, IPO7, IPO8, IPO9, IPPK, IQCB1, IRAK2, IRF1, IRF3, IRF6, IRF7, IRS1,
ISCA2, ISCU, ISG15, ISLR, ISLR2, ISOC2, ISY1, ITCH, ITFG2, ITIH3, ITM2B, ITM2C,
ITPK1, ITSN1, ITSN2, IWS1, JAG1, JAG2, JAK1, JAK2, JUN, JUNB, JUND, KANK2,
KAT2A, KAT2B, KAT5, KAT7, KCMF1, KCNH3, KCNH6, KCNK3, KCNRG, KCTD1,
KCTD2, KCTD5, KCTD6, KCTD9, KDM1A, KDM3A, KDM4B, KDM4D, KDM5A,
KDSR, KEAP1, KHNYN, KIF11, KIF12, KIF14, KIF17, KIF1B, KIF1C, KIF22, KIF2C,
KIF3B, KIF3C, KIF5A, KIF6, KIF7, KIF9, KIFC3, KLC1, KLC2, KLC3, KLC4, KLF3,
KLHL7, KLHL9, KLK5, KLK6, KMT2A, KNG1, KNOP1, KNTC1, KPRP, KRCC1, KRR1,
KRT35, KRT36, KRT81, KRT83, KRT86, KTN1, LACTB, LAD1, LAMA1, LAMA2,
LAMA3, LAMA5, LAMB1, LAMB2, LAMB3, LAMC1, LAMC2, LAMC3, LAMP1,
LARP1, LARP4, LARP7, LASP1, LAYN, LBR, LCE2B, LCK, LCN1, LDB1, LDHA,
LDHB, LDLR, LEMD2, LENG1, LENG8, LEO1, LETM1, LGMN, LIFR, LIMA1, LIMD1,
LIMS2, LMAN1, LMAN2, LMBR1, LMF2, LMNA, LMNB1, LMNB2, LMO3, LMO4,
LMO7, LMOD1, LNX1, LNX2, LOXL1, LPAR1, LPP, LPXN, LRIG1, LRIG2, LRP1,
LRP10, LRP12, LRP5, LRRC7, LSM12, LSM3, LSM4, LSR, LTBP3, LTBP4, LTN1,
LTV1, LUC7L, LUZP1, LY6D, LYAR, LYN, LYNX1, LYST, LZTR1, LZTS2, MACC1,
MACF1, MAEA, MAF, MAFB, MAFG, MAG, MAGI1, MAML1, MANF, MAP1B, MAP1S,
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MAP4, MAP7, MAPK3, MARCO, MARK2, MARK3, MAST1, MAST2, MAST4, MAT2B,
MATN2, MATR3, MAVS, MAX, MBD2, MBD3, MBTD1, MCFD2, MCL1, MCM2,
MCM3, MCM4, MCM5, MCM6, MCM7, MCM8, MCPH1, MCRS1, MDC1, MDFI,
MDFIC, MDM2, MDM4, MDN1, MECR, MED1, MED11, MED13, MED15, MED16,
MED17, MED20, MED23, MED24, MED25, MED26, MED27, MED28, MED29, MED4,
MED6, MED7, MED8, MED9, MEGF6, MEGF8, MEIS2, MEN1, MEOX2, MEPCE,
MFAP1, MFN1, MFN2, MFSD1, MFSD3, MFSD5, MGAT1, MGME1, MGP, MGST1,
MGST2, MGST3, MIA3, MIB2, MIF, MINA, MISP, MITD1, MKLN1, MKNK1, MKRN1,
MKRN2, MKRN3, MKS1, MLEC, MLF1, MLF2, MLH1, MLTK, MLX, MLXIP, MMAB,
MMP1, MMP14, MMRN2, MMS19, MNDA, MOB1A, MOB1B, MOB2, MOGS, MON2,
MORN3, MOV10, MPI, MPP7, MPRIP, MPZL1, MRC2, MROH1, MROH7, MRS2, MSH2,
MSH3, MSH6, MSRB1, MSTO1, MSX2, MT1F, MTA1, MTA2, MTA3, MTAP, MTCH1,
MTCH2, MTOR, MTPN, MTUS2, MTX1, MTX2, MUC5B, MUS81, MVP, MX1, MXRA7,
MXRA8, MYB, MYC, MYCN, MYD88, MYEF2, MYH10, MYH11, MYH14, MYH2,
MYH9, MYL6, MYL6B, MYLK, MYLK2, MYNN, MYO1B, MYO1C, MYO5A, MYO5C,
MYO6, MYO9A, MYO9B, MYOF, MYOM1, MYOZ1, MYSM1, MZT2B, N4BP1, NAA16,
NACA, NAGK, NASP, NAT10, NAT14, NAV1, NBN, NBPF8, NCAN, NCBP1, NCBP2,
NCDN, NCEH1, NCK1, NCLN, NCOA1, NCOA2, NCOA3, NCOA5, NCOA7, NCOR1,
NCOR2, NDC80, NDE1, NDEL1, NDRG1, NDRG2, NDST1, NEDD4, NEDD8, NEK1,
NEK5, NEK7, NELFB, NELL1, NELL2, NEMF, NFAT5, NFE2, NFIA, NFIC, NFIL3,
NFKB1, NFKB2, NFU1, NFX1, NGLY1, NHSL1, NID1, NID2, NIN, NINJ1, NINL,
NIPBL, NISCH, NKAPL, NLRX1, NMB, NMI, NMT1, NMT2, NMU, NOA1, NOC2L,
NOC4L, NOL12, NOL7, NOL9, NOLC1, NOM1, NOMO1, NOMO2, NOMO3, NOP14,
NOP16, NOP2, NOP56, NOP58, NOP9, NOS3, NOXA1, NPC1, NPC2, NPHP1, NPHP3,
NPL, NPM3, NPS, NPTN, NQO2, NR1H4, NR2C2, NR4A1, NRF1, NSA2, NSD1, NSF,
NSUN2, NUBP2, NUCB1, NUCB2, NUDC, NUDT5, NUMA1, NUMBL, NUP50, NUP54,
NUP62, NUP85, NUP88, NUP93, NUP98, NUPL2, NUTM1, NVL, NXF1, NXT1, OAS1,
OAT, OAZ1, OAZ2, OBSCN, OLA1, OLIG3, OPA1, OPTN, ORC1, ORC2, ORC3, ORC4,
ORC5, OS9, OSBP2, OSGEP, OSMR, OSTC, OSTF1, OSTM1, OTX1, OTX2, OXA1L,
OXSM, P2RX1, P2RX5, P4HA1, P4HA2, P4HA3, P4HTM, PA2G4, PACS1, PAF1, PAIP1,
PAIP2, PAK1, PAK2, PAK4, PALLD, PALM, PALMD, PANK4, PAPD5, PARK7, PARP1,
PARP2, PARP4, PARP9, PARVG, PATZ1, PAWR, PCBP1, PCBP2, PCBP3, PCCA, PCCB,
PCDH1, PCF11, PCGF6, PCID2, PCLO, PCM1, PCNA, PCNT, PCSK5, PCSK6, PCSK9,
PDCD2, PDCD6, PDE3B, PDIA2, PDIA3, PDIA4, PDIA5, PDIA6, PDK2, PDPK1, PDPN,
PDS5A, PDS5B, PEBP1, PEF1, PEG10, PEG3, PELO, PELP1, PEPD, PEX14, PEX19,
PEX3, PEX5, PGAM1, PGAM2, PGAM5, PHAX, PHB, PHB2, PHC2, PHC3, PHF14,
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PHF5A, PHTF1, PI4KA, PI4KB, PIAS1, PIAS2, PIAS3, PIAS4, PICK1, PIGG, PIGO,
PIGQ, PIGS, PIGT, PIGU, PILRA, PIN1, PIP, PITX1, PJA2, PKD2, PKN1, PKN2, PKP4,
PLAC8, PLCB3, PLCD3, PLD3, PLEC, PLEK, PLIN3, PLK1, PLK2, PLK3, PLOD1,
PLOD2, PLOD3, PLRG1, PLS1, PLTP, PML, PMM2, PMS1, PMVK, PNKD, PNKP,
PNMA1, PNO1, PNRC1, POGZ, POMP, PON2, PON3, POP1, POP5, POP7, POTEE,
POTEF, POTEI, POTEJ, PPARA, PPARG, PPIA, PPIB, PPIC, PPIE, PPIG, PPIH, PPIL3,
PPIL4, PPM1A, PPM1B, PPM1G, PPME1, PPRC1, PPT1, PQLC3, PRC1, PRDX1, PRDX2,
PRDX3, PRDX5, PRDX6, PREB, PRKDC, PRKRA, PROM2, PRPF3, PRR15, PRR3,
PRRC1, PRTN3, PSIP1, PSMD1, PSMD2, PSMD3, PSMD4, PSMD5, PSMD6, PSMD7,
PSMD8, PSMD9, PSME1, PSME2, PSME3, PSME4, PSMF1, PSMG1, PSPC1, PTBP1,
PTBP2, PTBP3, PTCD1, PTCD3, PTGDS, PTGES, PTH2, PTK7, PTMA, PTOV1, PT-
PRF, PTPRK, PTRF, PUF60, PUM1, PUM2, PURA, PURB, PUS7, PVR, PWP1, PYGB,
PYGL, PYGM, PYGO2, QKI, QPCTL, QSOX1, QSOX2, RAB10, RAB14, RAB15, RAB18,
RAB1A, RAB1B, RAB21, RAB24, RAB25, RAB2A, RAB32, RAB34, RAB3D, RAB4A,
RAB5A, RAB5B, RAB5C, RAB6A, RAB7A, RAB8A, RABL3, RAC1, RAC2, RAD18,
RAD50, RAD51, RAF1, RAG2, RAI14, RALA, RALY, RAN, RAP1A, RARA, RARB,
RASA2, RASD1, RBAK, RBBP4, RBBP6, RBL1, RBL2, RBM14, RBM15, RBM19,
RBM22, RBM23, RBM25, RBM27, RBM39, RBM4, RBM42, RBM4B, RBM5, RBM6,
RBM8A, RBMS1, RBMS2, RBP2, RBPMS, RBX1, RCAN1, RCAN3, RCC1, RCC2,
RCN1, RCN2, RCN3, RCOR1, RDH11, RDH13, RDH14, REEP2, REEP5, REL, RELL2,
RER1, REST, REV1, REXO4, RFC1, RFC2, RFC3, RFC4, RFC5, RFT1, RFTN1, RFWD2,
RFX4, RFX6, RGL2, RGP1, RGS14, RHOA, RHOC, RHOG, RHOJ, RIBC2, RIC8A, RIF1,
RIMS1, RIMS2, RIMS3, RIN1, RING1, RINT1, RIOK1, RIPK1, RIPK3, RIPK4, RLF,
RNF10, RNF11, RNF31, RNF4, RNF41, RNF5, RNF6, RNF8, RNFT1, RNPS1, ROBO1,
ROCK1, ROCK2, ROGDI, ROMO1, RPA1, RPAP2, RPAP3, RPF2, RPN1, RPN2, RPP30,
RPP40, RRAGA, RRAS, RRAS2, RRBP1, RRP1, RRP12, RRP7A, RRP8, RRS1, RSBN1,
RSF1, RSPH3, RSRC2, RSU1, RTCB, RTF1, RTN3, RTN4, RUFY3, RUNX1, RUNX2,
RUSC2, RXRA, RXRB, RYBP, S1PR3, SAAL1, SAE1, SAFB2, SAP18, SAR1A, SARNP,
SART3, SATB1, SBSN, SCAI, SCFD1, SCLT1, SCMH1, SCN9A, SCNM1, SCO1, SCO2,
SCOC, SCRIB, SCYL2, SDC2, SDC4, SDF2, SDHA, SDHB, SDK1, SDPR, SEC13, SEC62,
SEC63, SELK, SENP1, SENP2, SENP3, SEPP1, SERF2, SERP1, SET, SETD2, SETD5,
SETX, SF3A1, SF3A2, SF3A3, SF3B1, SF3B2, SF3B3, SF3B4, SF3B5, SFI1, SFPQ,
SFRP1, SFRP4, SFXN1, SFXN3, SGCB, SGCD, SGPL1, SGTA, SGTB, SHC1, SHOC2,
SIAH1, SIAH2, SIDT2, SIK1, SIK3, SIKE1, SIL1, SIN3A, SKP1, SKP2, SLBP, SLIRP,
SLIT1, SLIT2, SLIT3, SLK, SLMAP, SLPI, SLU7, SLX4, SMAD1, SMAD2, SMAD3,
SMAD4, SMAD7, SMC2, SMC3, SMC4, SMC5, SMC6, SMCO1, SMG7, SMOC1, SMU1,
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SMUG1, SMYD3, SND1, SNF8, SNIP1, SNRPA, SNTB1, SNTB2, SNW1, SNX14, SNX17,
SNX18, SNX19, SNX27, SNX3, SNX4, SNX5, SNX7, SNX9, SOAT1, SOCS1, SOGA1,
SON, SOX4, SOX5, SP1, SP100, SP110, SPAG5, SPC24, SPCS1, SPCS2, SPCS3, SPEM1,
SPERT, SPG21, SPG7, SPI1, SPIB, SPIN1, SPNS1, SPOP, SPRR4, SPTA1, SRBD1, SRC,
SRCAP, SREK1, SRP14, SRP19, SRP54, SRP68, SRP72, SRPK1, SRPK2, SRPRB, SRR,
SRRM1, SRRM2, SRRT, SRSF1, SRSF2, SRSF3, SRSF4, SRSF5, SRSF6, SRSF7, SRSF9,
SSBP2, SSFA2, SSNA1, SSRP1, ST14, STAB1, STAM2, STAT1, STAT2, STAT3, STAU1,
STAU2, STIM1, STIP1, STK11, STK24, STK38, STMN1, STOM, STRAP, STRBP, STRN,
STRN3, STRN4, STT3A, STT3B, STX10, STX12, STX17, STX18, STX4, STX5, STX7,
STX8, STYX, SUGP2, SULF2, SUMF2, SUMO1, SUMO2, SUMO3, SUN1, SUN2, SURF4,
SURF6, SUZ12, SV2A, SVEP1, SVIL, SVIP, SYBU, SYK, SYNC, SYNE1, SYNE2, SYNM,
SYPL1, SYT11, SYT16, SYT6, SYTL1, SYVN1, TAAR1, TAB1, TAB2, TACC1, TACC3,
TADA3, TAF11, TAF12, TAF1A, TAF1B, TAF2, TAF4, TAF5L, TAF6, TAF6L, TAF7,
TAF9, TANK, TAOK1, TAOK3, TAP1, TAP2, TBCB, TBCD, TBK1, TBL2, TBL3, TBP,
TBRG4, TCF21, TCF25, TCFL5, TCHP, TCTA, TEAD1, TEAD2, TEAD4, TEC, TECR,
TEFM, TEKT4, TELO2, TERF1, TERF2, TERT, TES, TEX10, TEX2, TFAM, TFAP4,
TFB1M, TFB2M, TFCP2, TFDP1, TFDP2, TFG, TGFA, TGM1, TGM2, THADA, THAP1,
THEM6, THOC1, THOC3, THOC5, THOC6, THRB, THRSP, THY1, TIA1, TIPIN, TIRAP,
TLE2, TLN1, TLN2, TLR2, TLR4, TMA7, TMCO1, TMCO3, TMCO4, TMED1, TMED2,
TMED3, TMED4, TMED7, TMED9, TMF1, TMOD3, TMPPE, TMX1, TMX2, TMX3,
TNIP1, TNIP2, TNKS2, TNNI1, TNNI2, TNNI3, TNNT3, TNPO1, TNPO2, TNPO3, TOB1,
TOB2, TOE1, TOP1, TOP2A, TOP2B, TOR1A, TOR3A, TOR4A, TOX4, TPD52, TPM1,
TPM2, TPM3, TPM4, TPP1, TPP2, TPR, TPRA1, TPRKB, TRA2A, TRA2B, TRADD,
TRAF1, TRAF2, TRAF3, TRAF4, TRAF5, TRAF6, TRAIP, TRAM1, TRAP1, TRHDE,
TRIM5, TRIO, TRIP6, TRPA1, TRPM4, TRPM7, TRPS1, TRPT1, TRPV2, TRPV4, TR-
RAP, TRUB1, TRUB2, TSC1, TSC2, TSN, TSR1, TSSC1, TSTD2, TTC1, TTC12, TTC13,
TTC16, TTC23, TTC27, TTC38, TTC4, TTC7B, TTF1, TTI1, TTI2, TTLL7, TULP3,
TUSC1, TUSC2, TXNIP, TYK2, U2AF1, U2AF2, UACA, UAP1, UBA3, UBAC1, UBAC2,
UBAP1, UBB, UBC, UBD, UBE2C, UBE2F, UBE2K, UBE2O, UBE2S, UBE2T, UBE2W,
UBE3A, UBE3C, UBE4A, UBN1, UBN2, UBR2, UBR4, UBR5, UBXN1, UCHL5, UCK2,
UCKL1, UCP3, UFL1, UGDH, UIMC1, UNG, UPP1, USF1, USF2, USH1C, USMG5,
USO1, USPL1, UTP15, UTP6, UTS2, UVRAG, UVSSA, UXS1, VAC14, VAMP3, VAMP5,
VAPA, VAPB, VASP, VAT1, VAV2, VDAC1, VDAC2, VDAC3, VDR, VEGFB, VGF, VHL,
VMP1, VPRBP, VPS11, VPS18, VPS28, VPS29, VPS35, VPS39, VPS4A, VPS51, VPS52,
VPS53, VPS54, VPS72, VRK1, VRK2, VRK3, VTI1A, VWA8, VWA9, VWF, WASF1,
WASF3, WASL, WBP11, WDFY3, WDR11, WDR18, WDR26, WDR3, WDR33, WDR36,
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WDR5, WDR6, WDR60, WDR61, WFS1, WIPF2, WLS, WNK1, WNK2, WNT5A, WRN,
WWC2, WWOX, WWP1, WWP2, XCL1, XKR7, XPA, XPC, XPO1, XPO4, XPO5, XPO6,
XPO7, XPOT, XRCC1, XRCC4, XRCC5, XRCC6, XRN2, YAF2, YAP1, YDJC, YIF1B,
YIPF3, YIPF4, YKT6, YLPM1, YPEL5, ZAP70, ZBED4, ZBP1, ZBTB1, ZC3H8, ZDBF2,
ZER1, ZFP14, ZFP42, ZFP91, ZFPL1, ZFR, ZG16, ZG16B, ZGPAT, ZHX2, ZHX3, ZMAT2,
ZMAT3, ZMAT4, ZMIZ1, ZMYM2, ZMYM6, ZNF44, ZNF74, ZNF83, ZNF84, ZW10,
ZWINT, ZXDC, ZYX, ZZEF1, ZZZ3
A.2.3 HP.Prot
ACTB, ATG12, MBP, UBL5
A.2.4 HP.Amoe
CDC42, MBP, PASK, RAC1, RAN
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Appendix B
Full lists of genes in population and
immune gene category combinations that




Table B.1 Genes from each significantly enriched immune category and population combination from
the nSL test, part 1
B.1 Positive selection 235
Table B.2 Genes from each significantly enriched immune category and population combination from
the nSL test, part 2
236 Full list of genes in categories significantly enriched for immune genes
B.1.2 iHS enrichments
Table B.3 Genes from each significantly enriched immune category and population combination from
the iHS test, part 1
B.1 Positive selection 237
Table B.4 Genes from each significantly enriched immune category and population combination from
the iHS test, part 2
238 Full list of genes in categories significantly enriched for immune genes
Table B.5 Genes from each significantly enriched immune category and population combination from
the iHS test, part 3
B.1 Positive selection 239
B.1.3 Tajima’s D enrichments
Table B.6 Genes from each significantly enriched immune category and population combination from
the Tajima’s D test (positive selection), part 1
240 Full list of genes in categories significantly enriched for immune genes
Table B.7 Genes from each significantly enriched immune category and population combination from
the Tajima’s D test (positive selection), part 2
B.1 Positive selection 241
Table B.8 Genes from each significantly enriched immune category and population combination from
the Tajima’s D test (positive selection), part 3
242 Full list of genes in categories significantly enriched for immune genes
B.1.4 di enrichments
Table B.9 Genes from each significantly enriched immune category and population combination from
the di test
B.1 Positive selection 243
244 Full list of genes in categories significantly enriched for immune genes
B.2 Balancing selection
B.2.1 HKA enrichments
Table B.10 Genes from each significantly enriched immune category and population combination
from the HKA test
B.2 Balancing selection 245
Table B.11 Genes from each significantly enriched immune category and population combination
from the HKA test, excluding MHC genes
246 Full list of genes in categories significantly enriched for immune genes
B.2.2 b enrichments
Table B.12 Genes from each significantly enriched immune category and population combination
from the b test
B.2 Balancing selection 247
Table B.13 Genes from each significantly enriched immune category and population combination
from the b test, excluding MHC genes
248 Full list of genes in categories significantly enriched for immune genes
B.2.3 Tajima’s D enrichments
Table B.14 Genes from each significantly enriched immune category and population combination
from the Tajima’s D test (balancing selection)
Table B.15 Genes from each significantly enriched immune category and population combination
from the Tajima’s D test (balancing selection), excluding MHC genes
Appendix C
Full lists of significant SNPs from the
window-based positive selection analyses
The following tables are the full lists per population of all SNPs that were significant
after being in the top 1% of test results, at least 3 standard deviations above the neutral DIND
cutoff, and having a CADD score of greater than or equal to 15.
250 Full lists of significant SNPs from the window-based positive selection analyses
Table C.1 Part one of the full list of significant SNPs from the window-based tests in the AFR
population
251
Table C.2 Part two of the full list of significant SNPs from the window-based tests in the AFR
population
252 Full lists of significant SNPs from the window-based positive selection analyses
Table C.3 Part three of the full list of significant SNPs from the window-based tests in the AFR
population
253
Table C.4 Full list of significant SNPs from the window-based tests in the WAA population
254 Full lists of significant SNPs from the window-based positive selection analyses
Table C.5 Full list of significant SNPs from the window-based tests in the SWE population
255
Table C.6 Full list of significant SNPs from the window-based tests in the ENE population
256 Full lists of significant SNPs from the window-based positive selection analyses
Table C.7 Full list of significant SNPs from the window-based tests in the VOL population
257
Table C.8 Full list of significant SNPs from the window-based tests in the SOA population
258 Full lists of significant SNPs from the window-based positive selection analyses
Table C.9 Full list of significant SNPs from the window-based tests in the WSI population
259
Table C.10 Full list of significant SNPs from the window-based tests in the SSI population
260 Full lists of significant SNPs from the window-based positive selection analyses
Table C.11 Full list of significant SNPs from the window-based tests in the CSI population
261
Table C.12 Full list of significant SNPs from the window-based tests in the NSI population
262 Full lists of significant SNPs from the window-based positive selection analyses
Table C.13 Full list of significant SNPs from the window-based tests in the COL population
263
Table C.14 Full list of significant SNPs from the window-based tests in the SEM population
264 Full lists of significant SNPs from the window-based positive selection analyses
Table C.15 Full list of significant SNPs from the window-based tests in the SEA population
Appendix D
Graphical representations of significant
selection enrichments in each immune
gene category and selection statistic
It is interesting to consider the selection history of each population using the combination
of enrichment results for all seven selection tests used in this thesis. These results are
combined into Tables D.1 through D.13. Note that balancing selection enrichments contain
MHC genes.
West and Central Africa
Table D.1 Summary of significant results in each class of genes and selection test for the AFR
population. Squares filled in black indicate significant enrichment.
266
Graphical representations of significant selection enrichments in each immune gene category
and selection statistic
West Asia and Armenia
Table D.2 Summary of significant results in each class of genes and selection test for the WAA
population. Squares filled in black indicate significant enrichment.
Southwest Europe
Table D.3 Summary of significant results in each class of genes and selection test for the SWE
population. Squares filled in black indicate significant enrichment.
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Northeast Europe
Table D.4 Summary of significant results in each class of genes and selection test for the ENE
population. Squares filled in black indicate significant enrichment.
Volga Uralic
Table D.5 Summary of significant results in each class of genes and selection test for the VOL
population. Squares filled in black indicate significant enrichment.
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Graphical representations of significant selection enrichments in each immune gene category
and selection statistic
South Asia
Table D.6 Summary of significant results in each class of genes and selection test for the SOA
population. Squares filled in black indicate significant enrichment.
West Siberia
Table D.7 Summary of significant results in each class of genes and selection test for the WSI
population. Squares filled in black indicate significant enrichment.
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South Siberia and Mongolia
Table D.8 Summary of significant results in each class of genes and selection test for the SSI popula-
tion. Squares filled in black indicate significant enrichment.
Central Siberia
Table D.9 Summary of significant results in each class of genes and selection test for the CSI
population. Squares filled in black indicate significant enrichment.
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Graphical representations of significant selection enrichments in each immune gene category
and selection statistic
Northeast Siberia
Table D.10 Summary of significant results in each class of genes and selection test for the NSI
population. Squares filled in black indicate significant enrichment.
Colla
Table D.11 Summary of significant results in each class of genes and selection test for the COL
population. Squares filled in black indicate significant enrichment.
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Mainland Southeast Asia
Table D.12 Summary of significant results in each class of genes and selection test for the SEM
population. Squares filled in black indicate significant enrichment.
Island Southeast Asia
Table D.13 Summary of significant results in each class of genes and selection test for the SEA
population. Squares filled in black indicate significant enrichment.

